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General Introduction 
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Chronic pain and its burden 
Pain is defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage or described in terms of such damage” 1. The 
definition clearly refers to the concept of pain as a subjective experience with an 
interaction of various factors, including sensory, cognitive and behavioural 
processes. There is no consensus however when pain is to be defined as chronic, 
though. Most commonly, researchers place the threshold at three months2 as it has 
been shown that patients who still experience persisting pain after more than 
twelve weeks are significantly more at risk of chronification. Moreover, within this 
initial period, the longer the pain lasts, the more emotions and cognitions, (newly 
learned) pain behaviour and pain consequences will make recovery more 
complex3. In this thesis chronic pain is conceptualised as pain of a benign origin 
that has persisted for more than 3 months and hence excludes pain sensations that 
occur as a direct consequence of an underlying pathophysiological process. 
With prevalence in Western countries of 2 to 46%, chronic pain constitutes a major 
societal problem4,5. A recent European survey5 reported a prevalence rate for pain 
lasting in excess of 6 months of 19% of the adult population, of whom 66% 
indicated to be suffering moderate (Numeric Rating Scale: 5-7) and 34% severe 
pain (Numeric Rating Scale: 7-10) with 46% of the patients reporting constant and 
54% intermittent pain. Yet, only 2% of these patients were being seen by a pain 
specialist. Elliot et al.6 found only 17% of all chronic pain patients to have no need 
for health-care services in order to be able to cope with their pain. In the 
Netherlands, the prevalence of chronic (>3 months) musculoskeletal pain was 
estimated up to 44.4% of the population7 with 26% being reserved for chronic low 
back pain only8.  
Chronic pain has severe consequences for society and leads to high economic costs 
chiefly due to functional disability, absenteeism and job loss6,8,9,10. In the 
Netherlands, the costs associated with low back pain alone are estimated at 4 
billion euros8 with only 7% of the expenditure being related to medical 
interventions; the bulk (93%) concerns indirect costs owing to absenteeism and 
disability benefits.  
Chronic pain strongly affects a patient’s daily functioning and may lead to 
functional disability6,8,9. Functional disability is defined as limitations in daily 
activities and in the fulfilment of regular roles in daily life11 e.g. work absenteeism 
and severe limitations self-care6,9. The condition may also affect mood12. The 
prevalence of depression in chronic pain patients depends on the definition of 
depression and ranges from 30 to 54%13 and is thus even higher than in other 
chronic disease populations2,12. Depression and chronic pain are often observed as 
co-existing conditions but their interaction is not yet fully understood. Although 
depression was frequently studied preceding pain, in recent years there is a 
growing consensus that depression should be viewed as a consequence of 
persistent and inescapable pain and that patients with more severe pain are at risk 
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of developing more severe depression14.  
While biomedical factors have frequently been shown to have a limited influence on 
pain levels, functional disability and depression15, there is relatively strong evidence 
that psychological factors do affect these outcomes in chronic pain patients and are 
at least as important for the patient’s functioning as the pain itself 16. Hence, in 
explaining the level of pain intensity, functional disability and depression in chronic 
pain and in addition to biomedical factors, a great deal of attention has been paid to 
the patients’ psychological makeup17,18,19,20,21.  
Figure 1: Fear-Avoidance Model (Vlaeyen et.al 37) 
 
 
Psychological determinants of chronic pain  
In recent decades, the fear-avoidance model (see Figure 1) has been studied for the 
prediction of the level of pain intensity, functional disability and depression and 
their course in chronic pain patients22,23,24,25,26,27,28,29,30. A central construct in this 
model is fear of pain. In the model fear of pain is thought to enhance avoidance 
behaviour with the fear of pain being based on the theory of kinesiophobia22,24. The 
construct refers to specific anxiety-related cognitions about the consequences of 
pain-related behaviour. In the learning history of pain, fear of pain functions as an 
anxiety response, directed towards the immediate consequences of active 
behaviour with regard to pain intensity. In the course of the pain problem, patients 
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may be caught in a vicious circle of fear, catastrophizing, avoidance behaviour and 
functional disability. In the fear-avoidance model, pain-avoidance behaviour is 
hypothesized as a mediator between fear of pain and negative pain 
outcomes26,27,28,29,30.  
The fear-avoidance model considers catastrophizing as an aggravating factor that 
amplifies the fear of pain and the subsequent avoidant behaviour. Catastrophizing 
is based on models of anxiety disorders and in this context refers to anticipated 
negative consequences of chronic pain in the future and the perceived lack of 
ability to cope with these consequences. Catastrophizing is defined as the tendency 
to magnify or exaggerate the threat value or seriousness of the pain sensation31. 
Although catastrophizing can be seen as adaptive in the short term, i.e. as an active, 
future-oriented, problem-focused attempt to escape from pain, it becomes 
maladaptive when the pain problem cannot be solved and becomes chronic. Recent 
research suggests that catastrophizing interacts with the social context and that the 
level of catastrophizing may fluctuate proportionate to the degree of satisfaction 
with the spouse’s responses32. Its negative impact on the musculoskeletal and 
cardiovascular system may increase functional disability and undesirable physical 
consequences and result in limited functioning. There are numerous studies 
available that emphasize the major role catastrophizing plays in chronic pain20. 
Catastrophizing proved to be an important predictor of pain intensity20,31, 
functional disability31,33,34 as well as depression32,35,36.  
Besides catastrophizing, fear of pain has recently been studied as a cognitive 
predictor of pain outcomes. Fear-of-pain beliefs are proposed as maladaptive 
responses to the pain experience and are defined as patient-specific fears that 
physical activities will result in reinjury and consequent pain30,37. Several studies 
have shown fear of pain to predict pain intensity39 and functional disability27,38,40,41 
in chronic pain samples, even when biomedical variables are controlled for. 
Several studies on low back pain provide support for the importance of fear of 
pain. In their experimental studies using various physical tasks Vlaeyen et al.37,38 
and Crombez et al.27 found that fear of pain had a relatively substantial impact on 
the patients’ performance levels. In their study with back-pain patients in primary 
care Klenerman and colleagues42 found fear of pain in combination with other 
variables to predict functional disability one year after the onset of the pain 
complaints. In a study with a pain-free sample18, the participants with heightened 
levels of fear of pain ran twice the risk of developing lower back pain in the 
following twelve months than their counterparts with lower-level or absent  
Avoidance behaviour has gained broad support as an important behavioural 
predictor of both pain intensity and functional disability within the fear-avoidance 
model. The phenomenon is defined as a behavioural means of pain coping aimed at 
avoiding any exacerbation of pain and patterns include avoidance of movement, 
activity, social interactions and leisure pursuits. Avoidance behaviour (i.e. resting 
and retreating) is considered a maladaptive response to pain. Apart from avoiding 
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physical as well as social activities that are expected to aggravate their pain and 
suffering, patients are prevented from correcting their negative expectations of the 
consequences of activities through their avoidant behaviour and instead strengthen 
their maladaptive cognitions of catastrophizing and fear of pain. Several studies 
support the role of avoidance behaviour in regenerating, perpetuating or 
magnifying pain complaints, functional disability and depression in chronic pain 
patients. For example, in a cross-sectional study of 76 war veterans with chronic 
pain, Snow-Turek et al.43 found that avoidance behaviour was closely related to 
depression. Brown et al.44 demonstrated that in a prospective study evaluating 
patients suffering from rheumatoid arthritis passive cognitive and behavioural 
pain-coping strategies contributed to the level of depression after 6 months. 
Avoidance behaviour has also been shown to solely predict the pain intensity, 
functional disability and severity of depression in different chronic-pain 
populations cross-sectionally and over time45,46,47. Evers et al.34,48 found that the 
level of avoidance of activity in recently diagnosed rheumatoid arthritis patients 
predicted their levels of functional disability after one and after three years. 
The constructs of the fear-avoidance model, the mechanisms of fear of pain, 
catastrophizing and avoidance behaviour, are almost exclusively focused on the 
immediate, anticipated consequences of pain and the model’s relevance for chronic 
pain is still under discussion. Firstly, the model originally focused on patients with 
musculoskeletal pain, especially low back pain, and the literature on the model’s 
role in cohorts with other pain sites is more limited. Secondly, the fear-of-pain 
model has a value in explaining the transition of acute to chronic pain but there are 
indications that other factors may also have a contribution in the chronic phase of 
the pain problem49. As suggested by Pincus et al.50, the question could be raised 
whether a more generalized attitude of helplessness, which is related to depression, 
might be more applicable in populations with long-term, heterogeneous pain, i.e. 
an acquired helplessness resulting from a longstanding history of unsuccessful pain 
coping. Based on the learned helplessness model of depression51, helplessness 
implies a focus on generalized, long-term consequences of chronic pain in daily 
life. It refers to an adopted, attributional style with which people interpret negative 
events (e.g. chronic pain) and its consequences as uncontrollable, unpredictable 
and unchangeable and hence generalize the consequences to their daily 
functioning51,52. Helplessness is characterized by negative outcome expectancies 
and general, stable negative attributions ascribed to the condition. In pain patients, 
it may sustain or amplify avoidance behaviour and hence give rise to or perpetuate 
chronic pain, functional disability and depression.. In chronic pain patients 
helplessness may be an important consequence of their learning history. Anxiety 
and depression models hypothesize that situations from which one cannot escape, 
such as chronic pain, are perceived as a threat and will hence induce specific 
negative cognitions about pain and its negative consequences53. In the short term, 
these cognitions will mainly evoke anxiety responses (e.g. fear of pain); in the long 
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term, however, they may lead to a generalized cognition of helplessness and 
ultimately to a more passive behavioural coping and a subsequent maintenance or 
aggravation of the pain, functional disability and depression54. 
Numerous studies have demonstrated the great significance of helplessness as a 
risk factor for chronic pain: several cross-sectional studies, for example, 
demonstrated that it considerably accounted for the level of pain, functional 
disability and depression in various chronic pain samples55,56,57,58,59. Prospective 
studies on patients with rheumatoid arthritis also supplied support for a central role 
of helplessness, indicating a predictive value for the level of pain, functional 
disability and depression over time52,60,61.  
In addition to the mentioned negative cognitive and behavioural pain-coping 
factors, acceptance has recently been studied as a positive cognitive coping 
strategy in the face of chronic pain52,62. Acceptance is defined as stopping to fight 
against the pain, acknowledging that one has pain, and being able to make an effort 
to live a satisfying life despite the pain52,62. It has been shown to be predictive of 
better functioning in the longer term52,62, and various authors have advocated the 
assessment of this positive, health-promoting variable in outcome studies19,52,62. 
Vowles et al.63 further showed that increase in acceptance after CBT treatment 
predicted less pain and functional disability. Within the fear-avoidance model, as 
opposed to catastrophizing inducing fear of pain and avoidance of pain-provoking 
activities, acceptance is seen as a precondition to confront the pain, which will 
subsequently help improve functioning over time. 
Taken together, there are strong indications that passive coping strategies of 
catastrophizing, fear of pain and avoidance behaviour, derived from the fear-
avoidance model, helplessness (derived from the helplessness model), as well as 
acceptance as a possible health-promoting strategy affect pain intensity, functional 
disability and depression in various populations suffering from chronic pain. 
Consequently, in this thesis the fear-avoidance model was extended by the learned 
helplessness model and acceptance as a health-promoting cognitive behavioural 
factor as the conceptual basis for our studies of chronic pain patients.  
 
Chronic pain treatment 
There is increasing evidence that chronic pain patients tend to benefit from 
multidisciplinary treatment schemes, especially programmes combining cognitive-
behavioural (CBT) and physiotherapy modules14,64,65,66. In their comprehensive 
review, Flor et al.64 showed that multidisciplinary pain treatment was superior to 
monodisciplinary interventions on various outcome measures among which pain 
intensity, functional disability, depression and medication consumption although 
effects are commonly modest19. Moreover, treatment effects tend to remain stable 
over time64,67,68. Yet, the literature on the efficacy of multidisciplinary treatment 
still does not allow firm conclusions to be drawn as Flor et al.64 could not isolate 
specific combinations of treatment modalities with superior treatment results, 
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rendering it difficult to compare the effectivity of the different pain treatment 
studies. However, most of the multidisciplinary interventions studied effects of 
specific pain sites (low back pain64, musculoskeletal pain69 or headache70) or 
specific groups of pain patients (e.g. geriatric patients71) facilitating interpretations 
of the treatments’ comparative effectivity. To further generalize treatment effects 
in this thesis, we studied the effectivity of various pain treatments in heterogeneous 
groups of chronic pain patients using a multidisciplinary treatment allocation 
approach.  
Large differences in treatment outcomes between individual pain patients impede a 
sound evaluation of the efficacy of the treatment under study. It is therefore 
imperative that patients that may benefit most of multidisciplinary treatment 
schemes are adequately identified14. Studies into the psychological predictors of 
treatment outcome may reveal patient characteristics that are essential for a proper 
selection of patients for specific treatment modalities, thus allowing an 
optimisation of overall treatment effects. Yet, empirical studies that have examined 
the relative predictive values of fear-avoidance factors, helplessness or acceptance 
in relation to the effects of multidisciplinary pain treatment approaches are scarce. 
The few studies that were directed at identifying cognitive-behavioural predictors 
at the start of treatment either yielded nonsignificant or inconsistent results14,72,73, 
and those charting changes during multidisciplinary treatment found decreases in 
catastrophizing or helplessness to be related to decreases in pain intensity, 
functional disability, depression and medication consumption74,75,76,77.  
 
Aims, structure and outline of the thesis 
The literature on chronic pain, as summarized above, indicates that fear-avoidance 
factors (catastrophizing, fear of pain and avoidance behaviour), helplessness and 
acceptance may have a predictive value in explaining pain outcomes and 
effectivity of chronic pain treatment. Consequently, the two main objectives of this 
thesis were to study cognitive-behavioural predictors of chronic pain during natural 
course and to identify predictors of the effects of multidisciplinary chronic pain 
treatments within the conceptual context of the fear-avoidance and learned 
helplessness models. Especially the cognitive-behavioural predictors of 
multidisciplinary pain treatment (including medical, paramedical and cognitive-
behavioural modules) as delivered in the Pain Centre of the Radboud University 
Nijmegen were the subjects of study. In addition, we wished to learn more about 
referral practices for chronic pain patients in the primary-care setting in the 
Netherlands and also charted the satisfaction of the referring GPs with the 
treatments our pain clinic provided for their patients.  
In Part 1, we look for predictive factors in a heterogeneous group of chronic pain 
patients and in Part 2 for potential predictors of the effects of medical and 
paramedical chronic pain treatments and those of the effects of a multidisciplinary 
allocation of pain treatment. We based our selection of potential predictors on the 
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fear-avoidance and helplessness models as these were in our view best suited to 
provide a valid explanation for pain outcomes after chronic pain treatment. Part 3 
of the thesis charts the way local general practitioners (GPs) that referred patients 
to the Nijmegen Pain Centre judged the care the centre provided. In addition, the 
dissemination and implementation of a cognitive-behavioural treatment of chronic 
pain by primary-care psychologists is described. Finally, a summary and discussion 
of the various chapters is given.  
Part 1 concerns the potential psychological predictors of chronic pain treatment 
outcomes. In Chapter 2, we investigate in a cross-sectional study the relative 
contribution of two fear-avoidance factors, viz. fear of pain and avoidance 
behaviour, and helplessness, to the level of pain intensity, functional disability and 
depression in a group of 169 chronic pain patients referred for treatment to the 
multidisciplinary Pain Centre of the Radboud University Medical Centre, the 
Netherlands. The main research question was whether helplessness contributed to 
the prediction of subjective pain levels, functional disability and depression beyond 
the two fear-avoidance factors. Chapter 3 reports a longitudinal study into the 
relative contribution of the fear-avoidance factors, i.e. fear of pain, avoidance 
behaviour and catastrophizing, and helplessness to fluctuations in the functional 
disability after three months of a group of chronic pain patients waiting for pain 
treatment in the multidisciplinary pain centre. The central question in this study 
was whether helplessness would predict the patients’ functional disability beyond 
the three fear-avoidance factors.  
Part 2 describes the outcomes and the psychological predictors of medical, 
paramedical and cognitive-behavioural pain treatment approaches on the pain 
intensity, functional disability and depression in chronic pain patients treated at the 
Nijmegen pain centre. In Chapter 4, we explored the effects of an invasive medical 
procedure, i.e. radio frequency lesioning of the cervical spinal ganglion (RF-DRG), 
with the aim to establish whether pre-treatment cognitive coping factors of 
helplessness and catastrophizing, and physical and social dysfunctioning were 
predictive of change in the patients’ post-treatment pain intensity. In Chapter 5, we 
studied the outcome predictors of Transcutaneous Electrical Nerve Stimulation 
(TENS) in a prospective, randomised, placebo-controlled trial in which we 
compared high-frequency TENS with sham TENS. We studied the question 
whether the cognitive factors of catastrophizing, helplessness and avoidance 
behaviour could predict change in the patients’ pain intensity after a 14-day TENS 
treatment. In Chapter 6, we studied the effects of a multidisciplinary pain treatment 
allocation protocol in an heterogeneous intervention group of 110 chronic pain 
patients three months after the start of treatment, on their pain intensity, functional 
disability, depression and medication use. We compared these short-term effects 
with the outcomes of a 110-waitinglist control group. We, in addition, examined 
the predictive value of the fear-avoidance factors fear of pain, catastrophizing and 
avoidance behaviour, as well as helplessness and acceptance for the significant 
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outcomes.  
In Chapter 7, we evaluated the longer-term, i.e. 12-month effects of a 
multidisciplinary allocation of pain treatment on the pain intensity, functional 
disability, depression and medication use in a heterogeneous group of 86 chronic 
pain patients. We also looked whether the 3-month changes in the patients’ fear-
avoidance factors (catastrophizing, fear of pain and avoidance behaviour), 
helplessness and acceptance predicted the significant 12-months’ changes. 
Part 3 evaluates Dutch referral practices for patients presenting with chronic pain 
and describes the implementation of a cognitive-behavioural pain treatment 
programme delivered by primary-care psychologists as based on the expertise of 
the Nijmegen Pain Centre of the psychological factors involved in the course of 
chronic pain. In Chapter 8, we examined the expectations of GPs of their referrals 
to the multidisplinary pain centre and analysed what aspects of the pain care 
contributed to the evaluation of the GPs of the care, the multidisciplinary pain 
centre provided for their chronic pain patients. In Chapter 9, we describe our 
endeavours to implement the current knowledge of the multidisciplinary pain 
centre of the psychological aspects involved in chronic pain, pain treatment and 
cooperation between psychologists and GPs in primary and secondary care 
settings. Psychologists practising in the catchment area of the pain centre who were 
interested in psychological pain treatment were trained in diagnosing chronic pain 
and delivering a cognitive-behavioural treatment protocol.  
Lastly, the main results of the different studies are summarised in Chapter 10, the 
final chapter of the thesis, where also the theoretical and clinical implications are 
discussed.  
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 Abstract 
Objective: The goal of this study was to examine the relative contribution of 
helplessness, fear of pain and passive pain-coping to pain level, disability and 
depression in chronic pain patients attending a Multidisciplinary Pain Centre.  
Methods: One hundred and sixty-nine chronic pain patients who had entered 
treatment at the Multidisciplinary Pain Centre completed various questionnaires 
and a pain diary.  
Results: Helplessness, fear of pain and passive pain-coping strategies were all 
related to the pain level, disability and depression. When comparing the 
contribution of the predictors in multiple regression analyses, helplessness was the 
only significant predictor for pain level. Helplessness and the passive behavioural 
pain-coping strategies of resting significantly predicted functional disability. The 
passive cognitive pain-coping strategy of worrying/catastrophizing significantly 
predicted depression.  
Conclusion: These findings indicate a role for helplessness and passive pain-coping 
in chronic pain patients and suggest that both may be relevant in the treatment of 
pain level, functional disability and/or depression. 
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Introduction 
Chronic pain can have multiple consequences for patients in daily life, such as 
limiting their daily functioning and causing heightened levels of depression1,2,3,4. 
While biomedical factors have frequently been shown to have a limited influence 
on pain level, functional disability and depression2, there is relatively strong 
evidence that psychological factors can affect these outcomes over time in chronic 
pain patients.  
In recent decades, the Fear-avoidance model has been studied as an explanation for 
the level of disability and depression and their course in chronic pain 
patients5,6,7,8,9,10,11,12,13. A central concept in this model is pain-avoidance 
behaviour5,7,8,9,11,12. Avoidance behaviour includes avoidance of movement, 
activity, social interactions and leisure pursuits. Avoidance behaviour (such as 
passive behavioural coping strategies of resting and retreating) is considered a 
maladaptive response to pain. Patients avoid physical as well as social activities 
that are expected to cause an increase in pain and suffering. Moreover, avoidance 
behaviour may prevent patients from correcting their negative expectations of the 
consequences of activities and strengthen the passive cognitive coping strategy of 
worrying. Worrying is based on models of anxiety disorders and refers to a 
tendency to prioritise the processing of threatening material, interpret ambiguous 
stimuli in a threatening way14. Although worrying/catastrophizing can be supposed 
to be adaptive in the short-term, since it can be characterized as an active future 
oriented problem-focused attempt to escape from pain, it becomes maladaptive 
when the pain problem cannot be solved and becomes chronic. In the specific 
situation of chronic pain as an uncontrollable and inescapable situation, the 
construct of worrying is similar to catastrophizing as it refers to ruminating about 
chronic pain and the consequences of chronic pain in the future15,16. In time, 
avoidance behaviour and worrying/catastrophizing are assumed to lead to a 
considerable reduction in the level of physical and psychological functioning. 
Their negative impact on the musculoskeletal and cardiovascular system may 
increase functional disability and undesirable physical consequences and result in 
limited functioning. 
Several studies support the role of avoidance behaviour and worrying/ 
catastrophizing for pain, functional disability and depression in chronic pain 
patients. For example, in a cross-sectional study on 76 veterans with chronic pain, 
Snow-Turek et al.17 found that passive pain-coping, including avoidance behaviour 
and worrying/catastrophizing, were closely related to depression. In a prospective 
study, Brown et al.18 demonstrated that passive pain-coping contributed to the level 
of depression after 6 months in rheumatoid arthritis patients. Avoidance behaviour 
and worrying/catastrophizing have also been shown to solely predict the pain level, 
functional disability and distress in different chronic pain populations cross-
sectionally and over time19,20,21. Finally, Evers et al.22,23 found that the level of 
functional disability after one and three years in recently diagnosed rheumatoid 
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arthritis patients could be predicted by the use of the passive coping strategies of 
both avoidance of activity and worrying/catastrophizing. Taken together, there is 
considerable evidence that passive cognitive and behavioural pain-coping 
negatively affect pain level, functional disability and depression in various pain 
patients. In the Fear-avoidance model, fear of pain beliefs are hypothesized as a 
maladaptive response to the pain experience13, which leads to avoidance behaviour. 
Fear of pain is based on the theory of kinesiophobia6 and can be defined as 
patients’ specific fear that physical activities will result in reinjury and consequent 
pain24. So the construct refers to specific anxiety-related cognitions about the 
consequences of pain-related behaviour. In the learning history of pain the fear of 
pain by patients functions as an anxiety response, directed towards the immediate 
consequences of active behaviour with regard to pain intensity. In the course of the 
pain problem, patients may be caught in a vicious circle of fear, 
worrying/catastrophizing, avoidance behaviour and functional disability13. Several 
studies on low back pain provide support for the importance of fear of pain. 
Vlaeyen et al.24 and Crombez et al.25 found that fear of pain had a relatively 
substantial impact on the level of performing physical tasks in experimental 
studies.  
In a study with back pain patients in primary care26, fear of pain in combination 
with other variables was found to predict functional disability one year after the 
onset of pain. In another study27 with a pain-free sample, subjects with heightened 
levels of fear of pain ran twice the risk of developing low back-pain in the 
following twelve months. 
Constructs of fear of pain and worrying/catastrophizing focus relatively closely on 
the immediate, anticipated consequences of pain. The question could be raised 
whether a more generalized attitude of helplessness might be more applicable in 
populations with long term pain, due to an enduring learning history of 
unsuccessfully coping with pain. Based on the theory of learned helplessness 
model of depression28, helplessness implies a focus on generalised, long-term 
consequences of chronic pain in daily life. Helplessness refers to an attributional 
style, explaining negative events such as chronic pain and its consequences as 
uncontrollable, unpredictable and unchangeable and generalizing these 
consequences to daily functioning22,28. Helplessness is characterized by negative 
outcome expectancies and general, stable negative attributions ascribed to the 
condition. In pain patients, it may further contribute to avoidance behaviour and 
hence may result in chronic pain, functional disability and depression. A 
considerable number of studies have demonstrated the major role of helplessness 
as a risk factor for pain, functional disability and depression in chronic pain 
patients. For example, several cross-sectional studies demonstrated that 
helplessness accounted considerably for the level of pain, functional disability and 
depression in various chronic pain samples29,30,31. Prospective studies on patients 
with rheumatoid arthritis supply further support the central role of helplessness, 
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indicating a predictive value for the level of pain, functional disability and 
depression over time32,33,34.  
The extent to which helplessness is useful in explaining pain, functional disability 
and depression beyond fear of pain and passive coping in chronic pain is a question 
that may be raised. Helplessness may be an important consequence of the learning 
history in chronic pain patients, particularly in patients with longstanding pain. 
Anxiety and depression models hypothesize that situations from which one cannot 
escape, such as chronic pain, are perceived as a threat and will induce specific 
negative cognitions on pain and their negative consequences35. These cognitions 
will in the short term induce anxiety reactions but may result in a generalized 
cognition of helplessness and ultimately lead to more depression, functional 
disability and pain36. To our knowledge, there is no available study that has 
examined the relative contribution of helplessness, fear of pain and passive pain-
coping for the prediction of the pain level, functional disability and depression in 
chronic pain patients. The goal of the present cross-sectional study was to clarify 
the relative contribution of helplessness, fear of pain and passive pain-coping to the 
level of pain, functional disability and depression in chronic pain patients entering 
for treatment at a multidisciplinary pain centre. 
 
 
Patients and Methods 
Patients 
Study participants were recruited from patients who were accepted for treatment at 
the Multidisciplinary Pain Treatment Centre of the Radboud University Medical 
Centre in Nijmegen, the Netherlands. In order to qualify for inclusion in the study, 
patients had to be at least 18 years old and their pain problem had to be present for 
more than 3 months. The sample consisted of patients with unexplained pain for 
whom no biomedical cause could be identified. Exclusion criteria were cancer-pain 
or other biomedical causes, serious psychiatric disorders that could interfere with 
treatment and/or the inability to read or write Dutch. All patients who were 
accepted for treatment and meeting the criteria from November 1999 to January 
2001 were asked to participate. From the total sample of 192 patients, 169 patients 
(88%) agreed to participate in the study.  
The average age of the participants was 47.1 years (SD 13.9, range 18-86). Most of 
the patients were women (63.9%) and married or living with a partner (79.1%). 
Twelve percent had completed a primary education, and 71% had finished 
secondary education (7 and 12 years mean duration of formal education, 
respectively). Patients reported pain at the following pain locations: back: 60 
(35.5%), legs: 45 (26.6%), neck and shoulders: 39 (23.1%), arms: 15 (8.9%), head 
and face: 9 (5.3%), belly: 7 (4.1%), breast: 7 (4.1%), pelvis: 5 (3.0%). In total 18 
patients (10.7%) reported pain at 2 sites. Mean pain duration was 59.9 months (SD 
70.1) with a range of 3-420 months. 
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Study design 
After acceptance for treatment at the Multidisciplinary Pain Treatment Centre, 
patients were sent a booklet of questionnaires and a pain diary. Patients were asked 
to complete the questionnaires and diary for 7 days and send them back to the 
hospital.  
 
Measures 
Pain Intensity 
Study participants were asked to rate their pain on a 10-centimeter Visual 
Analogue Scale for 7 days at 3 points in time each day. The Pain VAS scale ranged 
from no pain at all to the worst pain ever experienced. Twenty-one pain ratings 
were recorded for every patient and the average pain level was calculated on the 
basis of these ratings. Multiple VAS ratings have been shown to be more reliable 
and valid for measuring average pain intensity than a single rating37. Cronbach’s 
Alpha in our study was 0.96. 
Functional disability 
Functional disability was measured with the Dutch version of the Pain Disability 
Index (PDI)38,39,40. The PDI was developed as a brief, self-report indicator of pain-
related disability38. It was constructed as a 7-item questionnaire, which is scored on 
a scale of 0 (no disability) to 10 (total disability). The items ask for the level of 
limitations in the total range of role functioning: family/home responsibilities, 
recreation, social activities, occupation, sexual behaviour, self-care and life-
supporting activities. Reliability and validity were judged as satisfactory39,40. The 
average level of the items scored was used to calculate the disability index. 
Cronbach’s Alpha in our study was 0.86.  
Depression 
Depression was measured with the depression scale of the Dutch version of the 
Symptom Checklist-90 (SCL-90)41,42, measuring 16 symptoms of depression, 
which are rated on a 5-point scale (1: not at all to 5: very much). Representative 
items are: “feeling worthless” and “feeling desperate about the future”. The 
reliability and validity were judged as satisfactory41,42. Cronbach’s Alpha in our 
study was 0.92. 
Fear of pain 
Fear of pain was measured with the Dutch version of the Tampa Scale of 
Kinesiophobia (TSK)24,43, measuring fear of increasing pain and injury by physical 
activity. The questionnaire consists of 17 items, which are scored on a 4-point 
scale (1: highly disagree to 4: totally agree). Representative items are: “For 
someone in my condition, it is advisable not to be physically active”, “My pain 
means there is physical damage”. The level of pain-related fear is calculated on the 
basis of the total score. The TSK proves to be a valid instrument for measuring 
pain-related fear24,43,44. Cronbach’s Alpha in our study was 0.85. 
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Passive pain-coping 
Passive pain-coping was measured with the Pain Coping Inventory (PCI)22,45,46, 
which measures 3 passive cognitive and behavioural coping strategies when 
dealing with pain. Both reliability and validity are judged as satisfactory 22,45,46. 
The PCI is rated on a 4-point Likert scale (1: rarely or never to 4: very frequently). 
Cognitive passive coping was assessed on the basis of worrying/catastrophizing (9 
items). Representative items are: “I start worrying when in pain” and “I think that 
the pain will worsen.” For worrying/catastrophizing, Cronbach’s Alpha in our 
study was 0.76. Behavioural passive coping was assessed with two scales, 
retreating and resting (7 and 5 items, respectively). Representative items for 
retreating are: “When I am outdoors, I try to return home as soon as possible” and 
“I retreat to a restful environment.”. For retreating, Cronbach’s Alpha in our study 
was 0.74. Representative items for resting are: “I quit my activities” and “I rest by 
sitting or lying down.”. For resting, Cronbach’s Alpha in our study was 0.81.  
Helplessness 
Helplessness was measured with the Helplessness scale of the Illness Cognition 
Questionnaire (ICQ), measuring different cognitions about the way patients think 
about and give meaning to their chronic illness34. In order to make a comparison 
possible with other pain-related predictors of passive pain-coping and fear of pain, 
the term “illness” in the ICQ was replaced by “pain”. The Helplessness-items of 
the ICQ are: 1: my pain frequently makes me feel helpless. 2: my pain limits me in 
everything that is important to me. 3: my pain controls my life. 4: because of my 
pain, I miss the things I like to do most. 5: my pain prevents me from doing what I 
would really like to do. 6: my pain makes me feel useless at times. The items are 
rated on a 4-point scale (1: not at all to 4: completely). The reliability and validity 
of the ICQ were found to be highly satisfactory34. Cronbach’s Alpha in our study 
was 0.84. 
 
Statistical analysis. 
Pearson correlation coefficients were calculated to explore the interrelations 
between helplessness, fear of pain and passive pain-coping strategies and the 
outcome measures of pain, functional disability and depression. Sequential 
regression analyses were then performed with pain level, functional disability and 
depression as dependent variables. 
The following independent variables were entered in the sequential regression 
analysis: helplessness, fear of pain and passive pain-coping were entered in 
consecutive steps after controlling for demographic variables, physical and 
psychological functioning (functional disability and depression for pain, pain and 
depression for functional disability, pain and functional disability for depression). 
The entry order of helplessness, fear of pain and passive pain-coping strategies was 
also changed to study the single contribution of the predictors after controlling for 
baseline levels of pain, functional disability and depression.  
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Results 
In Table 1 the means and standard deviations of all variables for all subgroups 
(back pain, leg pain, neck/shoulder pain other pain locations and more than one 
pain location) are presented. Since there were no significant differences between 
any of these subgroups on any of the measures, analyses were done for the whole 
sample. When studying relationships between predictors (see Table 2), the 
constructs of helplessness, fear of pain and passive pain-coping strategies were 
found to be moderately associated (between .24 and .50). In relation to the outcome 
measures (see also Table 2), helplessness, fear of pain and passive pain-coping 
strategies of worrying/catastrophizing, retreating and resting were significantly 
positively correlated with pain level (between r=.17 and .38), functional disability 
(between r=.34 and .62) and depression (between r=.17 and .56). 
 
Table 1: Means and standard deviations for the total sample and the subgroups of back 
pain, neck/shoulder pain, leg pain, other pain locations and more than one pain location of 
all measures. 
 
 
All outcome variables were significantly correlated, except pain and depression. 
Finally, demographic variables and pain duration were overall not significantly 
related to the outcome measures. Only male sex (r=-.17, p<.05), age (r=-.15, 
p<.05) and education level (r=-.16, p<.05) were marginally negatively related to 
depression.  
The relative contributions of fear of pain, helplessness and passive coping to the 
pain level, disability and depression were subsequently analysed with sequential 
regression analyses. 
 Total 
Sample 
 
Back Pain Leg Pain Neck/ 
Shoulder 
Pain 
Other 
Pain 
locations 
More than 
one Pain 
location 
 n=169 n=48 n=41 n=26 n=36 n=18 
 M sd M sd M sd M sd M sd M sd 
Pain  54.3 19.9 56.6 16.2 56.9 18.7 57.0 20.4 51.0 15.6 51.6 17.1 
Disability 4.2 1.9 4.8 1.8 4.3 2.0 5.4 1.9 4.3 1.5 4.7 1.8 
Depression 24.4 6.9 27.4 11.7 24.6 14.7 32.6 7.5 27.0 8.9 26.1 7.9 
Helplessness 14.6 4.7 15.6 4.2 14.1 4.0 16.2 5.1 14.5 3.7 16.3 3.7 
Fear of pain 39.3 7.7 38.7 9.0 39.3 9.9 39.7 7.8 38.0 8.0 36,6 7.7 
Pass. pain-coping         
- worrying/  
  catastrophizing 
 
2.0 
 
0.5 2.2
 
0.5 2.0
 
0.5 2.2
 
0.5 2.2
 
0.5 
 
2.1 
 
0.5 
- retreating 1.5 0.5 1.5 0.4 1.5 0.5 1.8 0.5 1.6 0.5 1.5 0.4 
- resting 2.5 0.6 2.6 0.6 2.5 0.8 2.7 0.6 2.6 0.7 2.6 0.6 
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Table 2: Correlates of pain, disability, depression, helplessness, fear of pain and passive 
pain-coping. 
* p < .05, **p < .01 
 
First, the contributions of demographic variables (gender, age, education) and pain 
duration were analysed by entering them as independent variables. Results 
indicated that these variables did not explain any significant variance. 
Consequently, demographic variables and pain duration were no longer entered in 
the regression analysis. The regression analyses for the different outcome measures 
of pain, functional disability and depression were conducted with helplessness, fear 
of pain and passive pain-coping as independent variables, after controlling for 
baseline levels of pain, functional disability and depression in all analyses (see 
Table 3). 
 
Pain level. After controlling for the level of functional disability and depression, 
helplessness at step 3 added 6% of the variance (F-change=9.88, p<.01). Fear of 
pain and passive coping strategies did not significantly add further variance. The 
results did not change when entering fear of pain or passive pain-coping at step 3, 
fear of pain and passive pain-coping still did not significantly contribute any 
variance. Beta coefficients for the whole model demonstrated that only 
helplessness significantly contributed to pain level (t=2.63, p<.01).  
Disability. After controlling for pain level and depression at step 1 and 2, 
helplessness at step 3 explained an additional 8% of the variance (F-change=44.47, 
p<.001). Fear of pain did not significantly explain additional variance for disability 
at step 4. The results did not change when entering fear of pain at step 3. Passive 
pain-coping explained another 6% at step 5 (F-change=4.92, p<.01). When 
entering passive pain-coping at step 3, it significantly predicted 8% of the variance 
(F-change=18.14, p<.001). However, helplessness still explained 6% at step 4 (F-
change=14.22, p<.001). Beta coefficients for the whole model showed that 
helplessness (t=3.77, p<.001) and the passive pain-coping strategy of resting 
(t=3.77, p<.001) significantly predicted functional disability. 
 Pain Disability Depression Helpless 
ness 
Fear of 
pain 
Worrying Retreating 
Disability .36**       
Depression .11 .40**      
Helplessness  .38** .62** .40**     
Fear of pain .24** .37** .24** .50**    
Pass. pain-coping        
- worrying/ 
  catastrophizing 
 
.17* 
 
.34** 
 
.56** 
 
.45** 
 
.43** 
  
- retreating  .20* .41** .43** .38** .36** .49**  
- resting  .21* .47** .17* .48** .37** .24** .26** 
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Table 3: Hierarchical regression analyses of pain, disability and depression 
Order of entry R2 
Change 
Beta Order of entry R2 
Change 
Beta Order of entry R2 
Change 
Beta 
Dep. variable: 
Pain  level 
  Dep. variable: 
Disability 
  Dep. variable: 
Depression 
  
         
1. Disability .12*** .18 1. Pain level .12*** .14 1. Pain level .01 -.07 
2. Depression  .00 .16 2. Depression .10*** .24** 2. Disability .10*** .18* 
3. Helplessness .06** .27** 3. Helplessness .08*** .22** 3. Helplessness .06** .07 
4. Fear of pain .00 .00 4. Fear of pain .00 .04 4. Fear of pain .01 -.01 
5. Pass. pain-coping .00  5. Pass. pain-coping .06**  5. Pass. pain-coping .28***  
- worrying/ 
  catastrophizing 
 -.03 -  worrying  .04 -  worrying  .55*** 
- retreating  .05 -  retreating  .04  -  retreating  .11 
- resting  -.00 -  resting  .27*** -  resting  -.11 
Total R2 .18   .36   .46  
* p < .05, **p < .01, ***p< .001  
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Depression. After controlling for pain and functional disability at step 1 and 2, 
helplessness at step 3 explained an additional 6% of the variance in depression (F-
change=9.72, p<.01). Fear of pain did not significantly explain additional variance 
for depression at step 4. In addition, when fear of pain was entered at step 3 no 
significant result was obtained. Passive pain-coping in step 5 explained an 
additional 28% of the variance (F-change=25.14, p<.001). When helplessness was 
entered at step 4, and passive pain-coping at step 3, passive pain-coping explained 
33% of the variance (F-change=30.06, p<.001). However, helplessness still 
significantly explained 3% of the variance (F-change=4.45, p<.01). Beta 
coefficients for the whole model indicated that only the cognitive coping strategy 
of worrying/catastrophizing significantly explained depression (t=7.29, p<.001).  
 
 
 
Discussion 
The purpose of the study was to examine the role of helplessness, fear of pain and 
passive pain-coping in pain level, functional disability and depression in chronic 
pain patients.  
Firstly, the study showed that in a heterogeneous chronic pain population 
helplessness and passive pain-coping strategies have a greater contributing value 
than fear of pain. Secondly, it showed that pain level, functional disability and 
depression are explained by different predictors. Pain level is best predicted by 
helplessness, functional disability is best predicted by helplessness and the passive 
behavioural coping strategy of resting, and depression is best predicted by the 
passive cognitive coping strategy of worrying/catastrophizing. 
Helplessness appeared to be the strongest contributor to functional disability and 
pain level, independent of fear of pain and passive pain-coping. The central role of 
helplessness is in line with findings from other studies29,30,31,32,33,34. Independent of 
helplessness, the passive behavioural pain coping strategy of resting additionally 
explained functional disability. This corresponds with findings from previous 
studies showing a relationship between passive pain coping and functional 
disability22,47,48,49, underscoring the hypothesis that avoidance behaviour is an 
important predictor for functional disability. Finally, the passive cognitive pain 
coping strategy of worrying/catastrophizing largely explained levels of depression, 
in addition to helplessness. This matches findings from other studies50 that 
worrying/catastrophizing has additional value in explaining depression beyond 
other predictors. This finding is also consistent with the great amount of studies, 
which emphasize the close relation between worrying/catastrophizing and 
depression in chronic pain patients2,19,21,51,52,53. Together, these findings indicate 
that helplessness is an important factor for explaining pain level and functional 
disability. Passive behavioural coping is an additional factor for explaining 
functional disability, while the passive cognitive coping of worrying/ 
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catastrophizing is important for explaining depression. Fear of pain had no value 
for explaining any of the outcome variables in addition to helplessness and passive 
pain coping. This finding seems to be inconsistent with other studies, which 
indicate that fear of pain contributes to the prediction of functional disability. A 
possible explanation for this finding could be that the construct of fear of pain 
might only apply to musculoskeletal pain9,11. In order to test this hypothesis, post 
hoc analysis was performed to analyse the TSK scores for different subgroups 
(back pain, neck/shoulder pain, leg pain and other pain locations). For the purpose 
of this analysis, patients with more than one pain location were excluded. An 
independent samples T-test revealed no significant differences between the 
different subgroups in the level of TSK, indicating that fear of pain is similar 
common in pain patients with different pain locations. Since fear of pain is 
supposed to be particularly relevant in back pain, post hoc analyses of the 
regression analyses were additionally performed with back pain patients only 
(n=60). Results showed that the beta coefficients of fear of pain for pain level, 
functional disability and depression were also nonsignificant in this sub sample. 
Instead, the same contributors were found as in the main sample, i.e. helplessness 
had a unique and significant predictive value for pain level and functional 
disability. In addition, resting contributed most to the level of functional disability 
and worrying/catastrophizing had the greatest value for explaining depression. 
Overall, these results suggest that the main contributing factors to pain level, 
functional disability and depression in chronic pain patients are their view of the 
uncontrollability and negative outcome expectation of their condition 
(helplessness) together with passive pain coping (avoidance of activity and 
worrying/catastrophizing), and not their fear of increasing pain and injury by 
physical activities (fear of pain). However, prospective and experimental studies 
are needed to further clarify the role of helplessness, fear of pain and passive pain-
coping, as well as the role of other possible relevant fears (e.g. fear of functional 
disability or fear of disease progression) in various populations of patients with 
chronic pain. 
A number of limitations of our study should be acknowledged. This is a cross-
sectional study and therefore conclusions about causal relationships cannot be 
drawn. Secondly, the sample of pain patients is heterogeneous. Patients with 
heterogeneous pain sites may have different limitations in daily life, treatments and 
relevant fears. In addition, all patients were included in a specialized University 
Pain Clinic. In the Netherlands, chronic pain patients first start treatment in the 
pain ward of a general hospital. Patients may only be referred to a University Pain 
Centre when their pain problem has not been solved to a satisfying extent. 
Accordingly, the sample of pain patients in our study might only be representative 
for patients with complex pain problems who seek treatment in a specialized pain 
centre. Finally, the study is based on self-report measures. This means that all 
variables were subjectively measured by questionnaires and this may have 
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implications for the internal validity of the study as there may be an overlap in the 
constructs, measured in the study. 
 
When the relationships found in our study will be supported by future prospective 
and experimental research, specific recommendations for treatment modules may 
be drawn. Our findings suggest that helplessness and passive pain-coping are 
important factors in patients with chronic pain, and it may be relevant to examine 
the presence of helplessness and passive pain-coping in chronic pain patients in the 
diagnostic phase of pain treatment and to integrate the treatment of these process 
variables in outcome-specific treatment modules50,54,55.  
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 Abstract 
Objective: Based on Fear-avoidance and Helplessness models, the relative 
contribution of fear-avoidance factors (fear of pain, avoidance behaviour and 
worrying) and helplessness was examined to fluctuations in functional disability in 
chronic pain patients. 
Methods: One hundred and eighty-one chronic pain patients completed various 
questionnaires and a pain diary after acceptance for treatment at an 
Interdisciplinary Pain Centre and three months later.  
Results: Fear of pain, avoidance behaviour and helplessness at baseline all 
predicted functional disability after three months. When comparing these 
predictors in stepwise regression analyses, helplessness contributed to the 
prediction of change in functional disability beyond fear of pain. Of all predictors, 
avoidance behaviour most strongly predicted change in functional disability.  
Conclusion: Findings support a role for factors of both the fear-avoidance and the 
helplessness model, and suggest a central role for avoidance behaviour in 
functional disability in chronic pain patients, waiting for treatment. 
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Introduction 
Chronic pain is a major problem in the community with prevalence between 2- 
46% in Western countries, leading to high economic costs mainly as a consequence 
of functional disability1,2,3. In addition to biomedical factors, a great deal of 
attention has been given to psychological factors in explaining the level of 
functional disability in chronic pain4,5,6. Functional disability is defined as 
limitations in daily activities and in the fulfilment of regular roles in daily life7. 
In the last decades, the Fear-avoidance model was supposed to play a central role 
in explaining functional disability for subacute and chronic pain8,9. The Fear-
avoidance model is theoretically based on anxiety cognitions, particularly fear of 
pain, which affect catastrophizing about the painful consequences of activities and 
enhance avoidance behaviour. In the acute phase of the pain problem, 
catastrophizing about the consequences of pain may enhance specific anxiety 
related cognitions (fear of pain) that movements/activities will lead to reinjury and 
pain and may subsequently induce avoidance behaviour which in turn will lead 
towards functional disability and depression. Fear of pain refers specifically to the 
fear that activity will lead to an increase in pain9, based on the theory of 
kinesiophobia10,11. So, the construct refers to specific anxiety-related cognitions 
about the consequences of pain-related behaviour. In the learning history of pain, 
fear of pain functions as an anxiety response, directed towards the immediate 
consequences with regard to pain intensity. Fear of pain in turn is supposed to 
initiate catastrophizing and avoidance behaviour9. Fear of pain and avoidance 
behaviour are reinforced by the experience that it is a way to limit the pain but in 
the chronic phase they lead to increased functional disability9,10,12,13,14. Many 
studies have shown the empirical validity of the fear-avoidance model. For 
example, fear of pain has been shown to play an important role in the development 
of back pain and lower levels of physical functioning15,16 and to predict future 
functional disability and work status in both subacute and chronic pain 
patients17,18,19,20. Moreover, the role of avoidance behaviour21,22 and 
worrying/catastrophizing22.23 in the development and maintenance of chronic pain 
and functional disability was widely supported.  
However, in the chronic phase of the pain problem, the ongoing experience of 
unsuccessful coping may also induce depressogenic cognitions of helplessness in 
accordance with the learned helplessness theory24,25,26 and act as an additional 
negative cognition as activities are not expected to enhance better overall 
functioning and in time may lead to further increase in functional disability and 
depression27. Helplessness is defined as an attributional style, explaining negative 
events such as chronic pain and its consequences as uncontrollable, unpredictable 
and unchangeable and generalizing these consequences to daily functioning26,28, 
possibly enhancing avoidance behaviour and functional disability in time. In 
contrast to both fear of pain and worrying/catastrophizing, helplessness is directed 
towards coping with the present situation in stead of possible future events and is 
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focused on general functioning. So in time, helplessness may gain significance 
over fear of pain as controlling pain seems not possible and consequences of the 
chronic pain condition in daily functioning appear inescapable. This means that, 
next to fear-avoidance factors, the learned helplessness model of depression may 
have an additional important role in explaining fluctuations in chronic pain 
functional disability28,29. Both cross-sectional and prospective studies support the 
role of helplessness in predicting functional disability in chronic pain28,30,31,32. 
However, there is only limited knowledge about the relative role of fear-avoidance 
factors and helplessness in chronic pain functional disability and whether they both 
may affect the maintenance of functional disability. In this study, predictors of both 
models are integrated in order to examine their relative and independent 
contribution to the fluctuations of functional disability in time. To our knowledge, 
this is the first prospective study, examining the role of the fear-avoidance model 
and the helplessness model in chronic pain functional disability in one study. 
The goal of the present prospective study was to clarify the role of the fear-
avoidance model (i.e. fear of pain, avoidance behaviour and worrying/ 
catastrophizing) and the helplessness model in explaining the short-term 
fluctuations in functional disability in chronic pain patients waiting for treatment at 
a multidisciplinary pain centre. It was hypothesized, that helplessness would 
contribute to the prediction of fluctuations in functional disability beyond fear-
avoidance factors. 
 
 
Patients and Methods 
Patients 
Study participants were recruited from patients who were accepted for treatment at 
the Interdisciplinary Pain Treatment Centre of the Radboud University Nijmegen 
Medical Centre, the Netherlands. In order to qualify for inclusion in the study, 
patients had to be at least 18 years old and their pain problem had to be present for 
more than 3 months. Exclusion criteria were cancer-pain or other biomedical 
causes such as rheumatoid arthritis, serious psychiatric disorders that could 
interfere with treatment and/or the inability to read or write Dutch. In total 181 
patients meeting these criteria participated in the study.  
The average age of the participants was 48.7 years (sd=12.9, range=18-79). Most 
of the patients were women (64.1%). The majority of the patients (76.9%) were 
married or living with a partner. Of all patients, 13.8% had completed a primary 
education and 75.5% had finished secondary education (7 and 12 years mean 
duration of formal education, respectively). The primary pain sites were: back: 58 
(32.0%), legs: 56 (30.9%), neck and shoulders: 36 (19.9%), arms: 24 (13.3%), 
pelvis: 12 (6.6%), whole body: 11 (6.1%), head and face: 9 (5.0%), belly: 9 (5.0%) 
and breast: 8 (4.4%). In total 27 patients reported 2 sites, 6 patients reported 3 sites 
and 1 patient reported 4 sites. Mean pain duration was 64.1 months (sd=71.2) with 
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a range of 3-420 months. 
 
Study design 
After acceptance for treatment at the multidisciplinary pain centre, patients were 
sent a booklet of questionnaires and a pain diary. Patients were asked to complete 
the questionnaires, to keep the pain diary for 7 days and send them back to the 
hospital. After 3 months, 2 weeks before entering the pain centre for treatment, 
patients were again sent a booklet of questionnaires and a pain diary. They were 
asked to complete the questionnaires, to keep the pain diary for 7 days and take the 
booklets with them when entering for treatment. 
 
Measures 
Pain Intensity 
Since multiple VAS ratings have been shown to be more reliable and valid for 
measuring average pain intensity than a single rating33, study participants were 
asked to rate their pain on a 10-centimeter Visual Analogue Scale for 7 days at 3 
points in time each day. The Pain VAS scale ranged from no pain at all to the worst 
pain ever experienced. Twenty-one pain ratings were recorded for every patient 
and the mean pain level was calculated on the basis of these ratings. Cronbach’s 
alpha for pain intensity in our study was 0.96. 
Functional disability 
Functional disability was measured with the Dutch version of the Pain Disability 
Index7,34,35. The PDI was developed as a brief, self-report indicator of pain-related 
disability34. It was constructed as a 7-item questionnaire, which is scored on a scale 
of 0 (no disability) to 10 (total disability). The items reflect the total range of role 
functioning: family/home responsibilities, recreation, social activities, occupation, 
sexual behaviour, self-care and life-supporting activities. The average level of the 
items scored was used to calculate the disability index. Cronbach’s alpha for 
functional disability in our study was 0.86. 
Fear of pain 
Fear of pain was measured with the Dutch version of the Tampa Scale of 
Kinesiophobia11,36,37, measuring fear of increasing pain and injury by physical 
activity. The questionnaire consists of 17 items, scored on a 4-point scale (1: 
highly disagree to 4: totally agree). Representative items are: “For someone in my 
condition, it is advisable not to be physically active” and “My pain means there is 
physical damage”. The total score reflects the level of pain-related fear. 
Cronbach’s alpha in our study was 0.80. 
Avoidance behaviour  
Avoidance behaviour was measured with the composite score of the Retreating and 
Resting scale (respectively 7 and 5 items, respectively) of the Pain Coping 
Inventory (PCI)22,38,39. The PCI measures cognitive and behavioural attempts to 
cope with pain on a 4-point Likert scale (1: rarely or never to 4: very frequently). 
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Representative items of avoidance behaviour are: “When in pain, I retreat to a 
restful environment”, ”When in pain, I quit my activities” and “When in pain, I rest 
by sitting or lying down.”. Cronbach’s alpha for avoidance behaviour in our study 
was 0.77.  
Worrying/catastrophizing 
The construct of worrying is similar to catastrophizing and refers to anticipated 
negative consequences of pain and the lack of ability to cope with these 
consequences in the future. Worrying/catastrophizing was assessed by the 
Worrying (9 items) scale of the Pain Coping Inventory (PCI)38,39. Representative 
items are: “I start worrying when in pain” and “I think that the pain will worsen.” 
Cronbach’s alpha for Worrying in our study was 0.75. 
Helplessness 
Helplessness was measured with the Helplessness scale of the Illness Cognition 
Questionnaire (ICQ). The ICQ assesses cognitions about the way patients think 
about and give meaning to their chronic illness28. In order to enable comparison 
with the other pain-related predictors, the term “illness” in the ICQ was replaced 
by “pain”. Representative items of the Helplessness scale are: “my pain frequently 
makes me feel helpless”, “my pain limits me in everything that is important to me” 
and “my pain controls my life”. The items are rated on a 4-point scale (1: not at all 
to 4: completely). Cronbach’s alpha for helplessness in our study was 0.87. 
 
Statistical analysis 
Because of skewed distributions of scores at pain duration, square root 
transformations were applied. In order to explore the relationship between the 
study variables at first assessment and the change in functional disability, Pearson 
correlation coefficients were calculated between the predictors at first assessment 
and the change scores of functional disability. Residual gain scores for functional 
disability were used as change scores and were calculated by regressing the 
outcome variable at the second assessment on the baseline score of the variable40. 
Sequential regression analyses were then performed with functional disability at 
second assessment as dependent variable to study the contribution of the predictors 
at baseline, after controlling for functional disability and pain at first assessment at 
step 1 and 2. At first, all predictors that were significantly related to change in 
functional disability were entered separately in step 3 to determine whether they 
significantly predicted change in functional disability, after controlling for 
functional disability and pain intensity at first assessment. Secondly, all predictors 
were entered in different steps to study their relative contribution, when 
simultaneously controlling for the other predictors. 
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Results 
Changes in functional disability 
During the study period, mean functional disability decreased significantly: 
T0=5.00 (sd=2.0) and T1=4.77 (sd=2.0) (t=2.12, p<.05). However, there were 
considerable individual variations in the course of functional disability: 75 patients 
(41.0%) showed a decrease in functioning in the study period (of whom 40 (22%) 
more than 0.5 sd and 15 (8%) more than 1 sd) whereas 105 patients (58%) showed 
an increase in functioning (of whom 64 (35%) more than 0.5 sd and 29 (16%) more 
than 1 sd). 
 
Table 1: Correlates of study variables at first assessment 
 Functional 
disability 
Pain 
Intensity 
Helpless-
ness 
Fear         
of pain 
Avoidance 
behaviour 
Pain intensity .42***     
Helplessness .57*** .27***    
Fear of pain .42*** .24** .50***   
Avoidance 
behaviour .53*** .20* .48*** .45*** 
 
Worrying .33*** .11 .44*** .43*** .45*** 
*  p < .05, ** p < .01, *** p < .001 
 
Correlates of functional disability at first assessment 
As presented in Table 2, functional disability at first assessment was moderately 
correlated with more pain intensity (r=.42, p<.001). No significant relations were 
found for any of the demographic variables (gender, age and education) and pain 
duration (data not shown).  
Functional disability was moderately to strongly correlated with all predictors 
(between r=.33 and r=.57, p<.001), indicating that more fear of pain, avoidance 
behaviour, worrying/catastrophizing and helplessness were related to higher levels 
of functional disability at study entry. 
 
Correlates of change in functional disability. 
When studying relationships of functional disability over time, demographic 
variables and pain duration were not significantly associated with change in 
functional disability (data not shown). However, pain intensity at first assessment 
was significantly correlated with an increase in functional disability (r=.30, 
p<.001). In addition, with the exception of worrying/catastrophizing (r=.07, n.s.), 
all predictors at first assessment proved to be correlated with change in functional 
disability, i.e., higher levels of helplessness, fear of pain and avoidance behaviour 
were significantly related to an increase in functional disability after 3 months (see 
first column of Table 2). 
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Table 2: Sequential regression analyses of functional disability at second assessment 
 Functional disability T2 
    ra Adj. ∆ R2   β 
1. Functional disability T1 .75*** .57*** .50*** 
2. Pain intensity T1 .30*** .05*** .23*** 
3. Fear of pain .17* .01* .03 
4. Helplessness .19** .01* .11 
5. Avoidance behaviour .19** .01* .15** 
    
Total adj. ∆R2  .65  
* p < .05, ** p < .01, *** p< .001 
a correlations with residual gain scores of functional disability (except for functional disability T1) 
 
Predictors of change in functional disability  
Hierarchical regression analyses were performed with all predictors that were 
significantly related to change in functional disability: i.e. fear of pain, avoidance 
behaviour and helplessness, after controlling for functional disability at step 1 
(explaining 57% of the variance, F-change=234.13, p<.001) and for pain intensity 
at step 2 (explaining another 5%, F-change=21.02, p<.001). When entering the 
predictors separately at step 3, fear of pain (F-change=5.05, p<.05), avoidance 
behaviour (F-change=12.70, p<.001) and helplessness (F-change=9.27, p<.01), all 
significantly predicted change in functional disability.  
In order to study the relative effects of the predictors that were significantly related 
to change in functional disability (fear of pain, avoidance behaviour and 
helplessness), they were entered in different steps in the analyses. When entering 
fear of pain at step 3, helplessness at step 4 and avoidance behaviour at step 5, all 
predictors added 1% to the total variance on a p<.05 basis (F-change=5.05, 5.79 
and 6.91 respectively), indicating that helplessness and avoidance behaviour 
independently contributed to the course of functional disability above fear of pain 
(see Table 3). When entering helplessness at step 3, avoidance behaviour still had a 
significant contribution when entering at step 4 (F-change=8.15, p<.01). Fear of 
pain had no additional contribution at step 4, showing that fear of pain had made 
no independent contribution to the course of functional disability beyond 
helplessness. Finally, when entering avoidance behaviour at step 3, neither fear of 
pain nor helplessness significantly contributed to the variance at step 4, suggesting 
that helplessness and fear of pain had no independent contribution beyond 
avoidance behaviour. Beta coefficients of the whole model demonstrated that only 
avoidance behaviour contributed significantly to the change in functional disability 
(t=2.63, p<.01), independent of entry order. 
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Discussion 
Based on the fear-avoidance and helplessness model, the purpose of the present 
prospective study was to examine the relative contribution of fear-avoidance 
factors (fear of pain, avoidance behaviour and worrying/catastrophizing) and 
helplessness to the prediction of the short-term fluctuations in functional disability 
in a heterogeneous sample of chronic pain patients, waiting for multidisciplinary 
pain treatment. Our study showed that, after controlling for initial pain level and 
functional disability, the fluctuations in functional disability were predicted by 
more fear of pain, avoidance behaviour and helplessness. Specifically, helplessness 
contributed to the prediction of change in functional disability beyond fear of pain. 
In addition, avoidance behaviour most strongly predicted functional disability 
when compared with fear of pain and helplessness. 
In line with previous studies, fear of pain predicted change in functional disability, 
emphasizing the role of fear of pain in functional disability in subacute and chronic 
pain41,42. However, fear of pain had no unique contribution to the course of 
functional disability above the level of helplessness and avoidance behaviour. 
Findings are similar to a previous cross-sectional study, in which helplessness and 
avoidance behaviour both explained the level of functional disability while fear of 
pain did not have a significant additional contribution43. Fear of pain includes 
cognitions that pain may be avoided by ending or preventing from pain-provoking 
activities, which presupposes a level of controllability. However, in a pain 
population with a long-term chronification of pain, the specific fear of pain may 
eventually have been generalized into a broader cognition of not being able to 
control and stop the pain experience, resulting in helplessness cognitions and 
avoidance behaviour which are more directly linked to functional disability.  
Helplessness had a predictive value for change in functional disability. This finding 
is congruent with previous studies showing the relevance of helplessness for the 
course of functional disability in time28,31. Beyond these studies, this prospective 
study extends previous findings in showing that helplessness may have an 
independent contribution to change in functional disability beyond fear of pain. 
Findings confirm the relevance of depressogenic cognitions in long-term pain 
when pain cannot be prevented or avoided. The construct of helplessness implies 
cognitions of uncontrollability to change the problem of pain that may initiate 
avoidance behaviour, aimed at preventing pain instead of changing the experience 
of pain or trying to actively cope with the consequences of pain in daily life.  
Relative to the other predictors, avoidance behaviour was the most important 
predictor of the fluctuations in functional disability. The predictive value of 
avoidance behaviour for functional disability is consistent with the great number of 
studies on functional disability9,22,44. This study also indicates that, relative to 
helplessness and fear of pain, the behavioural component of the fear-avoidance 
model may be a key component as it is directly linked to functional disability. 
Further analyses confirmed that the relation between helplessness and functional 
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disability was explained by avoidance behaviour. The findings are in line with a 
prospective study of Smith and Wallston30, who in a path-analysis found that 
avoidance behaviour mediated the relations between helplessness and disability, 
indicating that the fear-avoidance model and the helplessness model may be linked 
in their relation to functional disability (also see Sullivan et al29) in such a way that 
both fear of pain and helplessness induce avoidance behaviour, resulting in 
functional disability. This means that our study presents preliminary indications 
that both the fear-avoidance model and the learned helplessness model may 
contribute to explaining functional disability in chronic pain.  
In contrast with other studies, underscoring the relationship between 
worrying/catastrophizing and functional disability in different chronic pain 
populations22,45,46,47,48, worrying/catastrophizing had no predictive value for the 
prediction of change in functional disability. The construct of worrying/ 
catastrophizing as an anxiety-related coping strategy may be directed towards a 
future with pain, which should be avoided29. When the pain problem does not end, 
the fear of a painful future proved to be unavoidable and it may be suggested that 
worrying/catastrophizing may generalize into a more depressive cognition of 
uncontrollability, such as helplessness cognitions.  
Patients in our study were waiting for treatment in the pain centre. It cannot be 
excluded that this condition may have affected the present findings. The 
perspective of a possible pain reduction by means of an effective treatment may 
have influenced cognitive and behavioural coping and subsequent fluctuations in 
functional disability. It may be speculated that expectation of pain relief may 
especially be relevant for fear of pain and helplessness cognitions. Fear of pain is 
directly linked with the fear that activities will induce pain increase. A perspective 
of less pain may reduce the fear that more activities will lead to more future pain. 
This perspective may also directly affect cognitions of helplessness as the 
expectation of a possible pain decrease might renew cognitions of control and 
decrease cognitions of pain as an uncontrollable condition in daily functioning. 
Since functional disability on average slightly decreased, we cannot exclude this 
possibility. However, there were considerable individual variations in the course of 
functional disability in the study sample, indicating that there was no general 
decrease in functional disability as a result of treatment expectations. In addition, 
findings are in line with other studies showing that fear of pain and helplessness 
prospectively predict changes in functional disability in chronic pain15,22,32 . 
Some limitations of our study have to be considered. Firstly, three months between 
the first and the second assessment is a rather short time period to assess the 
fluctuations in functional disability for patients with average pain duration of more 
than five years. Future studies have to replicate the findings for longer time 
intervals, following Evers et al49 who found in a study on rheumatoid arthritis 
patients that avoidance behaviour at times of diagnosis predicted functional 
disability after one and three years. Secondly, although significant contributions to 
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the variance of functional disability were found, the total amount of explained 
variance was modest. This means that the conclusions should be interpreted with 
caution. Thirdly, we studied the fear-avoidance model and the learned helplessness 
model separately though it may be hypothesized that the predictors of both models 
might interact and enhance each other. However, more repeated measurements 
over a longer period are required to additionally examine possible reciprocal and 
reinforcing effects of fear of pain and helplessness. Future studies should focus on 
the integration of the fear-avoidance model and the learned helplessness model in 
order to examine functional disability in time. Fourthly, all patients were included 
in a specialized university pain clinic. Patients are usually referred to a university 
pain centre when their pain problem has not been solved to a satisfying extent. 
Accordingly, the sample of pain patients in our study might only be representative 
for patients with complex pain problems who seek treatment in a specialized pain 
centre. 
Despite these limitations, our study suggests that in future studies it may be useful 
to integrate the fear-avoidance and learned helplessness model in chronic pain by 
showing that both fear-avoidance factors and helplessness predict functional 
disability in time. In addition to fear of pain and helplessness, attention may be 
particularly directed towards avoidance behaviour as a possible link between the 
fear-avoidance and learned helplessness model for functional disability in chronic 
pain. Future prospective studies should examine if and in which way the two 
models may interact in explaining functional disability in chronic pain patients. 
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 Abstract 
In this study 54 patients suffering from chronic cervicobrachialgia (mean pain 
duration 7 years) were treated with radiofrequency lesioning of the cervical spinal 
dorsal root ganglion (RF-DRG). 
The aim of the study was to investigate whether psychological variables would be 
predictive for the changes in pain intensity after medical treatment. 
The following psychological aspects were measured: pain cognitions: helplessness 
and catastrophizing, physical and psychosocial dysfunctioning and overall distress. 
The level of catastrophizing before treatment appeared to predict 10% of the 
changes in pain intensity after treatment. 
Changes in pain intensity after RF-DRG were positively correlated with changes in 
psychosocial dysfunctioning and negative self-efficacy.  
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Introduction 
Recently three studies demonstrated the effectiveness of a radiofrequency lesion of 
the cervical dorsal root ganglion (RF-DRG)1,2,3. Short term success rates were 
observed between 501 to 88%2 in patients suffering from cervicobrachialgia in 
terms of pain reduction. For instance, Kleef et al2 reported a mean decrease of 3.1 
on VAS scores, Slappendel et al1 found a mean 1.7 VAS decrease.  
Noteworthy is that Slappendel et al1 found no differences between the two study-
conditions (67 and 40 degrees C). This finding raises questions with respect to the 
working mechanisms in pain reduction after treatment. 
Another way to justify the RF-DRG treatment besides pain VAS-scores is the 
improvement in psychosocial functioning after treatment. There is a substantial 
evidence for a relatively high level of psychosocial dysfunctioning in chronic pain 
patients. Pain is associated with elevated levels of depression, inactivity, negative 
thinking and overall distress4,5,6. There are also indications that cognitive coping 
strategies, especially perceived lack of helplessness and catastrophizing, are 
positively correlated with pain intensity7 and even predict psychosocial functioning 
in time8,9,10. These are important findings because they show the impact of at least 
some psychological factors on pain intensity. 
The aim of the present study, as part of the study of Slappendel et al1, was to 
answer the following questions: 
Do pain cognitions, physical and psychosocial functioning and/or psychological 
distress predict the change in pain intensity after treatment with RF-DRG? 
Are changes in psychological variables correlated with changes in pain intensity 
after treatment with RF-DRG? 
 
 
Patients and methods 
Treatment of patients with cervicobrachialgia 
All patients with cervicobrachialgia were examined by an anaesthesiologist during 
the first visit to the pain clinic and were also seen by a neurologist as well as an 
orthopaedic surgeon. A neurosurgeon or rheumatologist was also consulted if 
indicated. Cat-scans were obtained in all patients. In addition psychological 
assessment was completed by the clinical psychologist. 
After the intake procedure a therapeutic protocol was established, which consists of 
conventional measures e.g. analgesics, trigger-point injections with local 
anaesthetics, physical therapy, transcutaneous nerve stimulation, psychological 
intervention and social support. Only when causal therapy was not possible 
(orthopaedic or neurosurgical surgery) and conventional therapy was not effective 
the patient was advised to undergo RF-DRG. 
 
Study design 
When the patient complained of unilateral monosegmental cervical pain diagnostic 
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blockades were performed to identify the putative pain provoking cervical spinal 
root. These blocks included the levels C3 to C7. After a clearly identified cervical 
spinal root by a prognostic blockade patients were asked to participate in the study 
and to provide a written informed consent. Inclusion and exclusion criteria are 
summarized in Table 1.  
 
Table 1: Inclusion- and exclusion criteria for treatment with Rf-DRG. 
 
Measures 
Physical and psychosocial functioning was studied by The Sickness Impact Profile 
(SIP). The Sickness Impact Profile was designed to assess the effects of health care 
on different aspects of daily functioning. It consists of 136 items, divided in 12 
different scales: sleeping/resting, emotional behaviour, physical care, 
housekeeping, mobility, social interactions, walking, intellectual functioning, 
communication, work, recreation and eating. It is possible to distinguish 2 major 
scales from these scales: physical functioning and psychosocial functioning. The 
items are scored on a yes/no basis. In this study the Dutch version was used. The 
reliability and validity of the SIP are judged as sufficient11,12,13. 
Psychological distress was assessed by the Hopkins Symptom Check List (HSCL), 
which is used in order to evaluate therapeutic treatments14. The items are scored on 
a 5-points scale. For the purpose of this study only the overall distress scale was 
used, which consists of all 57 items. The instrument was validated for the Dutch 
population by Luteijn et al15 and both reliability and validity are judged as 
sufficient. 
Inclusion criteria 
- Patients suffering from unilateral pain in neck, shoulder or arm of chronic 
benign pain origin 
- Age: between 20 and 60 years 
- A duration of pain for at least six months 
- Conventional therapeutically approach not effective 
- No indication for surgical therapy as validated by X-ray and CAT-scan   of 
the cervical spinal column 
- Positive diagnostic blockade for monosegmental pain 
Exclusion criteria 
- Evidence of deafferentation pain (hyperpathia, hypoesthesia, dysesthesia) 
in the upper extremity involved 
- Previous surgery of the cervical spinal column 
- Hypersensitivity to radiopaque dye solutions and / or local anaesthetics 
- Clotting disorders, major mental disease 
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The pain cognitions were studied by the Pain Cognition List (PCL-E). This Dutch 
instrument was designed to judge the cognitions of chronic pain patients 
concerning their pain. It consists of 81 items that are scored on a 1-5 basis and 
clustered in 5 major scales. For the purpose of the present study use was made of 
the scales: helplessness (negative self-efficacy: 17 items) and catastrophizing (17 
items). The reliability and validity are judged as sufficient16. 
Pain intensity was measured by the Visual Analogue Scale, which is a pain scale 
between zero and ten, whereas zero indicates no pain and ten indicates maximum 
pain. 
 
The present battery of instruments was composed in order to have a broad view on 
important aspects of dimensions of psychological dysfunctioning and pain 
cognitions, which are associated with chronic pain. 
The questionnaires were administered before RF-DRG was performed and three 
months after treatment. 
 
Medical treatment: RF-DRG of the cervical spinal root ganglion 
RF-DRG was being executed using fluoroscopy with a C-arm. The C-arm was 
positioned parallel to the axis of the intervertebral foramen. Under direct vision an 
electrode was introduced parallel to the beam of the X-rays into the selected 
cervical foramen (tunnel vision). Under direct vision an electrode (54 mm insulated 
23 Gauge needle with 4 mm bare tip, Radionics®) was introduced into the selected 
cervical foramen, by preference the dorsal caudal part of the foramen, were the 
ganglion is located17. The stylet was replaced by a thermocouple electrode, of 
which the correct position was verified by electrical 50 Hz stimulation. A 
twinkling sensation in the corresponding dermatome had to be obtained between 
voltages of 0.3 and 0.7 Volt. After obtaining correct sensory physiological 
placement, a motor response was provoked under 2 Hz stimulation. This should not 
occur below a voltage of at least two times the threshold value obtained during the 
sensory 50 Hz stimulation parameter. The anatomical placement of the electrode 
was controlled by fluoroscopy in anterior posterior view finding the electrode in 
line with the facetal joints. After these conditions were met the electrode was 
withdrawn and 2 ml lidocaine 2% was injected through the needle. Subsequently 
after five minutes the electrode was reinserted in the cannula and a 90 second RF-
DRG was applied18. Because of the finding that the groups in the two study-
conditions did not differ in pain reduction was found after treatment and that the 
demographic variables were similar the two groups of participating patients were 
taken together for the purpose of this study.  
 
Patients 
In total 314 patients with cervicobrachialgia visited the pain clinic in the 
participating hospitals in the period of January 1993 to June 1995. Inclusion and 
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exclusion criteria are formulated in Table l. Only patients between 20 and 60 years 
old were admitted to the study. The duration of the pain was at least six months. 
After diagnostic blockades of the cervical spinal ganglion sixty-three patients, with 
a clearly identified spinal root, were included in the study. Nine patients were 
excluded because of insufficient data. The data of fifty-four patients could be 
analysed. The participating patients were dominantly female (67%). The mean age 
was 44.8 years (sd=12.6). 
 
Statistics 
Differences between pre-treatment and post-treatment scores were calculated with 
Wilcoxon’s Signed Rank Test (see Table 2). 
In order to study correlations between the pre-treatment psychological variables 
and the pre-treatment and post-treatment VAS the Spearman Correlation 
coefficient was calculated (see Table 3). In order to explore the predictive value of 
psychological variables on change in VAS scores after 3 months, a stepwise 
multiple linear regression analysis was conducted with the changes in VAS-scores 
as dependent variable and the following independent variables: age, gender, base 
line VAS-score, psychological distress (HSCL, 1 scale); psychological and 
physical dysfunctioning (SIP, 2 scales) and pain cognitions: helplessness and 
catastrophizing (PCL, 2 scales). 
In order to investigate whether changes in psychological variables were related to 
the changes in pain scores Spearman Correlation coefficients were calculated (see 
Table 4). 
 
Results 
In Table 2 the means and standard deviations of pain intensity and psychological 
variables: pain cognitions (helplessness and catastrophizing, psychological and 
physical dysfunctioning and psychological distress) are shown before and after RF-
lesioning treatment. VAS-scores after three months showed a significant reduction 
(1.7, p<0.001). In contrast with the pain reduction none of the psychological 
variables demonstrated any significant changes after treatment. 
Table 3 shows Spearman’s correlation coefficients between all psychological 
variables before treatment and VAS before RF-DRG treatment and difference 
scores in terms of percentage between pre-treatment and post-treatment VAS. 
Before treatment physical dysfunction and psychological distress were 
considerably associated with pain intensity (.42 and .35).  
A relatively low level of change in pain intensity was significantly associated with 
a relatively high level of pre-treatment catastrophizing (-.35, p<0.01).  
In Table 4 correlations between change-scores are presented. Helplessness (.33, 
p<0.05) and psychosocial dysfunction (.32, p<0.05) showed significant 
correlations with the pain reduction. In contrast with expectations physical 
dysfunctioning and distress did not relate positively with changes in pain scores. 
Psychological predictors of the effectiveness of radiofrequency lesioning 63 
Stepwise regression analyses indicated that the only significant predictors of post-
treatment pain intensity are the initial VAS-scores and catastrophizing. The total r2 
(=multiple correlation coefficient) is 0.20. Both VAS and catastrophizing before 
treatment are responsible for 10% of the variance. None of the other psychological 
variables show any predictive power. 
 
Table 2: Mean, standard deviation and difference for all psychological variables before and 
3 months after RF-DRG treatment (Wilcoxon’s Signed Rank Test) 
 T0 T3  
variable M sd M sd Dif mean 
VAS 6.4 1.6 4.7 2.9 -1.7 * 
Helplessness 44.8 13.0 43.9 15.6 -0.9 
Catastrophizing 45.5 13.9 45.8 15.4  0.3 
Physical dysfunctioning 8.2 9.0 7.3 9.8 0.5 
Psychosocial dysfunctioning 11.5 9.1 11.9 12.0 -0.3 
Total distress 40.5 13.0 39.8 11.9 -0.7 
*  p<.001 
 
Table 3: Spearman’s correlation coefficients between all psychological variables before 
treatment and (1) VAS before RF-DRG treatment and (2) procentual difference scores in 
VAS 
 VAS rel dif VAS 
Helplessness .26 -.12 
Catastrophizing .16 -.35 ** 
Physical dysfunctioning .41** -.15 
Psychosocial dysfunctioning .28* -.24 
Total distress .35 ** -.24 
*  p<.05;  **  p<.01 
 
Table 4: Spearman’s correlation coefficients between the difference in psychological 
variables before and after RF-DRG treatment and the procentual difference scores in VAS 
 rel dif VAS 
Helplessness .33 * 
Dif catastrophizing .17 
Dif physical dysfunctioning .00 
Dif psychosocial dysfunctioning .32* 
Dif total distress .22 
*  p<.05 
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Discussion 
In this study one psychological variable, catastrophizing, was able to predict the 
outcome after RF-DRG treatment. Catastrophizing is defined as a cognitive 
process characterized by a lack of confidence and control and an expectation of 
negative outcome. In a recent study Sullivan et al19 suggest that the construct of 
catastrophizing may be viewed as a conceptually integrated construct that 
comprises three related components: rumination, magnification and helplessness. 
In their study they found that especially rumination was most strongly associated 
with functional disability. Rumination is considered a maladaptive coping strategy 
that intensifies the experience of pain20,21. 
The value of catastrophizing as a predictive variable for pain variance is not 
generally accepted. Some authors consider catastrophizing as the cognitive 
component of depression and/or overall psychological distress and not as a 
different construct4,5,8. However, our results clearly indicate that catastrophizing 
and not psychological distress is able to predict changes in pain scores after 
medical treatment. Although patients were treated with RF-DRG this psychological 
variable accounted for 10% of the change in pain scores. Our findings may lead to 
the hypothesis that a psychological treatment, which decreases the level of 
catastrophizing, may increase the effect of medical treatment. For treatment 
planning it may be a useful strategy to identify pain patients with a high level of 
catastrophizing. This selection of patients might profit from an additional 
psychological treatment, before and/or accompanying the medical treatment which 
is applied. Future studies should target the increase of positive effects on pain 
experience as a result of a multidisciplinary treatment, including psychological and 
medical treatment, compared with monodisciplinary treatment or no treatment at 
all.  
In our study the cognitive coping pre-treatment scores show that no high 
correlation (>.30) could be established between any of the pain cognitions and pain 
intensity. This finding means that the conclusion of Jensen et al4 in a review on 
coping with chronic pain and several authors on correlational studies of chronic 
pain8,22,23 that catastrophizing is correlated highly with pain intensity could not be 
confirmed.  
When examining the changes after RF-DRG treatment, however, the results show 
that only helplessness and psychosocial dysfunctioning correlate significantly with 
the changes in VAS. These may be surprising results because they show that pain 
reduction does not correspond with better physical functioning. More specifically 
physical dysfunctioning was associated with pain intensity before medical 
treatment but did not improve when pain was reduced as a result of treatment. Also 
distress showed no correlation in change scores. Although distress is correlated 
with VAS before medical treatment, pain reduction was not accompanied by an 
improvement in distress-scores. It may be hypothesized that changes in physical 
dysfunctioning and distress may be ruled by more complex mechanisms than only 
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by pain level and may demand other multidisciplinary treatment strategies. 
Conclusion 
What are the clinical implications of these findings? Aspects of psychosocial 
functioning may be considerable consequences of the pain as suggested by Linton6. 
When these are not focused within a treatment program they will persist in spite of 
changes in pain scores. This means that treatment of cervicobrachialgia should not 
only focus on medical treatment but should be combined with psychological 
treatment in a multidisciplinary pain program for those patients with a higher level 
of dysfunctioning or catastrophizing coping strategies. This corresponds with the 
findings of Flor et al24 in a meta-analytic review, who showed that 
multidisciplinary pain treatments are superior to unimodal treatments and no 
treatment in pain clinics. The overall conclusion may be twofold. Conclusion one: 
there is a considerable correlation between physical, psychological dysfunctioning 
and pain intensity before treatment with RF-DRG. However, conclusion two, 
because successful RF-DRG treatment (in terms of decrease in VAS-scores) is not 
accompanied by a better total functioning (in terms of less physical and 
psychosocial dysfunctioning and overall distress) the findings in our study support 
the recent developments in which pain clinics focus in their treatment programs on 
both pain reduction and better overall functioning24. In a review, article Turk et al26 
mentioned no less than 9 possible treatment goals that were used in chronic pain 
treatment, covering all major aspects of physical and psychosocial functioning.  
In addition, it may be important to specify pre-treatment diagnostic instruments in 
order to identify pain patients with cervicobrachialgia who have catastrophizing 
coping strategies so that this group may profit from an additional psychological 
pain treatment in addition to a treatment with RF-DRG. 
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 Abstract  
Transcutaneous electrical nerve stimulation (TENS) is an easy to use non-invasive 
analgesic intervention applied for diverse pain states. However, effects in man are 
still inconclusive, especially for chronic pain. Therefore, to explore the factors 
predicting result of TENS treatment in chronic pain we conducted a prospective, 
randomized, placebo-controlled trial (n=163), comparing high frequency TENS 
(n=81) with sham TENS (n=82). Patients’ satisfaction (willingness to continue 
treatment; yes or no) and pain intensity (VAS) were used as outcome measures. 
The origin of pain and cognitive coping strategies were evaluated as possible 
predictors for result of TENS treatment.  
Results: Fifty-eight percent of the patients in the TENS group and 42,7% of the 
sham-TENS group were satisfied with treatment result (chi square=3.8, p=0.05). 
No differences were found for pain intensity. Patients diagnosed with osteoarthritis 
and related disorders (especially of the vertebral column) or peripheral neuropathic 
pain were less satisfied with high frequency TENS [OR=0.12 (95% CI 0.04-0.43) 
and 0.06 (95% CI 0.006-0.67) respectively]. Injury of bone and soft tissue 
(especially postsurgical pain disorder) provided the best results. Treatment 
modality or interactions with treatment modality did not predict intensity of pain as 
a result of treatment. We conclude, that predicting the effect of high frequency 
TENS in chronic pain depends on the choice of outcome measure. Predicting 
patients’ satisfaction with treatment result is related to the origin of pain. 
Predicting pain intensity reflects mechanisms of pain behaviour and perceived 
control of pain, independent of treatment modality. Pain catastrophizing did not 
predict TENS treatment outcome. 
Predicting outcome of TENS in chronic pain  69 
Introduction 
Transcutaneous electrical nerve stimulation (TENS) is an easy to use non-invasive 
analgesic intervention, applied for diverse pain states and introduced in the early 
1970s. However, its effects are still inconclusive for chronic pain1, although a 
systematic review indicates benefit for pain in osteoarthritis of the knee2.  
A number of causes are considered responsible for inducing or maintaining chronic 
pain, e.g. inflammation and nerve or spinal cord injury3. There are however 
significant differences in the underlying peripheral mechanisms of nociceptive and 
neuropathic pain. Damage of deep (muscle, joint and viscera) tissue is typically 
associated with peripheral inflammation, while injury of nerves often leads to 
neural degeneration, neuroma formation and generation of spontaneous neural 
inputs4. However, both are significantly influenced by changes in the central 
nervous system (i.e. central sensitization/disinhibition). Interestingly, long-lasting 
or intense nociceptive barrage from the periphery has been reported to give rise to 
persistent and self-sustaining central hyperexcitability long after all possible tissue 
healing has occurred4. In osteoarthritis however, evidence is found that central 
hyperexcitability is maintained by nociceptive barrage5, probably by peripheral 
sensitisation, as a result of neurogenic inflammation6. There is growing evidence 
that the pain in osteoarthritis is at least partly due to inflammation7. 
In animal models, effects of high and low frequency TENS have been extensively 
studied in inflammation and to a lesser extent in nerve ligation, for review see 
Sluka and Walsh8. High-frequency TENS reverses primary and secondary 
hyperalgesia induced by carrageenan inflammation9,10,11,12,13,14, but does not 
diminish mechanical allodynia following chronic constriction injury of the rat 
sciatic nerve15. However whether these results are true for high frequency TENS in 
chronic pain in human research, still needs to be explored. In predicting effect of 
TENS16 found that patients with intractable, stabbing, pulsating, electrifying, 
paroxysmal and un-modulated pain - suggesting neuropathic pain17 - have less 
chance to achieve successful treatment outcome.  
Besides mechanisms of peripheral and central hyperexcitability, psychological 
factors also influence chronic pain processing and treatment outcome. Cognitive 
coping strategies appeared to be correlated with pain intensity18 and especially 
helplessness19 and catastrophizing20,21 are found to predict outcome of treatment in 
chronic pain. However, effects of cognitive copings strategies on results of TENS 
treatment are unknown16 found that, marked depression, highly stressful conflict 
situations and ongoing litigation diminished success rate of TENS treatment.  
Therefore, the purpose of this study is to explore the effects of the origin of pain 
and cognitive coping strategies and mood on predicting short-term results of high-
frequency TENS in the treatment of chronic pain. We expect pain in osteoarthritis 
and related disorders, but not peripheral neuropathic pain to be a positive predictor 
for results of high frequency TENS. 
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Methods  
Design 
To predict outcome of TENS treatment, we performed a prospective, randomized 
and controlled trial comparing TENS and sham TENS. A concealed block-wise 
randomisation procedure was used, and patients, therapists and research assistants 
were blinded for treatment allocation. 
 
Randomisation procedure and concealment of allocation 
The researcher assigned consecutive numbers to eligible patients, when they 
agreed to participate in this study. The research assistant, only delivering the TENS 
or sham TENS devices to the patients, used these numbers to determine treatment 
assignment, as provided by the randomisation list. This list of sequential numbers, 
which-block wise refer to treatment allocation, was generated with help of a 
computer by the department of Epidemiology & Biostatistics. To further guarantee 
concealment, patients were asked to leave their treatment device with the 
receptionist before visiting the researcher for evaluating treatment after the 
treatment period. 
 
Subjects  
Patients with chronic pain participating in this study were referred to the Pain 
Centre of the Radboud University Medical Centre Nijmegen by their General 
Practioner or by a medical specialist. Results of medical investigations were 
retrieved from the specialists before the patient was invited for the first visit to the 
Pain centre. Both anaesthesiologists and physiotherapists of the Pain Centre 
screened patients for TENS treatment. 
Patients were eligible for this study if they met the inclusion criteria. Inclusion 
criteria were: 1. patients with chronic non-cancer pain referred to the Pain Centre; 
2. duration of pain > 6 months; 3. age above 18 years. Exclusion criteria were: 1. 
previous TENS treatment (because this could affect sham TENS credibility22); 2. 
pain in face or head (because visible electrode placement might affect compliance, 
and hair could impair optimal electrode placement); 3. several different pain sites 
(because of the limited area TENS electrodes can serve); 4. history of a cerebral 
vascular accident (because possible spinothalamocortical pathway damage could 
affect the outcome of TENS – and possibly sham TENS treatment, too); 5. no 
assistance at home – e.g. relatives or friends - to help replace or connect the 
electrodes, thus jeopardizing optimal TENS use; 6. involvement in ongoing 
litigation because of their pain16; and 7. psychological intervention proposed by the 
Pain Centre psychologists (this would interact with TENS treatment outcome in an 
unpredictable way, and withholding it would be unethical). Eligible patients were 
included in this study after signing informed consent. The Central Committee on 
Research Involving Human Subjects approved this study. 
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Apparatus  
For TENS and sham TENS treatment, identical devices (ELPHA II 1000, 
Danmeter A/S, Denmark) were used, which were specially prepared for this study. 
For high frequency TENS, stimulation pulse frequency was set to 80 Hz and pulse 
width to 50ms. Disposable 5 cm x 6.4 cm self-adhering electrodes were used with 
an active area of 6.5 cm2. Sham TENS devices showed a maximum of 10 or 20 
mA on the display (current intensity below the level of perception of the patient; 
assessed during the visit by the physiotherapist), but no current was actually 
delivered to the electrodes.  
 
General procedure 
Patients eligible for the TENS treatment received written information in which 
they were asked to participate in the study. In the letter, it was explained that 
TENS seems to be effective at high and low intensities, and that treatment would 
be by one of these two options. There would also be a chance of receiving a sham 
TENS device in which the settings of pulses were neither effective nor harmful.  
 
After inclusion, baseline measures were carried out and one week later patients 
visited the physiotherapist for TENS application and for instruction on both TENS 
treatment modalities. Electrodes were applied over the superficial cutaneous nerves 
in the painful segment(s)23. Once acquainted with the method of treatment, the 
patient left the physiotherapist and visited the research assistant whose only task 
was to deliver the high frequency or sham TENS device to the patient, as 
determined by the randomisation list. “With the assignment to apply TENS 
treatment continuously during the day, and the written instruction how to use the 
device and not to change pain medication, the patient left the outpatient clinic. Ten 
days later, the patient returned for evaluation of the treatment effect. More details 
of the methods are described elsewhere24. 
 
Outcome measures  
Two outcome measures were used to predict result of TENS treatment. 
The primary outcome measure was the proportion of patients satisfied with the 
initial treatment result and willing to continue treatment (yes or no). This outcome 
measure can be regarded as an index of patient’s assessment of the benefits 
(efficacy) of the treatment versus its side effects (e.g. problems in handling the 
device), providing a patient-based evaluation of treatment25.  
The secondary outcome measure was pain intensity. Pain intensity was measured 
using a 10-centimeter VAS, ranging from no pain at all to the most intense pain 
imaginable26. Patients were instructed to rate their pain from that particular 
moment on the same time every day, for a period of 14 consecutive days, starting 
one week before treatment. For this purpose a pain diary was used. 
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Predictors  
Based on medical causes of pain, patients were classified in three pain diagnoses 
groups: Osteoarthritis and related disorders (ORD), assuming peripheral 
sensitisation by neurogenic inflammation6,7; Peripheral neuropathic pain (PNP) as a 
result of lesions of the peripheral nervous system; and finally, the remainder of 
patients was classified as Injury of bone and soft tissue and visceral pain disorders 
(IBST) - assuming self-sustaining central hyperexcitability4, as there were no signs 
of inflammation or peripheral nerve lesions, for visceral pain disorders it is 
suggested that central sensitisation may contribute to the pain hypersensitivity27. 
ORD was specified as pain related to osteoarthritis, osteoporosis, bursitis and 
tendonitis - both osteoarthritis and bursitis and tendonitis share mechanisms of 
peripheral sensitisation; the number of nerve fibers immunoreactive to substance P 
are increased around the vessels of the tissue related to the site of pain28,29, which 
also applies for the number of vessels in that area29,30. The diagnosis of PNP was 
established when symptoms for neuropathic pain (e.g. allodynia, hyperalgesia, 
hyperpathia, dysesthesia, paroxysms) were accompanied by a pain related 
neurological dysfunction, caused by nerve or root injury or compression and 
because of diabetic neuropathy.  
According to Lampl et al.16 factors describing severity of pain adversely affect the 
outcome of TENS treatment. We therefore added the following pain characteristics 
as possible predictors: intensity of pain, duration of pain, variation in pain, and 
disability because of pain. 
For pain intensity, the average pain level (VAS) of the base-line week was 
calculated. The standard deviation (sd) was used as a measure of variation of pain.  
Disability because of pain was measured with the Dutch version of the Pain 
Disability Index (PDI)31,32,33, which is scored on a scale of 0 (no disability) to 10 
(total disability). The items ask for the level of limitations in the total range of role 
functioning: family/home responsibilities, recreation, social activities, occupation, 
sexual behaviour, self-care and life-supporting activities. Reliability and validity 
were judged as satisfactory33,34. The sum of levels of the items scored was used to 
calculate the disability index.  
For psychological factors we selected cognitive coping strategies and perceived 
control over pain and finally depression as possible predictors for result of TENS 
treatment. 
Pain coping was measured with the Pain Coping Inventory (PCI)35,36, which 
measures 3 passive cognitive and behavioural coping strategies when dealing with 
pain. The PCI is rated on a 4-point Likert scale (1: rarely or never to 4: very 
frequently). Cognitive passive coping is assessed by means of worrying/ 
catastrophizing (9 items). Behavioural passive coping is assessed with two scales, 
retreating and resting (7 and 5 items, respectively). A priori, based on face validity 
we expected questions 10-13 of retreating (avoid upsetting events, seeking restful 
environment, avoid annoying sound and avoid light; when in pain) - referring to 
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coping with arousal due to pain- would reflect a separate factor within retreating. 
We therefore performed a principal component analysis with retreating, which 
revealed two factors, with only question 14 (Take care of food/drink) loading on a 
different factor. Accordingly we added the modified construct of retreating 
containing questions 10-13 and 32-33 (separate myself and return home soon; 
when in pain) as a possible separate predictor. Arousal due to pain might reflect 
ongoing or recurrent nociceptive pain caused by peripheral nociceptive stimulation 
presumably acting in addition to peripheral and central (dorsal horn) sensitisation; 
a condition in which TENS is found to be effective, for review see Sluka and 
Walsh8. 
Pain cognition was measured with the Pain Cognition List (PCL)37. This 
instrument represents a measure for the verbal-cognitive response system of 
chronic pain and consists of fifty items, each of which is assigned to one of five 
factors (pain impact, catastrophizing, outcome efficacy, acquiescence and reliance 
on health care). Items are scored on a 5-point scale (1: highly disagree to 5: totally 
agree). In our study the scales for catastrophizing and helplessness (negative self-
efficacy) were used to predict outcome.  
Helplessness (perceived control) over pain was measured by answering the 
following question: “Can you decrease the severity of your pain by performing 
activities; distracting from pain; relaxation exercises; reducing activities or resting; 
or none of these possibilities?” Patients were assigned to one of three groups. 
Group number one comprised of patients perceiving no control; group number two 
consisted of patients only perceiving control by decreasing activities or resting and 
group number three were patients perceiving control by activities, distraction or 
relaxation exercises. 
Depression was measured with the Dutch version of the Beck Depression 
Inventory (BDI)38. Validity was judged as satisfactory39. 
 
Statistical methods  
All analyses were done on the intention-to-treat population, defined as all 
randomized patients that started with treatment (also called modified intention-to-
treat population). Level of significance used was 0.05. Apart from the primary 
parameters, all analyses were exploratory in nature. The primary outcome 
parameter was the proportion of patients satisfied with treatment result and willing 
to continue (sham) TENS treatment (yes or no). The difference between the two 
treatment groups was tested with the chi square test. The second outcome 
parameter was the difference in the time course of the VAS-score during the first 
treatment week and the mean of the VAS-score in the baseline week. These were 
analysed using a mixed repeated measures model. 
To investigate the possible predictive role of given parameters on the result 
outcome (patients’ satisfaction), the following procedure was used. Using as 
criterion the highest likelihood score statistic within a logistic model, the best 
 Table 1: Baseline prognostic variables; pain and psychological characteristics 
 TENS 
(n = 81) 
Sham-TENS 
(n = 82) 
TOTAL 
(n = 163) 
Pain diagnoses1, n (%)  
Peripheral neuropathic pain 
Osteoarthritis and related disorders 
Injury of bone and soft tissue and visceral pain 
 
16 (20) 
31 (38) 
34 (42)
 
25 (30) 
26 (32) 
31 (38)
 
41 (25) 
57 (35) 
65 (40)
Intensity of pain, Mean ± SE mm 
Average pain in baseline week (VAS)2
 
62.2 ± 2.1
 
61.5 ± 2.0
 
61.9 ± 1.4
Variation of pain, Mean ± SE mm 
SD of pain intensity in baseline week
 
11.4 ± 0.8
 
11.1 ± 0.7
 
11.2 ± 0.6
Perceived control of pain, n (%) 
By decreasing activities or resting 
By performing activities or distraction 
None  
 
43 (53) 
16 (20) 
22 (27)
 
42 (51) 
20 (24) 
20 (24)
 
85 (52) 
36 (22) 
42 (26)
Pain disability (PDI)3 
Sum score, Mean ± SE mm
 
28.0 ± 1.8
 
28.8 ± 2.0
 
28.4 ± 1.34
PCI4, Mean ± SE mm 
Resting (5-20) 
Retreating (7-28) 
Worrying (9-36) 
 
12.8 ± 0.4 (n=77) 
11.2 ± 0.5 (n=77) 
17.6 ± 0.7 (n=77)
 
12.4 ± 0.4 (n=77) 
11.9 ± 0.5 (n=77) 
17.3 ± 0.6 (n=77)
 
12.6 ± 0.3 (n=154)  
11.6 ± 0.3 (n=154) 
17.4 ± 0.5 (n=154)
PCL5, Mean ± SE mm 
Helplessness (17-85) 
Catastrophizing (17-85)
 
43.4 ± 1.2 (n=78)  
43.6 ± 1.7 (n=78)
 
44.5 ± 1.4 (n=77) 
44.2 ± 1.7 (n=77)
 
43.9 ± 0.9 (n=155) 
43.9 ± 1.2 (n=155)
BDI 6, Mean ± SE mm 
Depression-score (0-63) 
 
10.2 ± 0.8 (n=77) 
 
10.5 ± 0.8 (n=77) 
 
10.3 ± 0.6 (n=154) 
1See table 2 for more details; 2Visual analogue scale (0-100); 3Pain Disability Index (0-70); 4Pain Coping Inventory; 5Pain Cognition List; 
6Beck Depression Inventory 
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subset of 1, 2, 3, … parameters at a time was determined. For each of these best 
subsets, Akaike’s Information Criterion (AIC) was computed, a measure of the 
goodness of fit, corrected for the number of predictors. As final predictor set, that 
subset was chosen for which AIC was smallest (starting with the best subset with 1 
predictor), before increasing again. 
To investigate the possible predictive role of given parameters on the VAS score 
on day 14 the following procedure was used. Using as criterion the highest R2 
within a multiple linear regression model, the best subset of 1, 2, 3, … parameters 
at a time was determined. As final predictor set, that subset was chosen for which 
R2, compared with the subset with one predictor less, still increased with at least 
0.01 (starting with the best subset with 1 predictor). 
 
 
Results  
Subjects  
Two hundred and three patients were included in this study. One hundred and 
sixty-five patients signed informed consent and 38 patients refused. Two of the 
included patients withdrew before the actual treatment took place; they were both 
assigned to the TENS group. Pain diagnoses, pain characteristics and psychological 
assessment revealed no differences between TENS and sham TENS groups (see 
Table 1), neither did demographic data or other pain characteristics, as reported 
previously24. The results of the classification of pain diagnoses groups are shown in 
Table 2. Because some booklets were not returned or lost, data of the PCL from 
three patients, and data of the PCI and BDI from four patients in the TENS group 
and five patients of the sham TENS group (PCL, PCI and BDI) were missing. 
 
Outcome  
The proportions of patients satisfied with treatment result, differed significantly for 
high frequency TENS compared to sham TENS (58,0% and 42,7% respectively, 
chi square=3.8, p=0.05). However, no significant differences in pain intensity were 
found for patients treated with TENS or sham TENS (p=0.53). 
 
Predicting patients satisfaction with treatment result (willingness to continue 
treatment)  
Descriptive data of the predictors are presented in table 3, arranged by type of pain 
diagnoses and including success rate (patients satisfied with treatment result) of 
TENS and sham TENS. 
As can be seen by the odds ratios in Table 4, both for the ORD-group as for the 
PNP-group, the chance that patients were satisfied and willing to continue 
treatment was less for high frequency TENS. However, for patients with higher 
sum scores of the modified retreating scale of the PCI the chance for continuing 
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Table 2: Type of pain diagnoses and rate of patients satisfied with treatment result for TENS 
and sham TENS 
Peripheral neuropathic pain 
(n=41) 
Treatment (n) Rate of patients 
satisfied with  
treatment result 
Nerve injury TENS (0) - 
 Sham  (2) 0 
Dorsal root injury TENS (0) - 
 Sham  (1) 0 
Nerve compression TENS (5) 3/5 
 Sham  (8) 5/8 
Dorsal root compression TENS (10)   6/10 
 Sham  (14)   7/14 
Diabetic neuropathy TENS (1) 1/1 
 Sham  (0) - 
Osteoarthritis and related 
disorders (n=57) 
  
Osteoarthritis (vertebral column) TENS (21)   6/21 
 Sham  (21)   7/21 
Osteoporosis of the spine TENS (3) 2/3 
 Sham (1) 0 
Osteoarthritis (hip, knee, ankle) TENS (2) 2/2 
 Sham  (2) 1/2 
Bursitis and tendonitis TENS (5) 2/5 
 Sham  (2) 0 
Injury of bone and soft tissue   
and visceral pain (n=65) 
  
Soft tissue lesions TENS (5) 4/5 
 Sham  (5) 2/5 
Bone fractures TENS (7) 4/7 
 Sham  (2) 1/2 
Whiplash injury TENS (4) 3/4 
 Sham  (4) 3/4 
Postsurgical pain * TENS (13) 10/13 
 Sham  (12) 4/12 
Visceral pain TENS (5) 4/5 
 Sham  (8) 5/8 
* Indicates significant difference between TENS and sham TENS; p=.047, Fisher’s exact test. 
  
 
 
 
 
Table 3: Proportions of patients satisfied with treatment result for TENS and sham TENS1 a and mean scores (SD) of predictors arranged by 
type of pain diagnoses 
 Peripheral neuropathic 
pain 
(n=41) 
Osteoarthritis and related 
disorders 
(n=57) 
Injury of bone and soft 
tissue and visceral pain 
(n=65) 
 TENS Sham TENS Sham   TENS Sham 
Satisfied patients, % (rate) 
 
  62.5 (10/16)   48.0 (12/25) 38.7 (12/31)    30.8 (8/26)   73.5 (25/34) 48.4 (15/31)* 
PCI2, retreating3(6-24) 10.4 (4.5) 9.1 (2.9) 10.0 (3.2) 11.9 (  4.8) 8.9 (3.7) 9.4 (2.9) 
Duration of pain (years)  6.7 (5.2) 6.7 (6.0) 5.6 (7.8) 9.1 (11.7) 6.4 (6.6) 4.4 (3.7) 
Variation of pain intensity4 9.7 (6.3) 11.3 (6.6) 11.9 (7.7) 10.7 (  6.9) 11.7 (8.0) 11.1 (6.4) 
1not corrected for the effects of retreating , duration of pain or variation of pain intensity. 2Pain Coping Inventory. 3modified retreating 
subscale (see text). 4SD of VAS scores in baseline week. * Indicates significant difference (Х2=4.33, p= .037) between TENS and sham TENS.  
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scale of the PCI the chance for continuing treatment was greater for high frequency 
TENS. As regards patients of the PNP-group, longer duration of pain increased the 
(diminished) chance for willingness to continue high frequency TENS. 
Independent of treatment modality, greater variation of pain intensity during the 
base-line week resulted in a greater chance in continuing treatment. 
 
Table 4: Logistic regression report predicting willingness to continue treatment 
Variable ORs (95% CI) p-value 
Treatment*ORD1 0.12 (0.04-0.43) 0.001 
Treatment*PCI2 retreating3 1.18 (1.07-1.31) 0.001 
Treatment*PNP4 0.06 (0.006-0.67) 0.022 
Treatment*duration*PNP4 1.40 (0.94-2.08) 0.099 
Variation of pain intensity5 1.05 (1.0-1.10) 0.066 
Treatment: TENS=1, sham TENS=0. Percentage concordant: 69.5%. 1Osteoarthritis and 
related disorders; 2Pain Coping Inventory; 3modified retreating subscale (see text); 
4Peripheral neuropathic pain; 5sd of VAS scores in baseline week. ORs: odds ratios; 95% 
CI: 95% confidence intervals. 
 
 
Predicting pain (VAS) 
Results of predicting pain intensity are shown in Table 5. Treatment modality or 
interactions with treatment modality did not predict intensity of pain as a result of 
treatment. Pain intensity (adjusted for baseline values) was predicted by resting 
(PCI subscale) scores (negative), and pain disability (PDI) scores (positive). 
Perceiving reduction of pain by decreasing activities and resting, or with 
performing activities, relaxation exercises and distraction from pain, were positive 
predictors of pain intensity.  
 
Table 5: Multiple linear regression report predicting VAS score on day 14 (after one week 
of treatment) 
Variable Regression 
Coefficient
Standard 
Error 
t-value Probability 
Level 
Mean baseline pain intensity, VAS1 0.80 0.09 8.62 <0.001 
PCI, resting 2 -2.24 0.56 -3.99 <0.001 
PDI3, total sum score 0.50 0.15 3.22 <0.002 
Perceiving pain reduction by resting 11.31 3.83 2.95 <0.004 
Perceiving pain reduction by activities 10.31 4.67 2.21 0.028 
Model: F(5.146)=26.19. p< .001. R2=0.47. 1Visual analogue scale; 2subscale “resting” of 
Pain Coping Inventory; 3Pain Disability Index. 
Predicting outcome of TENS in chronic pain  79 
Discussion  
The results of our study show that predicting the effect of high frequency TENS 
depends on the choice of outcome measure. The chance that patients were satisfied 
with high frequency TENS treatment was reduced, both for pain related to 
osteoarthritis and related disorders as for peripheral neuropathic pain, whereas for 
patients, who retreat more because of arousal when in pain (modified retreating 
scale of the PCI), the chance was increased. Only for chronic pain because of bone 
or soft tissue injury the proportion of patients satisfied with treatment result was 
significantly higher for high frequency TENS compared to sham TENS (Table 3).  
However, contrary to patient’s satisfaction with treatment result, pain intensity as 
result of treatment was not explained by treatment modality. Furthermore, pain 
catastrophizing and depressive mood did not predict treatment outcome. 
As hypothesized - based on results of animal research15 - we found that peripheral 
neuropathic pain was a negative predictor for results of high frequency TENS. A 
possible explanation is that high frequency TENS as applied in the present study, 
decreases nociceptive input in the dorsal horn by means of selectively stimulating 
large diameter afferent neuron fibers40, resulting in activating inhibitory 
interneurons in lamina II. This A-fiber mediated inhibition is diminished in rats 
with sectioned nerves41, probably by apoptosis of inhibitory interneurons as a result 
of peripheral nerve injury42. Only for this group we found that with increasing 
duration of the existing pain, the chance of patients to be satisfied with treatment 
result augmented; whether this results from adaptive changes in the nervous system 
in the course of time, or that these patients are satisfied with less gain, needs 
further investigation. 
We expected pain in osteoarthritis and related disorders to be a positive predictor 
for high frequency TENS treatment, but instead, it appeared a negative predictor. 
In a review Osiri et al.2 conclude that high frequency TENS is shown to be 
effective in pain control over sham TENS in the treatment of osteoarthritis of the 
knee. However in our study, - as can be deduced by the data from table 2 – a 
proportion of 73% of the patients in this group suffered from severe osteoarthritis 
of the vertebral column, with only 6/21 (29%) and 7/21 (33%) of the patients 
satisfied with high frequency TENS and sham TENS treatment respectively. 
Accordingly, in a comparable group of patients with chronic low back pain, Moore 
and Shurman43 found poor results from high frequency TENS treatment as well. A 
possible explanation is that inflammation near to the dorsal root and even a minor 
lesion of articular structures of the vertebral column is found to induce changes in 
neurotrophic factors in the dorsal root neurons44,45,46. These neuropathic changes 
might impair the working mechanisms of high frequency TENS, however this 
needs verification. 
Patients who retreat because of arousal when in pain, benefit from TENS treatment 
(modified retreating scale, PCI). As mentioned before, we assume higher scores 
reflect higher levels of nociceptive pain; in which TENS is found to be effective, 
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for review see Sluka and Walsh8. However, this modified scale needs further 
validation.  
Independent of treatment modality, baseline variation in pain intensity influences 
patients’ satisfaction in treatment result, with increased pain variation resulting in 
greater chance of success of treatment. This is in accordance with the results of 
Lampl et al16, who found that TENS in un-modulated pain is less effective. We 
assume that higher rates in fluctuation of pain intensity reflect a greater availability 
of inhibitory controls. Furthermore, participating in a study will heighten the 
sensitivity and vigilance of the patients, thereby increasing the detection of 
beneficial improvements47, especially when pain intensity fluctuates, 
improvements are more likely to be noticed by the patients and attributed to 
treatment effect. 
Only for chronic pain because of injury of bone and soft tissue (including a minor 
group of visceral pain disorders), the proportion of patients satisfied with treatment 
result was significantly higher for high frequency TENS compared to sham TENS 
(Table 3). This cannot easily be explained by the influence of the other predictors 
of patients’ satisfaction, as can be seen by the data in Table 3. 
 
Predicting pain (VAS) 
For predicting pain intensity (VAS), as a result of high frequency TENS or sham 
TENS application, treatment modality does not show any interference. So, in the 
present study intensity of pain seems not to be influenced differently by either 
TENS or sham TENS treatment. After treatment, patients who were more disabled 
because of pain and those perceiving control of pain (by resting, performing 
activities and distraction from pain) have higher pain intensity scores than less 
disabled patients and those not perceiving control. Presumably, those patients 
already experiencing control of their pain seem to tolerate more pain during either 
TENS or Sham TENS treatment or benefit less from either treatment modality. 
Furthermore, patients who seek more rest because of their pain manifest less pain, 
as a result of either Sham TENS or TENS treatment. 
Predictors found in other studies 
Other factors predicting less effect of TENS treatment, described in the study of 
Lampl et al16, were marked depression, and pain qualities as stabbing, pulsating, 
paroxysmal and electrifying pain. Marked depression, as predictor was not found 
in the present study, which could be due to the low depression score, explained by 
the exclusion of patients indicated for psychological treatment. Whereas for the 
various pain qualities, this agrees with our findings as these symptoms are more 
common in patients with neuropathic pain than those with non-neuropathic pain48. 
In a previous study in our centre, catastrophizing proved to be a factor explaining 
pain reduction by radiofrequency lesioning of the cervical spinal dorsal ganglion20. 
Catastrophizing did not explain pain or patients’ satisfaction with treatment result 
in the present study, although the study was performed with the same measure 
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(PCL) and only slightly different scores in both studies [mean and sd: 45.5 (13.9) 
and 43.9 (14.9)]. A possible explanation could be that both TENS and sham TENS, 
stimulated a perception of pain control because patients handled their (sham) 
TENS devices themselves, thus diminishing the feeling of helplessness about pain, 
which is a major characteristic of catastrophizing49.  
 
Predicting pain versus predicting patients’ satisfaction 
Most striking is the fact that predictors for pain intensity differ from those who 
predict patients’ satisfaction with treatment result, both in nature as in interaction 
with treatment modality. Although closely related, these two outcome measures 
differ because patients’ satisfaction comprises the considerations of the relevancy 
of the experienced improvements for the patient (e.g. for the pain that was most 
annoying, threatening, disturbing or disabling), whereas the VAS score reflects a 
measure of pain intensity perceived at a fixed time of the day. As described 
before24 the satisfied patients exhibited on average a 28.5% pain reduction, which 
signifies a clinical important relief of pain50. Patients’ satisfaction might therefore, 
predict clinical important relief of pain.  
Strong and weak points of the study  
High frequency TENS was applied in a standardized way and a main outcome 
measure was patients’ satisfaction with result of treatment, which would have 
warranted the relevance for daily practice. Furthermore compliance (registered 
operation time of the device) was not different for the TENS or sham TENS group, 
and there was only a weak correlation between the actual and perceived treatment 
application (i.e. TENS or sham TENS), as reported previously24.  
The main purpose of this study was to explore the effects of the origin of pain on 
the result of high frequency TENS in chronic pain. However the classification of 
the origin of pain may have flaws. Especially, the difference between the PNP 
group and the injury group (IBST) may be arguable, as a large proportion of the 
patients in the latter group developed chronic pain after surgery (see Table 2), and 
it is assumed that neuropathic pain is the most common type of post surgical pain51. 
Although there were no signs of sensory loss, we cannot fully exclude the 
existence of neuropathic pain in this group, as there is no gold standard for 
defining neuropathic pain52. However it would mean that the effect of high 
frequency TENS on PNP is not definite, because contrary to the PNP group, in the 
postsurgical pain group high frequency TENS performed significantly better than 
sham TENS (see, Table 3 and 2, respectively). Interestingly, TENS is found to 
reduce postoperative analgesic consumption53. However, there is a need for the 
development of a mechanism-based classification of pain, as proclaimed by Woolf 
et al54 and Woolf and Decosterd55.  
We conclude, that predicting the effect of high frequency TENS in chronic pain 
depends on the choice of outcome measure. Predicting patients’ satisfaction with 
treatment result is related to the origin of pain: both, peripheral neuropathic pain 
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and osteoarthritis, especially of the vertebral column negatively predict treatment 
outcome; whereas injury of bone and soft tissue (especially postsurgical pain 
disorder) is a positive predictor. Predicting changes in pain intensity following 
treatment reflects mechanisms of pain behaviour and perceived control of pain, 
independent of treatment modality. Pain catastrophizing did not predict TENS 
treatment outcome. 
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 Abstract 
Objectives: multidisciplinary treatment approaches have been found to be effective 
for chronic pain patients although there are large individual differences in 
outcomes. To increase overall treatment effects, tools are needed to identify 
patients most likely to benefit of tailored multidisciplinary modules oriented 
treatment.  
Design: the present study evaluates the effects of a multidisciplinary pain treatment 
allocation protocol in chronic pain patients and seeks to identify cognitive-
behavioural predictors of outcome. Pain intensity, functional disability, depression 
and use of medication in an intervention group of 110 chronic pain patients were 
compared to the outcomes of a 110 control group.  
Results: paired pre- and post-treatment t-tests indicated that all primary outcomes 
had significantly decreased in the intervention group. ANCOVA revealed a main 
group effect for pain intensity levels and functional disability after treatment. Both  
had significantly reduced in the intervention group in comparison with the control 
group. Multiple regression analyses of the predictors showed higher levels of 
acceptance to significantly predict larger reductions in pain intensity in the 
treatment but not in the control condition. 
Conclusion: the findings indicate that an outpatient multidisciplinary allocation of 
chronic pain treatment was effective with regard to pain intensity and functional 
disability. Especially those patients who were able to accept their condition may 
profit more from pain reduction.  
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Introduction 
There is increasing evidence that chronic pain patients tend to benefit from 
multidisciplinary pain treatment schemes, especially programmes combining 
cognitive-behavioural (CBT) and physiotherapy modules1,2,3,4. Flor et al.1 showed 
that multidisciplinary pain treatment was superior to monodisciplinary 
interventions on various outcome measures such as pain intensity, mood, 
functional disability and medication consumption, with the effects remaining 
relatively stable over time. However, the effects reported are generally modest, 
frequently attributed to the large individual differences in treatment outcomes. 
Consequently, it is essential that patients that may benefit most of multidisciplinary 
treatment schemes are identified2. 
Researchers have generally focused on the detection of relevant cognitive-
behavioural factors to predict treatment efficacy. Based on the fear-avoidance 
model, pain-related anxiety, particularly fear of pain and worrying/catastrophizing, 
have been assumed to enhance avoidance behaviour, resulting in increased pain, 
functional disability and depression in the long term5,6. Recently, helplessness, i.e. 
the notion that chronic pain and its consequences are uncontrollable and 
unchangeable and the generalization of the consequences to daily functioning7, has 
additionally been shown to play a significant role in explaining the course of 
functional disability in chronic pain within the framework of the fear-avoidance 
model8,9. As acceptance has been shown to be predictive of better functioning in 
the longer term8,10, various authors have also advocated the assessment of this 
positive, health-promoting variable in outcome studies4,8. Acceptance is defined as 
acknowledging that one has pain and being able to make an effort to live a 
satisfying life despite the pain8,11.  
For correct referrals, it is crucial to know whether chronic pain patients that 
worry/catastrophize about their pain and its consequences and/or feel helpless 
about their ability to change their situation and have accordingly developed 
avoidant pain behaviours, would indeed profit most of treatment modules aimed at 
changing pain cognitions and behaviour, as has been suggested. Perhaps patients 
that are unable to accept the pain and its consequences may profit from pain 
treatment programmes that are specifically aimed at their learning to shift their 
focus from pain reduction to coping with the pain as an unavoidable condition and 
to strive toward improving their daily functioning despite the pain11. Yet, empirical 
studies that have examined the relative predictive values of mentioned variables in 
relation to multidisciplinary pain treatment approaches are scarce. The few studies 
that were directed at identifying cognitive-behavioural predictors at the start of 
treatment either yielded nonsignificant or inconsistent results12,13,14,15. Studies 
charting changes during multidisciplinary treatment found decreases in fear of 
pain, worrying/catastrophizing or helplessness to predict decreases in pain 
intensity, functional disability, depression and/or medication 
consumption16,17,18,19,20,21. Increase in acceptance cognitions appeared to predict 
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better outcomes after treatment10. 
To bridge this gap in our knowledge, with the present study we sought to examine 
and compare the effects of a multidisciplinary allocation protocol on the self-
reported variables of pain intensity, functional disability, depression and use of 
medication in a cohort of chronic pain patients relative to a waiting-list control 
group and to identify cognitive-behavioural predictors (i.e. fear-avoidance factors, 
helplessness and acceptance) of treatment outcome in order to get more insight into 
the clinical impact of this strategy of chronic pain treatment. In this study, the 
consequences of the multidisciplinary pain treatment allocation protocol was the 
focus of study in stead of the effects of different treatment modules. We 
hypothesized that the treatment allocation protocol would be effective on all 
primary outcomes relative to the control condition. As previous studies indicated 
that patients with higher levels of worrying, avoidance behaviour, fear of pain and 
helplessness would suffer more from pain, functional disability and depression all 
predictive of inferior long-term outcomes6,22, we hypothesized that this type of 
patients would profit more from a multidisciplinary treatment allocation protocol 
as reducing cognitive-behavioural factors was the specific focus of one of the 
treatment modules. In addition, we assumed that higher levels of pre-treatment 
acceptance would induce more favourable outcomes  as acceptance might allow a 
more positive perception of changes in pain levels. However, based on recent 
studies showing that a lower level of acceptance predicts more pain and functional 
disability23,24, we further assumed that patients low on acceptance would also 
benefit more from a multidisciplinary treatment allocation protocol as one of the 
goals of one of the treatment modules specifically aimed at raising the participants’ 
acceptance levels. 
This implies that superior outcomes would be predicted by these cognitive-
behavioural variables, i.e. that patients with higher levels of worrying/ 
catastrophizing, avoidance behaviour, fear of pain or helplessness and lower levels 
of acceptance would show a more favourable outcome. 
 
 
Materials and methods 
Patients and procedure 
Participants were recruited from chronic pain patients who had been referred for 
treatment to the interdisciplinary outpatient pain centre of the Radboud University 
Nijmegen Medical Centre, the Netherlands. To qualify for inclusion in the present 
study patients had to be at least 18 years old and have suffered from specified pain 
complaints for more than 3 months. Exclusion criteria were pathophysiological 
causes such as pain due to cancer, serious psychiatric disorders that could interfere 
with treatment, and the inability to read or write Dutch. Also patients that were 
scheduled for one or more treatment modalities outside the treatment centre 
(exercise therapy and/or individual psychological treatment) or patients that were 
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not allocated to any treatment, were excluded from the study. The original sample 
comprised 286 patients. Based on the exclusion criteria a total of 35 patients were 
excluded. As to the demographic variables of age, marital status, education and 
pain duration, there were no statistically significant differences between the study 
group and the nonparticipant group although there were significantly more women 
in the latter group (76.8% vs. 58.8%: z=-2.57, p<.05). Of the sample of 251 
patients that met the inclusion criteria and initially agreed to participate, we 
eventually failed to obtain sufficient data for 31 patients (23%), which were 
subsequently excluded from the analyses (see Figure 1). Subsequent dropout 
analyses revealed that there were no statistically significant differences between 
Total sample 
n=286 
Nonparticipants 
n=35  (12.3%) 
Reasons: not meeting 
the inclusion criteria 
Allocated to 
Intervention group 
n=110 
Allocated to  
Control group 
n=110
Analysed (n=110) 
Medical treatment: n=19 (17.2%) 
TENS: n=50 (45.4%) 
CBT: n=21 (19.0%) 
Combined treatment: n=20 (18.1%) 
Dropout: n=31 
Reasons: 
Not interested anymore (n=19) 
Started treatment elsewhere (n=6) 
Other reasons (n=6) 
Analysed (n=110) 
Figure 1: Flowchart of the study participants 
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the final sample (n=220) and these dropouts. We thus tested a total of 220 patients 
in our study of whom we obtained all required data. Based on time of referral, the 
first 110 patients were allocated to the intervention group and the last 110 to the 
control group. 
The remaining 220 patients all completed the same set of validated questionnaires 
(see Measures) and 7-day pain and medication diaries prior to entering the centre’s 
standard three-month waiting-list period (T0) and again at the end of this period, 
i.e. one week prior to the study’s screening procedure (T1) and a third time 3 
months into their respective treatments (T2). The first 110 patients that were 
allocated to one or more of the treatment modalities were included in the treatment 
condition and the next 110 patients in the control condition (See Figure 1). The 
total inclusion period was 9 months. Prior to their participation to the study, which 
was approved by the hospital’s medical ethics committee, all patients gave their 
informed consent. 
 
Table 1: Demographic variables and pain duration for the two patient groups at study entry 
 Treatment group 
(n=110) 
Control group 
(n=110) 
Sex: number of women (%) 64.0  (58.2)  68.0 (61.8) 
Mean age (in years) 48.1 (sd= 14.3) 48.1 (sd=12.4) 
Married (%) 78.2  76.2  
Educational level    
     primary 12.6  12.8  
     secondary 83.5  85.4  
     tertiary 3.9  2.8  
Mean Pain duration (in months) 62.8 (sd=75.1) 63.5 (sd=77.6) 
 
 
The demographic variables of both the control and the intervention group are 
presented in Table 1. There were no significant group differences in sex, marital 
status or educational level: in both groups the majority of patients were women and 
most participants were married and had completed secondary education. The 
primary pain sites for the treatment and the control groups were: legs: 34 (30.9%) 
vs. 27 (24.5%); back: 33 (30.0%) vs. 38 (34.5%); neck and shoulders: 27 (24.5%) 
vs. 19 (17.3%); arms: 16 (14.5%) vs. 12 (10.9%); pelvis: 8 (7.2%) vs. 7 (5.5%); 
head and face: 5 (4.5%) vs. 8 (6.4%); belly: 3 (2.7%) vs. 7 (5.5%); whole body: 3 
(2.7%) vs. 10 (8.8%); breast 2 (1.8%) vs. 8 (6.4%). Fourteen (12.7%) and 16 
(14.5%) patients, respectively, reported pain at more than one site. However, there 
were no patients who met the criteria for fibromyalgia. Mean pain duration was 
62.8 months (sd=75.2, median 32.0) versus 63.5 (sd=77.6, median 36.0) with a 
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range of 6-420 months in both groups. There were no significant group differences 
on any of the pain locations and pain duration.  
 
Pain treatment modalities 
After the regular three-month waiting-list period an anaesthesiologist, a 
physiotherapist and a psychologist screened the questionnaires of all 220 patients. 
Allocation to one or more of the treatment modules was based on meeting the 
inclusion criteria of the different treatment modules as a result of screening the 
questionnaires, regarding demographic variables, painrelated variables, coping and 
pain outcomes and a standardised one-hour interview by the anaesthesiologist, 
physiotherapist and the psychologist. 
The standardised interview consisted of a standardised examination of anamnestic 
pain related data by the anaesthesiologist, physical activity and functional 
limitations by the physiotherapist and data concerning the etiology of the pain 
episode, cognitive, behavioural and social consequences of pain by the 
psychologist. There were no dropouts in the intervention group after treatment 
allocation and start of treatment. 
Medical treatment. Medical treatment was aimed at pain reduction by attuning and 
minimizing pain medication on a time-contingent basis. The inclusion criteria for 
this treatment modality were high medication use without strict medical indication, 
medication use on a pain-contingent basis, presence of adverse drug effects or use 
of conflicting or resembling pain medication. The mean number of face-to-face 
contacts was two. 
Transcutaneous electrical nerve stimulation (TENS) is a non-invasive intervention 
to alleviate pain. An experienced physiotherapist applies a small portable battery-
powered stimulator, connected by electric wiring to self-adhesive electrodes, to the 
patient’s skin. After proper instruction and adjustment of pulse variables and 
electrode placement, patients are able to manage the TENS treatment by 
themselves during their daily activities. They can monitor their pain level and 
adjust the pulses to alleviate the pain, which hence may reduce their cognitions of 
helplessness and avoidance behaviour. Eligible were patients suffering from pain 
due to peripheral nerve-root lesions, excluded were patients reporting pain in the 
face or head or on several pain sites. The mean number of face-to-face contacts 
was five. 
Cognitive-behavioural group therapy (CBT) consisted of ten 90-minute sessions 
and was targeted at reducing the patients’ functional disability and depression by 
reducing negative cognitions and avoidance behaviour using the following 
treatment components: stress-management and problem-solving techniques, 
cognitive therapy and relaxation exercises. In addition, patients worked on 
individual goals. In the first session, every patient formulated a specific CBT goal 
based on their personal underlying problems (e.g. work-related conflicts or marital 
problems). In the subsequent sessions, patients trained and implemented their 
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personalized problem-solving techniques. Groups consisted of minimally 5 and 
maximally 12 patients and were led by two psychologists both fully trained in 
CBT. Inclusion criteria for group CBT were untreatable pain (defined as pain that 
cannot be reduced by either medication and/or TENS) and severe limitations in 
physical or psychological functioning. Exclusion criteria were incapacity to 
function in a group or indications of a psychiatric disorder. The average number of 
attended CBT sessions was nine out of ten. 
 
Figure 1 provides an overview of the number of patients per treatment modality, 
showing that 19 patients (17.2%) received medical treatment, 50 patients (45.4%) 
received TENS treatment and 21 patients (19.0%) had CBT. Twenty patients 
(18.1%) that met the criteria for more than one treatment modality received a 
combination of medical treatment and TENS. Patients who already had received 
TENS treatment and were considered to have an optimal medication scheme, only 
received CBT with the goal of better functioning and reduction of depression We 
did not offer a combination of medical treatment or TENS with group CBT 
because it was expected that, due to their pain-reduction objectives, both the 
medical treatment and TENS would undermine CBT treatment compliance as this 
intervention is specifically directed at training effective, long-term pain-coping 
strategies. 
  
Measures 
Pain Intensity 
Since multiple Visual Analogue Scale (VAS) ratings have been shown to be more 
reliable and valid to establish average pain intensity than a single rating25, our 
participants were asked to rate their pain on a 10-centimeter VAS for 7 days at 3 
points during each day. The Pain VAS scale ranged from “no pain at all” to “the 
worst pain ever experienced”. The patient’s average pain level was calculated 
based on these 21 pain ratings. Cronbach’s Alpha for pain intensity in our study 
was 0.93. 
Functional disability 
Functional disability was measured with the Dutch version of the Pain Disability 
Index (PDI)26,27. The 7-item questionnaire was developed as a brief, self-report 
indicator of pain-related disability25 and is scored on a scale from 0 (no disability) 
to 10 (total disability). The items reflect the total range of role functioning: 
family/home responsibilities, recreation, social activities, occupation, sexual 
behaviour, self-care and life-supporting activities. To obtain the mean disability 
level, the items scores were averaged. Cronbach’s Alpha for functional disability in 
our study was 0.80. 
Depression 
Depression was assessed using the depression scale of the Dutch version of the 
Symptom Checklist-9028 measuring 16 symptoms of depression, which are rated 
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on a 5-point scale (“not at all” to “very much”). The Depression scale of the SCL-
90 has been amply validated for the Dutch population in various patient groups 
including chronic pain patients1. It also proved to be sensitive to change, does not 
contain somatic items that could interfere with other somatic complaints in chronic 
pain patients and is widely used to assess therapy outcomes in chronic pain17. 
Cronbach’s Alpha for depression in our study was 0.89. 
Use of medication 
Consistent with the ATC/DDD guidelines29 medication intake was measured by 
comparing the defined, average amount of drugs needed to obtain the desired effect 
on pain in the general population (Defined Daily Doses: DDD) and the actual use 
of drugs (Used Daily Doses: UDD). The actual use of medication is calculated by 
dividing the USD of a drug by the DDD of the same drug. When patients used 
more than one drug to alleviate their pain, the relative outcomes of the different 
drugs (UDD/DDD) were summed to obtain the total level of medication use29,30.  
Avoidance behaviour 
Avoidant behaviour was reflected by the composite score of the 13-item passive 
pain-coping scales Retreating and Resting of the Pain Coping Inventory (PCI)31,32. 
The PCI measures cognitive and behavioural attempts to cope with pain on a 4-
point Likert scale (“rarely or never” to “very frequently”). Representative items 
are: ”When in pain and I am outdoors, I try to return home as soon as possible” and 
“When in pain, I rest by sitting or lying down.”. Cronbach’s Alpha for avoidance 
behaviour in our study was 0.84. 
Worrying/catastrophizing 
Worrying/catastrophizing was assessed by the 9-item Worrying scale of the Pain 
Coping Inventory (PCI)31,32. Representative items are: “I start worrying when in 
pain” and “I think that the pain will worsen.” Cronbach’s Alpha for worrying in 
our study was 0.82.  
Fear of pain 
Pain-related fear was gauged with the recently adjusted version of the Tampa Scale 
of Kinesiophobia (TSK)33,34, reflecting level of fear of movement due to possible 
subsequent pain/reinjury. The scale’s 13 items are scored on a 4-point scale 
(“highly disagree” to “totally agree”). Representative items are: “My pain means 
there is physical damage” and “My pain tells me to stop exercising so I do not 
injure myself”. Cronbach’s alpha for fear of pain in our study was 0.78. 
Helplessness  
Patients completed the 6-item Helplessness scale of the Illness Cognition 
Questionnaire (ICQ). The ICQ was developed to measure illness cognitions in 
situations of an uncontrollable chronic condition like chronic pain8. To facilitate 
comparison with the other pain-related predictors, the term “illness” in the ICQ 
was replaced by “pain”. The ICQ proved to be reliable and valid in assessing 
illness cognitions (e.g. helplessness and acceptance) in patients with chronic pain8 
as well as in patients with other chronic diseases such as multiple sclerosis and 
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chronic skin diseases8,35. In addition, scales of the ICQ have earlier been shown to 
be sensitive to change in studies evaluating CBT in chronic pain36. The 
Helplessness scale measures cognitions that focus on the negative consequences of 
pain and to what extent the patient generalizes them to daily-life functioning on a 
4-point scale (“not at all” to “completely”). Representative items were: “My pain 
controls my life” and “My pain limits me in everything that is important to me”. 
Cronbach’s Alpha for helplessness in our study was 0.86. 
Acceptance 
Patients rated the 6 Acceptance items of the ICQ on a 4-point scale (“not at all” to 
“completely”) to gauge their cognitions with respect to acknowledgment of their 
chronic pain condition and their notions on their ability to manage the negative 
consequences of the pain. The items of acceptance in the ICQ are as follows: “I 
have learned to accept the limitations imposed by my pain”, “I have learned to live 
with my pain”, “I can accept may pain well”, “I can cope effectively with my 
pain”, “I can handle the problems related to my pain” and “I think I can handle the 
problems related to my pain, even if the pain gets worse”. These items reflect the 
cognition of being able to cope with the pain and the consequences of the pain, 
irrespective of the outcomes of the coping process. Cronbach’s Alpha for 
acceptance in our study was 0.89. 
 
Statistical analysis 
In our analyses we compared the pre- and posttreatment (T1 and T2) scores on the 
questionnaires and seven-day pain-and-medication diaries of the patients in the 
intervention group with the T0 (start of waiting-list period) and T1 (pre-screening) 
ratings of the patients in the control condition. 
Because of skewed distributions of the pain-duration scores, square-root 
transformations were applied. Differences between the intervention and the control 
group at study entry were tested with Student’s t-tests for continuous variables and 
Chi-square analyses for categorical variables. ANCOVA was used to measure the 
main group effect of the various pain treatments on the primary outcome measures 
(pain intensity, functional disability, depression and medication use) and the 
secondary outcomes (avoidance behaviour, worrying, fear of pain, helplessness and 
acceptance) with group as the fixed factor and baseline score as covariate. For 
significant main group effects for the outcome variables, paired t-tests between the 
first and second assessment were conducted separately to gain a better 
understanding of the nature of the interaction. Effect sizes were obtained by 
calculating the difference between the means of the two assessments divided by 
their pooled standard deviations (sd)37. To help detect potential predictors of the 
primary outcome variables in the treatment condition we adopted Baron and 
Kenny’s strategy for mediating effects38,39 and calculated correlations between all 
demographic variables, pain duration and all predictors at baseline and the change 
scores of the primary outcome variables. In accordance with the stepwise method, 
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when correlations were significant, the relevant predictors were included as 
covariates in the regression analyses. Residual gain scores were used to establish 
changes in outcome variables, which were calculated by regressing the outcome 
variable at the post-treatment assessment on the baseline score of the outcome 
measure39. To determine the predictive value of the predictor for the treatment 
condition, the centred interaction term of Group x Predictor was entered into the 
regression analysis as the final, fourth step after controlling for the outcome 
variable at T1 at step 1, the group condition (treatment vs. control condition) at 
step 2 and the predictor at step 3. 
 
 
Table 2: Means (M) and standard deviations (sd) of the primary and secondary outcome 
variables at first and second assessment for the treatment condition (TC: T1 and T2) and 
control condition (CC: T0 and T1); n=110 for both conditions; main group effect of all 
outcomes between treatment condition and control condition (F) 
  FIRST 
ASSESSMENT 
SECOND 
ASSESSMENT 
 
PRIMARY 
OUTCOME VARIABLES 
  
M 
 
sd 
 
M 
 
sd 
 
F 
Pain intensity TC 52.44 18.18 45.35 19.41 7.909  (p=.005) 
 CC 55.45 17.55 52.70 17.56
Functional disability TC 4.93 1.69 4.32 1.68 6.526  (p=.011) 
 CC 5.01 1.88 4.78 1.99
Depression TC 28.45 10.82 26.40 10.80 0.158  (p=.691) 
 CC 27.05 10.11 25.90 10.49
Medication use TC 0.63 0.82 0.53 0.67 1.371  (p=.243) 
 CC 0.76 0.94 0.64 0.94
SECONDARY 
OUTCOME VARIABLES 
    
Avoidance behaviour TC 2.11 0.47 2.02 0.46 0.129  (p=.721) 
 CC 2.14 0.49 2.03 0.53
Worrying TC 20.15 5.52 18.02 5.18 1.045  (p=.308) 
 CC 19.22 4.79 17.96 4.84
Fear of pain TC 28.27 8.81 26.15 7.83 0.158  (p=.801) 
 CC 27.16 7.58 25.25 7.66
Helplessness TC 14.72 4.42 13.84 4.44 0.548  (p=.460) 
 CC 15.14 3.70 14.27 4.11
Acceptance TC 12.83 3.75 14.31 4.11 9.145  (p=.003) 
 CC 13.08 4.06 13.57 4.07
  
Table 3: Cross-sectional correlations in the treatment condition between the study variables at first and second assessment (T1 and T2) 
*  p < .05, ** p < .01, *** p < .001 
 
Study variables  Pain 
intensity 
Functional 
disability 
Depression Medication Avoid. 
behaviour 
Worrying Fear 
of pain 
Helplessness 
Funct. disability T1 
T2 
.42*** 
.50*** 
       
Depression T1 
T2 
.23** 
.28*** 
.39*** 
.34*** 
      
Pain medication T1 
T2 
.22** 
.18** 
.16* 
.29*** 
.11 
.20** 
     
Avoid. behaviour T1 
T2 
.21** 
.22* 
.51*** 
.58*** 
.40*** 
.36*** 
.12 
.17** 
    
Worrying T1 
T2 
.15* 
.21** 
.33*** 
.44*** 
.60*** 
.60*** 
.15* 
.23*** 
.39*** 
.46*** 
   
Fear of pain T1 
T2 
.21** 
.11 
.40*** 
.35*** 
.24*** 
.27*** 
.19** 
.15* 
.29*** 
.40*** 
.44*** 
.43*** 
  
Helplessness T1 
T2 
.33*** 
.41*** 
.58*** 
.64*** 
.50*** 
.44*** 
.09 
.24*** 
.50*** 
.57*** 
.48*** 
.63*** 
.49*** 
.50*** 
 
Acceptance T1 
T2 
-.12 
-.26*** 
-.16* 
-.26*** 
-.23*** 
-.40*** 
-.10 
-.19** 
-.21** 
-.23*** 
-.40*** 
-.51*** 
-.18** 
-.19** 
-.29*** 
-.48*** 
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Results 
Pre-treatment patient characteristics 
Table 1 lists the means of the demographic variables and pain duration and Table 2 
the means and sd of the primary and secondary outcome variables at first 
assessment for the two study groups. Group comparisons did not yield any 
significant differences on any of the variables.  
At first assessment, all variables are moderately correlated (range r=.18-.50), 
indicating that all variables were related with each other but represented different 
constructs. As expected, correlations were about the same at both assessments. 
 
Primary outcomes  
Table 2 depicts the means and sd of the primary outcome variables at both 
assessments for both groups. ANCOVA revealed a significant main group effect 
for pain intensity (F(1, 215)=7.909, p=.005) and functional disability (F(1, 214)= 
6.526, p=.011). Paired t-tests showed that pain intensity had decreased significantly 
in the treatment condition (t=4.17, df=106: p<.001) but not in the control 
condition, which also applied to functional disability (t=6.20, df=106: p<.001). 
ANCOVA group effects were not significant for depression nor for use of 
medication (F(1, 217)=0.158, p=0.691 and F(1, 218)=1.371, p=.243, respectively). 
 
Secondary outcomes 
The ANCOVAs yielded a significant main group effect for acceptance (F(1, 214)= 
9.145, p=.003). Paired t-tests showed that acceptance had increased significantly in 
the treatment condition (t=-5.56, df=106: p<.001) but not in the control condition. 
ANCOVA group effects were not significant for worrying (F(1, 217)=1.045, 
p=.308) nor for avoidance behaviour (F(1, 217)=0.129, p=.721), fear of pain (F(1, 
210)=0.158, p=.801) or helplessness (F(1, 216)=0.548, p=.460). 
 
Effect sizes 
For the intervention group the effect sizes for the primary outcome measures of 
pain intensity and functional disability and for the secondary outcome measure of 
acceptance were close to medium (0.37, 0.36 and 0.38, respectively) 37. In contrast, 
the effect sizes for the control condition revealed almost no changes (0.15, 0.06 
and 0.12, respectively).  
 
Cognitive-behavioural predictors of treatment outcomes 
To facilitate the identification of predictors of the primary outcome variables, we 
computed correlations between all demographic variables, pain duration and all 
predictors at baseline (avoidance behaviour, worrying/catastrophizing, fear of pain, 
helplessness and acceptance) and the change scores of the outcome variables in the 
treatment condition. For pain intensity, no significant correlations were found apart 
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from a correlation with acceptance, which proved statistically significantly related 
to a decrease in pain intensity in the treatment (r=.20, p=.038) but not in the control 
condition (r=.05, p=.551). To examine the effect of group on the predictive value 
of acceptance, the centred interaction term of Group x Acceptance was entered into 
the regression analysis as the fourth step after controlling for the outcome variable 
at step 1, group (treatment vs. control condition) at step 2 and acceptance at step 3.  
 
 
Table 4: Regression analysis of change in pain intensity after multidisciplinary pain 
treatment 
Order of entry R.Sq.  
Change 
Beta 
Dep. Variable: Pain T2   
1. Pain T1 .34*** .57*** 
2. Group .02*** .10 
3. ZCL Acceptance .00 -.08 
4. Group x acc .01* -.12* 
   
Total R2 .37  
* p < .05, ** p < .01, *** p < .001 
 
 
Table 4 shows that, after having controlled for baseline pain level (explaining 34%: 
F-change=111.55, df=214, p=.000), condition (treatment vs. control, explaining 
another 2%, df=213, p<.007) and acceptance (not explaining any significant 
additional variance), the regression analyses with pain intensity at T2 as the 
dependent variable revealed that the interaction of acceptance and condition at step 
4 significantly predicted another 1% of the pain intensity at T2 (F-change=4.29, 
df=212, p<.024). Beta coefficients of the full model demonstrated that the 
interaction of acceptance and condition contributed significantly to the patients’ 
post-treatment level of pain (p<.05), indicating that after therapy those patients that 
had reported higher degrees of pre-treatment acceptance also had larger pain 
reductions than the patients reporting lesser degrees of pre-treatment acceptance 
(see Figure 2). With regard to functional disability, depression and use of 
medication, avoidance behaviour proved associated with changes in depression and 
helplessness significantly correlated with change in medication intake. However, 
regression analyses failed to yield significant predictors. For illustration purposes, 
we split the sample into two groups (acceptance ≥ 13 and acceptance < 13) to show 
that patients with a higher pre-treatment level of acceptance profited more from 
treatment with respect to pain reduction. 
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Figure 2: Change in pain intensity for patients with high/low acceptance (median split) in 
the treatment group between pre-treatment and post-treatment. 
 
 
Discussion 
With the current study we sought to determine the effects of a multidisciplinary 
outpatient allocation protocol of chronic pain treatment on the physical and 
psychological outcomes of chronic pain patients and to trace process variables that 
could have a predictive value for treatment efficacy. Our findings showed that the 
participating patients tended to benefit from our pain allocation approach with 
regard to pain intensity and functional disability. As regards cognitive-behavioural 
treatment predictors, we established that patients reporting higher pre-treatment 
levels of acceptance benefited more from treatment in terms of pain reduction than 
patients indicating lower levels of acceptance.  
In line with other studies on multidisciplinary treatment approaches1,2,3,4, the 
treatment effects for pain and functional disability were significant although 
generally not more than small. In contrast, depression did not diminish beyond 
natural course. This lack of effect may be due to negative mood not being the main 
focus of the treatment modalities delivered, which is especially the case in 
pharmacological and TENS programmes. As only a relatively small percentage of 
our patients received treatment specifically aimed at reducing their depressive 
symptoms, it would be worthwhile if future studies were to also evaluate such 
targeted treatment modules. We also did not find any significant reductions in 
medication consumption beyond the natural course, which is congruent with 
Becker et al.’s findings40. Before being referred to our pain centre many of the 
patients had already had their medication schedule revised in a regional pain 
centre. Moreover, our centre’s pharmacological intervention was not exclusively 
aimed at reducing the patients’ drug intake. It also targeted elimination of the 
uncontrolled, pain-contingent use of medication through which in many cases 
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stabilisation was obtained but no overall reduction. Clearly, an adequate 
delineation of treatment effects on medication intake merits a different 
operationalisation. The overall moderate effects may also be attributed to large 
individual differences in outcomes, underscoring the need for reliable predictors of 
treatment effects36,41.  
Of all possible cognitive-behavioural predictors of treatment outcome, only 
acceptance predicted pain reduction. Contrary to our expectations, the patients with 
higher pre-treatment levels of acceptance proved to show more reduction in pain. 
Several earlier studies had indeed supported the importance of acceptance in 
chronic pain. Cross-sectional and prospective studies evaluating various chronic 
pain populations showed that acceptance was consistently associated with lower 
pain intensity, superior daily functioning and fewer depressive symptoms8,11,23,42,43 . 
In their recent correlational study of chronic pain patients, McCracken and 
Eccleston44 reported that acceptance accounted for more variance in functional 
disability and depression than any of the other cognitive-behavioural factors. Pain 
treatment studies have reported similar findings. Geiser45, for instance, found that 
increases in acceptance during multidisciplinary pain treatment predicted a 
decrease in post-treatment functional disability. Vowles et al.46 showed that in 
chronic back-pain patients an acceptance-based pain treatment reduced impairment 
more than a control-based intervention did. Although in our study, higher 
acceptance only modestly predicted pain reduction, the results are a first indication 
of acceptance as a predictor of treatment outcome and as an instrument to optimise 
patient selection and subsequent treatment outcomes. Cognitions of acceptance 
may thus reflect that a patient’s focus is more directed towards (augmenting) 
adaptive coping behaviour, which positively affects treatment outcome, supporting 
previous findings correlating acceptance with less attention to pain43 and active 
coping behaviour8. These and the current findings underscore the contribution of 
acceptance as an adaptive coping strategy, thus extending our understanding of the 
mechanisms of improvement in multidisciplinary chronic-pain treatment 
approaches. The lack of significant predictive power of the other cognitive-
behavioural factors is generally in line with earlier chronic-pain-treatment 
studies4,14 that also yielded inconsistent results. Evidently, the interaction between 
the various cognitive-behavioural factors and pain treatment might be more 
complex, requiring more in-depth studies into potential reciprocal effects of 
cognitive-behavioural predictors for short-term treatment effects. 
Several aspects warrant a cautious interpretation of the results reported. Firstly, it 
cannot be excluded that there was some selection bias due to non-randomized 
treatment allocation. However, patients were allocated to the intervention or 
control condition on a consecutive basis so the investigators had no influence on 
the allocation of individual patients, one of the preconditions for randomisation. In 
addition, the two groups did not differ with respect to demographic or pain-related 
data. In future studies, propensity score matching47 may be applied if the patient 
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characteristics in the intervention and control groups do differ due to non-
randomized allocation. Secondly, the patients in the control condition were 
evaluated after a waiting-list period of three months. A randomized controlled trial 
or an active control condition (e.g. a support group) would have allowed 
elimination of a possible bias in treatment effects. Thirdly, as the allocation to the 
intervention or the control group was based on time of entry, a time bias (e.g. 
seasonal effects) cannot be excluded. Fourthly, all our participants were 
acknowledged chronic-pain sufferers referred for treatment to our specialized, 
academic pain centre and had, on average, experienced pain in excess of five years. 
Most of the participants indicated to have received previous medical treatment 
comprising one or more comparative treatment modules in recent years. Hence, we 
cannot exclude a selection bias. In addition, the anticipation of imminent pain 
treatment may have raised treatment expectations in the control group, which may 
have positively affected their pain cognitions and subsequent course of pain 
behaviour. Moreover, our search for outcome predictors was based on the short-
term effects of various, patient-tailored chronic-pain treatment modules and the 
reported results cannot be generalised to long-term outcomes. A follow-up study 
might provide more insight into the stability of treatment effects48. At this moment 
we know of only one study on the natural course in chronic-pain patients, showing 
that acceptance predicted a decrease of pain and depression after one year8. Finally, 
it can be argued that in daily life the multidimensional problems of chronic pain, 
functional disability, depression and use of medication are interrelated such that it 
hampers most attempts at outpatient interventions aimed at changing one or more 
of these modalities as the patient’s contacts are limited and treatment conditions 
can only marginally be controlled. This is confirmed by the findings of Williams et 
al.49 and Härkäpää et al.50 showing that a multidisciplinary inpatient pain treatment 
was superior to an outpatient programme in terms of pain reduction and 
improvement of functional ability. Possibly, the treatment intensity in time and 
frequency of inpatient interventions might be more important for treatment success 
than the content of specific (multidisciplinary) treatment schemes. 
Despite these limitations, our study has provided further evidence that patients 
suffering from chronic heterogeneous pain tend to profit from pain treatment 
schemes in that the tailored interventions reduce their pain levels and functional 
disability. We also found preliminary support that patients who are accepting their 
condition are most likely to benefit from treatment in terms of pain reduction. 
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 Abstract 
Objective: To investigate the long-term effects of multidisciplinary allocation of 
pain treatment on pain intensity, functional disability, depression, and medication 
use in outpatients with chronic pain, and to identify cognitive-behavioural 
predictors [worrying/catastrophizing, avoidance behaviour, fear of pain, 
helplessness, and acceptance] of the primary outcome measures. 
Methods: Eighty-six outpatients with chronic pain who were treated at a 
multidisciplinary pain centre completed various questionnaires and a pain diary 
one week before treatment started, and three and 12 months later.  
Results: Functional disability and depression improved significantly 12 months 
after the start of treatment in comparison with before treatment. The decrease in 
scores for the cognitive-behavioural variables worrying/catastrophizing, fear of 
pain, helplessness, and avoidance behaviour at three months was associated with 
the decrease in functional disability and depression at 12 months.  
Conclusion: Patients with chronic pain may benefit in the long term from 
multidisciplinary allocation to pain treatment with respect to functional disability 
and depression. Changes of cognitive-behavioural processes seem to contribute to 
achieving long-term effects of multidisciplinary allocation of pain treatment. There 
is a need for high quality clinical trials in this field in order to clarify the specific 
contribution of cognitive-behavioural process variables. 
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Introduction  
There is considerable evidence that multidisciplinary treatment of chronic pain, 
involving medical, physical, and cognitive-behavioural components is effective in 
improving pain intensity, functional disability, and depression in various chronic 
pain populations1,2,3,4. However, in most studies there were large inter-individual 
differences, with a considerable proportion of patients reporting no effects or even 
deterioration in functioning5,6, which may indicate that self-management skills 
have not improved sufficiently during treatment. 
Consequently, studying predictors of long-tem treatment effects may give relevant 
information about the factors that influence effects of treatment. The fear-
avoidance model of chronic pain7,8,9 provides a theoretical basis for studying 
cognitive-behavioural factors in chronic pain. Within this model, fear of pain 
functions as an anxiety response, directed towards the immediate consequences 
with regard to pain intensity. Fear of pain in turn is supposed to initiate 
worrying/catastrophizing about the consequences of pain and hence increases 
avoidance behaviour, leading in the long term to increased pain, functional 
disability, and depression9. Within the fear-avoidance model, avoidance behaviour 
is reinforced by the experience that it is a way to control pain by limiting the pain 
experience. However, in the chronic phase of the pain problem, the ongoing 
experience of unsuccessful coping may induce depressogenic cognitions of 
helplessness in accordance with the Learned Helplessness Theory10,11. Helplessness 
acts as an additional negative cognition as activities are not expected to enhance 
better overall functioning, and may in time induce avoidance behaviour and lead to 
a further increase in functional disability, depression12,13, and medication intake as 
a passive coping strategy. Consequently, both models separately may provide a 
valid contribution to explaining the course of functioning in patients suffering from 
a relative longer period of pain and may provide instruments for multidisciplinary 
pain treatment. There is also preliminary evidence that acceptance12,14 may be an 
important factor in people suffering from long-term functional disability and 
pain13,15. Accepting the experience of pain and its consequences may induce a more 
active, confrontational way of coping and subsequently lead to better 
functioning16,17. Previous studies have shown that changes in cognitive-behavioural 
predictors during the treatment period affect outcomes immediately after treatment 
and after a follow-up period. In particular, a decrease in worrying/ 
catastrophizing18,19, helplessness19,20, and an increased acceptance19,21,22 have been 
shown to be predictive of a favourable treatment outcome. However, long-term 
effects of multidisciplinary pain treatment and cognitive-behavioural correlates of 
treatment success, including fear-avoidance predictors (worrying/catastrophizing, 
fear of pain, and avoidance behaviour), helplessness, and acceptance have not yet 
been studied. 
It has been repeatedly suggested that tailoring medical, physical, and psychological 
pain treatment modalities to specified patient characteristics is a promising way to 
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optimise treatment effects, particularly in the long term4,23,24. An earlier study 
showed that such a multidisciplinary pain treatment strategy of tailoring medical, 
physical, and psychological pain treatment components to specified patient criteria 
has a short-term effect on pain intensity and functional disability15. In the present 
study we investigated the long-term effects of this outpatient, multidisciplinary 
allocation of pain treatment on pain intensity, functional disability, depression, and 
use of pain medication, and studied cognitive-behavioural correlates of outcome. 
We hypothesized that the pain treatment would be effective after 12 months on 
primary outcome measures (pain intensity, functional disability, depression, and 
use of pain medication) and that these long-term effects would be predicted by 
change in cognitive-behavioural factors (worrying/catastrophizing, avoidance 
behaviour, fear of pain, or helplessness) and less acceptance at three months after 
start of treatment as patients would learn to actively cope with their pain. 
 
 
Patients and procedure 
Patients  
Study participants were patients who had been accepted for treatment at the 
interdisciplinary pain treatment centre of the Radboud University Nijmegen 
Medical Centre in the Netherlands. To qualify for inclusion in the study, patients 
had to be at least 18-years-old and have had pain for more than three months. 
Exclusion criteria were cancer pain, biomedical disorders that could interfere with 
treatment (e.g., rheumatoid arthritis, serious psychiatric disorders), and/or the 
inability to read or write Dutch. In addition, patients who were treated elsewhere, 
i.e. received exercise therapy and/or individual cognitive-behavioural treatment, 
and patients who did not receive any treatment were excluded from the study. After 
inclusion, all patients completed questionnaires and a pain diary before treatment 
and after three and 12 months. Demographic variables of the study group are 
presented in Table 1.  
 
Multidisciplinary Allocation of Pain Treatment 
Patients who had been accepted for treatment by the multidisciplinary team were 
assessed by an anaesthesiologist, a physiotherapist, and a clinical psychologist, and 
completed questionnaires on medical and psychological functioning. Treatment 
consisted of a multidisciplinary pain diagnosis, based on agreement between the 
three disciplines and subsequent allocation to one or more of the following 
treatment modules on basis of meeting specified criteria: 
Medical Treatment 
The aim of medical treatment was to reduce pain by adjusting and minimizing pain 
medication on a time-contingent basis. Criteria for medical treatment were 
medication without pain effect, medication use on a pain-contingent basis, 
presence of negative side effects, and/or use of conflicting or similar pain 
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medication. 
Transcutaneous Electrical Nerve Stimulation  
Transcutaneous electrical nerve stimulation (TENS) is a non-invasive intervention 
that alleviates pain25. The TENS stimulator is a small portable battery-powered 
stimulator, connected by electric wiring to self-adhesive electrodes, applied to the 
skin. Patients can carry the stimulator while they perform their daily activities. 
After instruction and adjustment of pulse variables and electrode placement by an 
experienced physiotherapist, patients are able to manage TENS treatment by 
themselves. The aim of TENS treatment was to reduce pain. Criteria for TENS 
treatment was pain because of peripheral nerve root lesions.  
Group Cognitive-Behavioural Therapy 
Cognitive-behavioural therapy (CBT) consisted of 10 sessions of 1.5 hours with 
the following treatment components: stress management techniques, problem 
solving, cognitive therapy, and relaxation. In addition, patients worked on 
individual goals. In the first session, each patient formulated a specific CBT goal, 
based on specific underlying problems such as work-related conflicts or marital 
problems. In the following sessions, patients learned problem-solving techniques 
and practiced these to solve their problems. The group consisted of five to 12 
patients and was led by two psychologists. The aim of group CBT was to decrease 
functional disability and depression. Criteria for group CBT were medically 
untreatable pain and low levels of physical, psychological, and social functioning26. 
Patients who met the criteria for more than one treatment modality received a 
combination of treatments. Duration of all treatment modules was maximum of 
three months. We did not offer a combination of medical treatment or TENS with 
group CBT because it was expected that, due to their pain-reduction objectives, 
both the medical treatment and TENS would undermine CBT treatment 
compliance as this latter intervention is specifically directed at coping with pain. 
Patients who already had received TENS treatment and were considered to have an 
optimal medication scheme, only received CBT with the goal of better functioning, 
and reduction of depression. 
Figure 1. Study Design: study period of predictors (A) and study period of primary 
outcomes (B) 
T1: 
Start of treatment 
T2: 3 months after 
start of treatments 
T3: 12 months after 
start of treatments 
A
B
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Measures 
Patients completed validated questionnaires and a seven-day pain-and-medication 
diary one week before treatment started and three and 12 months later (Figure 1). 
 
Pain Intensity 
Since multiple visual analogue scale (VAS) ratings have been shown to be more 
reliable and valid for measuring average pain intensity than a single rating27, study 
participants were asked to rate their pain on a 10-centimeter VAS for seven days at 
three time points each day. The pain VAS scale ranged from no pain at all to the 
worst pain ever experienced. The average of the 21 pain ratings for each patient 
was calculated. Cronbach’s alpha for pain intensity in our study was 0.91. 
Functional Disability 
Functional disability was measured with the Dutch version of the Pain Disability 
Index (PDI)28,29. The Pain Disability Index was developed as a brief self-report 
indicator of pain-related disability27. It was constructed as a seven-item 
questionnaire scored on a scale from 0 (no disability) to 10 (total disability). The 
items reflect a range of role functioning: family/home responsibilities, recreation, 
social activities, occupation, sexual behaviour, and self-care and life-supporting 
activities. The average level of the items scored was used to calculate the disability 
index. Cronbach’s alpha for functional disability in our study was 0.82. 
Depression 
Depression was measured with the depression scale of the Dutch version of the 
Symptom Checklist-9030 measuring 16 symptoms of depression, rated on a five-
point scale from 1 (not at all) to 5 (very much). Cronbach’s alpha for depression in 
our study was 0.87. 
Use of Medication 
Use of medication was measured according to the Anatomical Therapeutical 
Chemical Classification/Defined Daily Dose (DDD) guidelines31 by comparing the 
defined, average amount of drugs needed to obtain the desired effect on pain in the 
general population (DDD), and the actual use of drugs (used daily dose (UDD)). 
The actual use of medication was calculated by dividing the UDD of a drug by the 
DDD of the same drug. When patients used more than one drug for pain, the 
relative amounts of the different drugs (UDD/DDD) were summed to give a total 
level of medication use31,32,33.  
Avoidance Behaviour 
Avoidance behaviour was measured with the composite score of the passive pain 
coping scales of Retreating and Resting [13 items] of the Pain Coping Inventory 
(PCI)34,35. The PCI measures cognitive and behavioural attempts to cope with pain 
on a four-point Likert scale from 1 (rarely or never) to 4 (very frequently). 
Representative items are, ‘When in pain and I am outdoors, I try to return home as 
soon as possible’, ‘When in pain, I rest by sitting or lying down, ‘When in pain, I 
quit my activities’. Cronbach’s alpha for avoidance behaviour in our study was 
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0.83.  
Worrying/catastrophizing 
Worrying/catastrophizing was assessed with the Worrying (nine items) scale of the 
PCI34,35. Representative items are “I start worrying when in pain” and “I think that 
the pain will worsen.” Cronbach’s alpha for worrying/catastrophizing in our study 
was 0.81.  
Fear of Pain 
Fear of pain was measured with the recently adjusted version of the Tampa Scale 
of Kinesiophobia (TSK)36,37, which measures fear of movement due to possible 
subsequent pain/reinjury. The TSK consists of 13 items, scored on a four-point 
scale, from 1 (highly disagree) to 4 (totally agree). Representative items are “My 
pain means there is physical damage” and “My pain tells me to stop exercising so I 
do not injure myself.” Cronbach’s alpha for fear of pain in our study was 0.79. 
Helplessness 
Helplessness was measured with the Helplessness scale of the Illness Cognition 
Questionnaire (ICQ). The ICQ assesses how patients think about and give meaning 
to their chronic illness12. Helplessness is assessed with six items and measures 
cognitions that focus on the negative consequences of pain and generalize them to 
daily functioning. In order to enable comparison with the other pain-related 
predictors, the term “illness” in the ICQ was replaced by “pain.” Representative 
items of the Helplessness scale of the ICQ are: “My pain frequently makes me feel 
helpless”, “My pain limits me in everything that is important to me”, and “My pain 
controls my life.” The items are rated on a four-point scale from 1 (not at all) to 4 
(completely). Cronbach’s alpha for helplessness in our study was 0.86. 
Acceptance 
Acceptance was measured with the Acceptance Scale of the ICQ12. The six-item 
scale measures acceptance in terms of cognitions that focus on the person 
acknowledging that he/she suffers from chronic pain and perceiving that he/she has 
the ability to manage the negative consequences of the pain. To enable comparison 
with the other pain-related predictors, the term “illness” in the ICQ was replaced 
by “pain.” Representative items of the Acceptance scale of the ICQ are: “I have 
learned to accept the limitations imposed by my pain”, “I have learned to live with 
my pain”, and “I can handle the problems related to my pain.” Cronbach’s alpha 
for Acceptance in our study was 0.87. 
 
Statistical Analysis 
Because of skewed distributions of scores at pain duration, square root 
transformations were applied. Differences in demographic variables, pain duration, 
and outcome variables between the completers (patients who completed pain 
treatment and provided follow-up data) and non-completers (patients who 
completed pain treatment but did not provide follow-up data) before treatment 
were tested with chi-square analyses for categorical variables and student’s t-test 
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for continuous variables, with p<.05 indicating a statistically significant difference. 
Univariate variance analyses were conducted to test differences between 
completers and non-completers for short-term treatment effects (at three months) 
on primary and secondary outcomes. The long-term effects of treatment (at 12 
months) on the primary outcomes (pain intensity, functional disability, depression, 
and use of medication) were tested by two-tailed paired t-tests. Cognitive-
behavioural factors (worrying/catastrophizing, avoidance behaviour, fear of pain, 
helplessness, and acceptance) were regarded as secondary outcome variables. 
Effect sizes were calculated in accordance with the formula of Dunlap et al.38. The 
number of patients with clinically significant changes was calculated by summing 
the number of patients with a positive change exceeding half a standard 
deviation39. To investigate cognitive-behavioural predictors, correlations were 
calculated between the long-term change in the scores of the significant primary 
outcome variables (between before and 12 months after start of treatment) and the 
short-term change in scores of cognitive-behavioural predictors (between before 
and three months after start of treatment). Residual gain scores were used to 
calculate changes in outcome and predictor variables and were calculated by 
regressing the variable at the three-month (predictor) or at the 12-month 
assessment (outcome) on the baseline score of the measure40. In the case of 
significant correlations between primary outcomes and the cognitive-behavioural 
predictors, these predictors were entered separately in univariate regression 
analyses with the outcome variable at the 12-month follow-up as dependent 
variable, after controlling for the outcome variable at baseline (before treatment). 
Subsequently, the predictors were entered in consecutive steps in multivariate 
regression analyses in order to study their relative contribution. To control for 
possible confounding effects of demographic variables (gender, marital status, age, 
education level) and pain duration at baseline, correlations were calculated 
between these variables and the change in the scores of the primary outcome 
variables at the 12-month follow-up. In the case of significant correlations, these 
variables were entered at step 2 before the predictors in the regression analyses. 
 
 
Results 
In total 110 patients meeting the inclusion criteria were consecutively included in 
the study. Most of the patients were women (61.6%), married (67.1%), and had a 
secondary education level (83.5%). 
The primary sites of pain were the legs (29 patients, 33.7%), back (28 patients, 
32.5%), neck and shoulders (24 patients, 27.9%), arms (14 patients, 16.2%), pelvis 
(three patients, 3.4%), head and face (three patients, 3.4%), belly (three patients, 
3.4%), whole body (one patient, 1.1%), and breast (one patient; 1.1%). In total 12 
patients (13.9%) reported pain at two sites and four patients (4.6%) reported pain at 
three sites. Mean pain duration was 68.1 months (median=42, sd=79.4, range 7-
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420 months). 
Of all patients, 24 patients (22%) did not complete the follow-up (moved house, 
n=3; not interested or no time available, n=21); they are referred to as “non-
completers.” Thus, of the 110 patients included in the study, the data of 86 (78%) 
were analysed.  
 
Table 1: Means of demographic variables and pain duration of the study group at study 
entry 
Measure n=86 
Gender: % women 61.6 
Mean age (sd) 48.9 (14.1) 
Married  67.1 
Educational level   
    primary 14.1 
    secondary 83.5 
    tertiary 2.4 
Mean pain duration in months (sd) 68.1 (79.4)  
 
In total 16 (18%) patients received medical treatment, 38 (44%) patients received 
TENS treatment, 14 (16%) patients received group CBT, and 18 (21%) patients 
received a combination of medical treatment and TENS. 
 
Comparison of Completers and Non-Completers 
Comparison of the final study sample (n=86) and non-completers (n=24) revealed 
no significant differences in demographic variables (gender, age, education, marital 
status), pain duration, or any of the primary (pain intensity, functional disability, 
depression, and medication use) and secondary outcome variables (worrying/ 
catastrophizing, avoidance behaviour, fear of pain, helplessness, and acceptance) at 
baseline between the groups. Additionally, no significant differences in short-term 
treatment effects were found for pain intensity, functional disability, depression, or 
use of medication between completers and non-completers.  
 
Long term effects 
Outcome variables (means and standard deviations) are presented in Table 2. 
Analysis of changes in the treatment group from before treatment to 12 months 
after treatment showed that functional disability and depression decreased 
significantly (t=3.80, p<.001 and t=2.47, p<.05, respectively), and that level of pain 
decreased, but not significantly (t=1.92, p=.058).  
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Table 2: Results of primary outcome variables and secondary outcome variables (n=86); 
(T1 = before start of treatment; T2 = 3 months after start of treatment; T3 = 12 months 
after start of treatment, sd=standard deviation) 
 T1 T2 T3 
 Mean sd Mean sd Mean sd 
Primary outcomes       
- pain intensity 53.96 17.7 45.32 19.4 49.55 22.0 
- disability 4.86 1.7 4.19 1.6 4.26 1.8 
- depression 28.05 10.6 26.29 10.7 26.06 10.3 
- medication use 0.71 0.95 0.51 0.70 0.59 0.97 
Secondary outcomes       
- worrying/catastrophizing 19.91 5.7 17.73 4.7 17.84 5.3 
- avoidance behaviour 2.09 0.48 1.99 0.48 1.99 0.50 
- fear of pain 27.87 9.11 26.04 7.84 27.10 7.70 
- helplessness 14.29 4.4 13.35 4.4 13.14 3.8 
- acceptance 12.93 3.9 14.73 4.3 14.72 4.2 
 
Table 3: Correlations between short-term changes in cognitive-behavioural predictors and 
long-term changes in disability and depression; (T1-T2 = before and 3 months after start of 
treatment, T1-T3 = before and 12 months after start of treatment) 
Prediction of long-term change Decrease in 
functional 
disability 
 (T1-T3) 
Decrease in 
depression 
 
(T1-T3) 
Decrease in avoidance behaviour (T1-T2) 0.15 0.27** 
Decrease in worrying/catastrophizing (T1-T2) 0.31** 0.32** 
Decrease in fear of pain (T1-T2) 0.24* 0.27* 
Decrease in helplessness (T1-T2) 0.21* 0.25* 
Increase in acceptance (T1-T2) -0.08 0.05 
*  p< .05, **  p< .01  
 
Medication use did not decrease significantly (t=1.29, p=.20). Effect sizes were 
moderate for functional disability (0.34) and small for pain intensity (0.19), 
depression (0.19), and use of medication (0.11). The number of patients with 
clinically significant improvement was moderate for pain intensity (n=28; 32%) 
and small for functional disability (n=17; 20%), depression (n=7; 8%) and 
medication use (n=10; 9%). Of the secondary outcomes, worrying/catastrophizing 
(t=4.46, p<.001), avoidance behaviour (t=2.09, p<.05), fear of pain (t=2.20, p<.05), 
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and helplessness (t=3.17, p<.01) significantly decreased, and acceptance (t=-4.82, 
p<.001) increased significantly (see Table 3). Effect sizes were small for 
worrying/catastrophizing (0.37), avoidance behaviour (0.20), fear of pain (0.21), 
helplessness (0.28), and acceptance (0.44). The number of patients with clinically 
significant improvement was moderate for acceptance (n=26; 30%), helplessness 
(n=19; 22%), and worrying (n=18; 21%), and small for fear of pain (n=7; eight 
percent). 
 
Prediction analyses of long-term changes were performed for the significant 
primary outcomes of functional disability and depression. No significant 
correlations were found between demographic variables and pain duration at 
baseline and long-term change scores for functional disability and depression. 
Subsequently, correlations were calculated between short-term change scores of 
the predictors (before and three months after treatment) and long-term change 
scores of functional disability (before and 12 months after treatment) (see Table 3).  
 
A decrease in worrying/catastrophizing (r=0.31, p<.01), fear of pain (r=0.24, 
p<.05), and helplessness (r=0.21, p<.05) up to three months after treatment was 
significantly correlated with the long-term decrease in functional disability.  
Hierarchical regression analyses were performed with functional disability at 12 
months as dependent variable, after controlling for baseline functional disability at 
step 1 of the regression analysis (see Table 4). Univariate analyses revealed that 
short-term decrease in worrying/catastrophizing at step 2 explained five percent (F-
change=9.21, p<.01) and short-term decrease in fear of pain at step 2 explained 
three percent (F-change=5.02, p<.05). Short-term decrease in helplessness tended 
toward significance (F-change=3.92, p=.051). Beta coefficients of the whole model 
revealed that, in addition to the baseline level of functional disability, only 
decreased worrying/catastrophizing had a tendency toward significance (t=1.98, 
p=.05). Multivariate analyses revealed no additional explained variance at step 3 
for any of the predictors. When analysing predictors of the reduction in depression 
(see Table 4), we found that a short-term (at three months) decrease in worrying 
(r=0.32, p<.01), avoidance behaviour (r=0.27, p<.01), fear of pain (r=0.27, p<.01), 
and helplessness (r=0.25, p<.05) was significantly correlated with the long-term (at 
12 months) decrease in depression. After controlling for depression at baseline 
(explaining 74% of the variance, F-change=102.91, p<.001), we found in 
univariate regression analyses with depression at 12 months as dependent variable 
that a decrease in worrying (F-change=9.51, p<.01), avoidance behaviour (F-
change=6.89, p<.01), fear of pain (F-change=6.16, p<.05), and helplessness (F-
change=5.42, p<.05) all significantly predicted the decrease in depression at 12 
months, when entering the predictors separately at step 2. Multivariate analyses 
revealed no additional explained variance at step 3 for any of the predictors. 
  
 
Table 4: Univariate regression analysis of functional disability and depression at T3 as dependent variables and the predictors entered  
separately at step 2 after controlling for the dependent variable at T1 at step 1 
(T1 = before start of treatment, T2 = 3 months after start of treatment, T3 = 12 months after start of treatment) 
Order of Entry F 
Change  
R2 
Change 
Beta Order of Entry F   
Change 
R2 
Change 
Beta 
Dependent Variable 
Functional Disability T3 
   Dependent  
Variable Dep. T3 
   
1. Functional Disability T1 71.20*** 0.46*** 0.70*** 1. Depression T1  102.91*** 0.55*** 0.74*** 
2. Worr/cat T1-T2 9.21** 0.05** 0.23** 2. Worr/cat T1-T2 9.51** 0.04** 0.21** 
        
1. Functional Disability T1 68.16*** 0.47*** 0.68*** 1. Depression T1  102.94*** 0.55*** 0.74*** 
2. Fear of pain T1-T2 5.02* 0.03* 0.14 2. Avoidance behaviour T1-T2 6.89* 0.03* 0.17* 
        
1. Functional Disability T1 70.93*** 0.46*** 0.68*** 1. Depression T1  91.60*** 0.54*** 0.74*** 
2. Helplessness T1-T2 3.92 0.02 0.15 2. Fear of pain T1-T2 6.16* 0.03* 0.18* 
        
    1. Depression T1  99.39*** 0.55*** 0.74*** 
    2. Helplessness T1-T2 5.42* 0.03* 0.17* 
* p< .05, ** p< .01, *** p< .001 
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Discussion 
The purpose of the present study was to examine the long-term effects of a tailored 
outpatient allocation of pain treatment strategy and to identify cognitive-
behavioural factors that may reflect treatment processes and predict long-term 
changes. We identified a small but significant long-term decrease in functional 
disability and depression, suggesting that patients with chronic pain patients have 
sustained benefit from a multidisciplinary allocation of pain treatment strategy with 
regard to functional disability and depression. We found that the long-term 
decrease in functional disability and depression was associated with the short-term 
decrease in the cognitive-behavioural factors worrying/catastrophizing, avoidance 
behaviour, fear of pain, and helplessness. This suggests that these factors have a 
role in the treatment process and that the long-term effects of treatment might 
partly be ascribed to changes in these factors.  
The sustained but limited long-term decrease in functional disability and 
depression is consistent with the findings of other studies of multidisciplinary pain 
treatment strategies1,41,42. In another study involving the same patient sample 
(Samwel et al., this thesis), we found that functional disability and depression also 
significantly decreased immediately after treatment in comparison to a waiting list 
control group, as was the level of pain; however, unlike the effects of treatment on 
functional disability and depression, the effect of treatment on pain was not 
sustained during the 12-month follow-up. Use of medication did not decrease 
beyond that expected, possibly because the main aim of treatment was to reduce 
the consequences of pain and the uncontrolled, pain-contingent use of medication 
rather than to reduce medication use, per se. In fact, medication use may increase 
to achieve adequate pain control, which implies that a decrease in medication use is 
not a goal in itself. 
In view of the limited long-term effects, it is important to study process variables 
moderating treatment effects. The long-term decrease in functional disability and 
depression was associated with the short-term decrease in worrying/ 
catastrophizing, fear of pain, avoidance behaviour, and helplessness. These 
findings suggest that treatment focused on changing these aspects would bring 
about a beneficial change in functional disability and depression. This finding also 
indicates that treatment for chronic pain that aims to improve functioning and 
which includes cognitive-behavioural components to increase self-management 
skills after treatment may help patients to sustain the improvements attained during 
treatment. This is in line with the fear-avoidance model, which hypothesizes that a 
decrease in fear-avoidance factors will in the long-term lead to a less pain 
preventing way of coping with pain and in stead and consequently less functional 
disability and depression. Our findings also suggest that within this model, less 
avoidance behaviour does not automatically lead to more fear of pain and 
consequently re-increase of avoidance behaviour. In addition, the learned 
helplessness model, hypothesizing that reducing helplessness cognitions may re-
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induce a more active coping behaviour and subsequent better functioning and 
mood. It may be concluded that applying treatment components reducing levels of 
worrying, fear of pain, avoidance behaviour, and helplessness may improve the 
effects of a tailored multidisciplinary pain treatment strategy. In addition, our study 
supports the hypothesis that both the fear-avoidance model and the learned 
helplessness model may contribute to a theoretical basis for understanding 
treatment processes in multidisciplinary treatment. 
Our study had a number of limitations. Firstly, we did not include a control group 
and the allocation to treatment was not randomized. Thus, we cannot exclude that 
the improvement was due to spontaneous remission rather than the treatment. 
However, the long-term effects on functional disability were consistent with effects 
reported earlier20,43,44. Secondly, it is possible that only those patients who 
considered treatment to have been beneficial were willing to provide follow-up 
data, which may lead to overestimation of the treatment results45,46. Thirdly, the 
small to moderate effect sizes may be due to the limitations of an outpatient-based 
treatment setting. It could be argued that inpatient treatment settings have more 
instruments for treating patients with chronic pain of unknown origin47,48. This 
could mean that hypotheses concerning treatment effects should be adjusted for the 
setting (inpatient versus outpatient) and should be studied with respect to cost-
effectiveness (for example, what are the overall costs for a mean decrease in pain 
intensity of one point on VAS scale for one pain patient?). Fourth, clinically 
significant improvement was calculated by means of minimally detectable 
changes39. It may be argued that the criteria as suggested by Norman et al.39 does 
not necessarily imply clinically meaningful changes. Future studies have to address 
this issue in more detail by examining, for example, various methods to assess 
clinically significant change in different health care programs. Finally, our follow-
up period was 12 months, but that of other studies varied from three months to four 
years49, which makes it difficult to compare results. Hazard et al.50 showed that 
different variables predict outcome depending of the length of the follow-up 
period. It may be worthwhile to standardize follow-up periods in future long-term 
studies on treatment effects in order to improve comparison of study data. 
Despite these limitations, our study provides further support that patients with 
chronic pain can attain long-lasting benefit, in terms of functional disability and 
depression, from an outpatient multidisciplinary treatment. Our findings suggest 
that the fear-avoidance and the learned helpless model may function as a solid 
conceptualisation of treatment processes in multidisciplinary pain treatment 
strategies, suggesting that cognitive-behavioural treatment processes may 
contribute to achieving long-term treatment effects. However, there is a need for 
high quality clinical trials in this field in order to clarify the specific contribution of 
cognitive-behavioural process variables to long-term treatment effects. 
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 Abstract 
Background: Chronic pain patients are often referred to specialised pain facilities 
only in an advanced stage of the pain condition. The referrers’ evaluation of the 
care of their patients in a pain centre may affect their willingness to continue to 
refer their patients to specific chronic pain treatment facilities. It may also yield 
important information of how to improve the quality of such a facility. Yet, there 
are no studies available that examined the factors, associated with general 
practioners’ evaluation of the care of patients by a specialised pain centre. 
Methods: As part of a larger study on treatment effectivity1, we carried out a 
survey among general practioners (GPs) of one hundred and ten subsequent 
patients who were treated in the multidisciplinary pain centre of the Radboud 
University. Referring GPs of eighty-three chronic pain patients (75%) who had 
been accepted for treatment at the multidisciplinary pain centre completed a 
questionnaire three months after start of treatment. The questions dealt with the 
expectations of the referral, the evaluation of different aspects of the pain care and 
the overall evaluation.  
Results: GPs had varied expectations of the referral: establishing the cause of pain 
(n=12: 14.3%), the installment of medical (n=28: 33.3%), paramedical (n=23: 
27.4%) or psychological (n=25: 29.8%) treatment. Thirteen patients were referred 
without a specific treatment goal (15.5%). GPs were satisfied with the overall care 
for their patients (mean score of 7.8 on a 0-10 scale, sd=0.9 ). Patients being 
diagnosed by the disciplines asked for was evaluated most positively while prior 
information about the waiting time before treatment was evaluated least. 
Correlation analyses indicated that meeting the expectations of the referral 
correlated most with the overall referral evaluation.  
Conclusion: GPs varied greatly in their expectations when referring their patient to 
a pain centre and regarded meeting their expectations of the referral as a key item 
for evaluating the care. Prior information, especially with regard to waiting time 
was least evaluated. In order to optimise referrer policies, a pain centre should 
communicate more actively with the GPs with regard to referral expectations and 
pretreatment waiting time. 
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Introduction 
Chronic pain patients are referred to specialised pain centres particularly in an 
advanced stage of the pain condition. Only 2 percent of these patients are currently 
treated by a pain-specialist2. From a patient perspective, sixty percent of the 
patients experienced their pain as not adequately treated. Only 17 percent of 
chronic pain patients had no need of health care services in order to be able to cope 
with their pain3 although numerous studies indicate that multidisciplinary chronic 
pain treatment can be effective,4,5,6,7. Consequently, it is important to investigate 
the reasons for referral for treatment to a specialised pain facility in order to 
provide the adequate care for patients, suffering from chronic pain. In the 
Netherlands, most chronic pain patients are referred to pain centres by general 
practioners (GPs). Therefore GPs can be considered as gate controllers who 
determine the accessibility to second echelon facilities and as such have a decisive 
role in controlling medical consumption. The way the GP perceives the quality of a 
possible treatment facility of their patient is mainly based on the experience with 
earlier referrals and therefore may affect the communication with a patient on 
referral questions and the willingness to refer. Therefore, it is crucial to know how 
GPs evaluate the quality of the pain treatment for their patients as this may affect 
the willingness to refer other chronic pain patients in the future. The evaluation of 
referring general practioners can be considered as an important criterion in the 
evaluation of a pain centre. However, this issue is still an unexplored territory as 
until recently it was not regarded as a possible outcome in chronic pain studies8. 
Consequently, the literature is scarse about satisfaction of referrers of chronic pain 
patients with the care of specific pain facilities. We found only one study on 
satisfaction of general practioners of chronic pain care9. This study revealed that, 
although 96% of the GP responders considered pain centres as beneficial, only 
14% of their chronic pain patients were referred to these facilities. However, this 
study examined evaluation regarding chronic pain treatment in the second echelon 
in general and not specified to the care of chronic patients in specific 
multidisciplinary pain centres.  
 
Our study aims specifically at getting insight into the expectations of GPs when 
referring chronic pain patients to a multidisciplinary pain centre. GPs are more 
inclined to refer their patients when they evaluate the outcomes of past referrals as 
positive. Therefore it is crucial to know on what basis GPs evaluate referrals. In a 
previous study among more than 40 general practioners as part of recurrent 
educational meetings, open interviews of general practioners pointed that the 
following: priori information, multidisciplinary screening and adequate reports are 
considered important. In line with these findings, the study questions were 
formulated as follows: firstly, what did GPs expect from the pain centre at referral 
and secondly, which of the above mentioned aspects of pain treatment (priori 
information about the pain centre, diagnostic procedures, adequate reports and 
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meeting the goals of the referral) were associated with the level of overall 
satisfaction..  
 
 
Procedure 
As part of a larger study on treatment effectivity1, we carried out a survey among 
GPs of 110 subsequent chronic pain patients who were treated in the Pain Centre of 
the Radboud University Medical Centre, Nijmegen, The Netherlands. A 
questionnaire was mailed to the GP of the patient they had referred, three months 
after the start of treatment. In total 69 GPs of total 83 patients completed the 
questionnaires (75.4%). This implies that some GPs were asked to participate in 
the study more than once according to their referrals.  
Minimal age of patients to be included was 18 years. Exclusion criteria were pain 
due to pathophysiological causes such as cancer, serious psychiatric disorders, and 
the inability to read or write Dutch. The average age of the 83 participating patients 
was 48.1 years (sd=12.8, range 18-79). Most of the patients were women (63.8%). 
The primary sites of pain were the lower extremities (28 patients; 33.7%), back (27 
patients; 32.5%), neck and shoulders (23 patients; 27.7%), upper extremities (14 
patients; 16.8%), pelvis (3 patients; 3.6%), head and face ( 3 patients; 3.6%), 
abdominal pain (3 patients; 3.6%), whole body (1 patient; 1.2%), breast (1 patient; 
1.2%). In total 12 patients (14.4%) reported pain at two sites and 4 patients (4.8%) 
reported pain at three sites. Mean pain duration was 68.1 months (median=42, 
sd=79.4) with a range of 7-420 months. 
After the regular three-month waiting-list period an anaesthesiologist, a 
physiotherapist and a psychologist screened all patients and allocated them to one 
or more of the treatment modules (medical treatment, transcutaneous electrical 
nerve stimulation TENS, cognitive-behavioral group therapy).  
 
Medical treatment. In this study, medical treatment consisted of optimising pain 
medication. Medical treatment was aimed at pain reduction by attuning and 
minimizing pain medication on a time-contingent basis. The inclusion criteria for 
this treatment modality were improper drug, medication use on a pain-contingent 
basis, presence of adverse effects or use of conflicting or resembling pain 
medication. 
Transcutaneous electrical nerve stimulation (TENS) is a non-invasive intervention 
to alleviate pain. An experienced physiotherapist applies a small portable battery-
powered stimulator, connected by electric wiring to self-adhesive electrodes, to the 
patient’s skin. After proper instruction and adjustment of pulse variables and 
electrode placement, patients are able to manage the TENS treatment by 
themselves during their daily activities. They can monitor their pain level and 
adjust the pulses to alleviate the pain, which hence may reduce their cognitions of 
helplessness and avoidance behaviour. Eligible were patients suffering from pain 
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Evaluation of pain care 
 
We want to know your opinion about the care of your patient by the Pain 
Center. Your patient: -------------------------------------------------- was seen in the Pain Center 
of the Radboud University on   --------------------------------------------- 
 
1 What did you expect of the pain center? 
 Please,  cross one or more of the answer  alternatives. 
 for an advice on the possibilities of pain treatment 
 for finding the cause of  the pain 
 for a specific treatment namely.: 
 medical  
 paramedical (e.g. physiotherapy) 
 psychological  
 otherwise, namely: 
 for  a psychological diagnosis  
 to finish the medical shopping 
 did not know any alternates 
 otherwise, namely: ----------------------------------------------------------------------------------------------- 
 
If you did not refer your patient yourself, did you support the referral:   yes / no 
 
2 How do you evaluate the care of your patient by the Pain Center? 
  Do not   Totally 
  agree at all             agree 
a)  I had sufficient information about the  
 Possibilities of the Pain Center before referring 1 2 3 4 5 
b) The reports on the diagnosis and treatment  
  of my patient were adequate 1 2 3 4 5 
c)  The diagnosis and treatment of my patient 
  met the goals of my referral 1 2 3 4 5 
d) My patiënt was examined by the disciplines 
  I asked for 1 2 3 4 5
  
Can you give a mark, between 0 and 10,  
for the total care of your patient?        ------------------------ 
 
Do you have any concluding remarks? 
--------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------
Figure 1: GP Evaluation questionnaire 
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due to peripheral nerve-root lesions, excluded were patients reporting pain in the 
face or head or on several pain sites. 
Cognitive-behavioural group therapy (CBT). CBT consisted of ten 90-minute 
sessions and was targeted at reducing the patients’ functional disability and 
depression by reducing negative cognitions and avoidance behaviour using the 
following treatment components: stress-management and problem-solving 
techniques, cognitive therapy and relaxation exercises. In addition, patients worked 
on individual goals. In the first session, every patient formulated a specific CBT 
goal based on their personal underlying problems (e.g. work-related conflicts or 
marital problems). In the subsequent sessions, patients trained and implemented 
their personalized problem-solving techniques. Groups consisted of minimally 5 
and maximally 12 patients and were led by two psychologists both fully trained in 
CBT. Inclusion criteria for group CBT were untreatable pain and severe limitations 
in physical or psychological functioning. Exclusion criteria were incapacity to 
function in a group or indications of a psychiatric disorder. 
 
Measures 
GP Evaluation questionnaire 
The GPs were asked to complete a short questionnaire, based on an earlier survey 
examining GP priorities when referring their patient to a pain centre (see Figure 1).  
Questions concerned the benefits for the GP to be obtained by the referral. 
Expectations consisted of clarification of the cause of pain including psychological 
aspects, advices on medical, paramedical and psychological treatment, or the 
advice to the patient to stop “medical shopping”. Items rated on a yes/no basis. 
Satisfaction with the following were rated on a scale of 1 (don’t agree at all) – 5 
(totally agree): I had sufficient information about the possibilities of the Pain 
Centre before referring; the reports on the diagnosis and treatment of the patient 
were adequate; the diagnosis and treatment of my patient met the expectations of 
my referral; my patient was examined by the right disciplines. Finally, overall 
satisfaction was rated by a mark between 0 (totally insufficient) –10 (excellent). 
 
Statistical analysis 
For the overall satisfaction, the mean and standard deviation were calculated. In 
order to examine the association of different aspects of care with an index of 
overall satisfaction, Pearsons correlations were computed.  
 
 
Results 
Evaluation of care 
Overall evaluation of the care of their patients was 7.58, sd=0.92 (10-points scale). 
GPs of 7 patients rated the overall care under 6.00 (see Table 1). Major reason for 
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low rating was lack of information on the length of the waiting period of the 
patients prior to entering the pain centre.  
The patient being seen by the disciplines asked for had the highest scores 
(mean=4.01, sd=0.85: scale 1-5: see Table 1). Also the reports about the diagnosis 
and treatment were rated with high scores (mean=3.98, sd=0.82: scale 1-5). Most 
GPs found that the referral of their patient had met the expectations they had in 
mind (mean=3.88, sd=0.85: scale 1-5). The information they had prior to the 
referral was rated somewhat lower (mean=3.76, sd=1.08: scale 1-5).  
 
Table 1: Evaluation of the care of their patients by the pain centre; n=83. Overall 
evaluation (between 0: absolutely insufficient, to 10: excellent) and evaluation of different 
aspects of care (between 1: don’t agree at all, to 5: agree totally) 
Subject Mean (range)  sd 
Overall evaluation 7.58  (0-10) 0.92 
Evaluation of specific aspects of care   
sufficient priori information of the Pain Center 3.76  (1-5) 1.08 
adequate diagnosis and treatment report 3.98  (1-5) 0.82  
care met the goals of referral 3.88  (1-5) 0.85 
patient was diagnosed by the right disciplines 4.01  (1-5) 0.85  
 
 
Table 2: Expectations of general practioners of referral to the pain centre (n=83) 
Expectations of referral Number (%) 
Advice on pain treatment 55 (65.5) 
Finding the cause of pain 12 (14.3) 
Specific pain treatment:   
medical 28 (33.3) 
paramedical 23 (27.4) 
psychological 25 (29.8) 
Psychological diagnosis 3 (  3.6) 
Finishing medical shopping 10 (11.9) 
I don’t know any more 13 (15.5) 
 
 
Expectations of referral 
With regard to pain diagnosis, GPs of in total 55 patients (65.5%) asked for an 
advice on pain treatment (see Table 2) and GPs of 12 patients (14.3%) wanted the 
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pain cause to be found. With respect to pain treatment, GPs of 23 patients (27.4%) 
specifically wanted a paramedical treatment and GPs of 25 patients (29.8%) 
wanted a psychological treatment. Although many GPs stated specific diagnosis or 
treatment goals, GPs of 13 patients (15.5%) admitted that their referral was 
motivated by not knowing any alternative for their patient and that the referral was 
the last hope for pain relief. GPs of 10 patients (11.9%) stated that their referral 
should be used to end further medical shopping behaviour. 
 
Correlations of treatment expectations with overall evaluation 
The way, the care of the pain centre met the expectations of the referrer correlated 
most with the overall evaluation (r=.63; p<.001, see Table 3). The general 
information prior to the referral correlated least with overall evaluation (r=.27; 
p<.001). 
 
Table 3: Correlation coefficients between evaluation of different aspects of care 
Aspects of care: Total evaluation 
Sufficient priori information of the Pain Centre .27*** 
Adequate diagnosis and treatment report .58*** 
Care met the expectations of referral  .63*** 
Patient was diagnosed by the right disciplines .55*** 
***  p<.001 
 
 
Discussion  
The goal of this study was to examine the way, GPs of chronic pain patients 
referred to the multidisciplinary pain centre evaluated the performance of the pain 
centre. Although GPs in general evaluated the care provided by the pain centre 
positively, they were less satisfied with the information, prior to their patient 
entering the pain centre. Specifically, most GPs not satisfied with this aspect 
indicated that they were not informed about the duration of the waiting period 
before assessment and treatment, inducing uncertainty, for both GP and patient. 
Long waiting lists are notorious in the treatment of chronic pain. Most chronic pain 
patients have a long history of waiting for diagnosis and treatment in different pain 
care facilities. Adequate information on this issue therefore is judged to be 
important by GPs as well as patients. 
The positive evaluation by the GPs of the care by the pain centre was closely 
related with the outcome that the pain centre complied with the expectations of the 
referral. However, there was a great variety in goals as mentioned by GPs, 
including medical diagnosis elucidating the cause of pain and treatment, 
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paramedical or psychological treatment or an advice to the patient to stop “medical 
shopping”. A fair number of 13 patients (15.5%) were referred without a special 
goal, only as a ‘jump into the dark or a cry for help”. In future studies it may be 
important to examine the question, whether the GP discusses non-medical goals or 
the lack of a clear strategy in pain treatment. This attitude may promote the 
openness of the communication the GP and the patient. This issue is also 
important, as the pain centre has to take into account the expectations of both the 
patient and the referrer.  
What might be the clinical implications of the present study? Firstly, in order to 
optimise the number of referrals by GPs, it is important to improve the service in 
reaction to the study findings, particularly to optimise the pre pain care 
communication. When patients are referred, the GP should receive more 
information about the approximate waiting period and the possibility of easy 
contact with the pain centre for further information and the possibility of a first 
advice for pain management. Secondly, more attention should be paid to address in 
detail the formulated expectations of referral by GPs in the post treatment reports 
by a pain centre. Thirdly, monitoring GP satisfaction should be a standardised 
regular procedure in order to assess the way, GPs evaluate pain care.  
There are some important limitations of the study to be mentioned. Firstly, we did 
not study the expectations of the individual patient. It may be crucial to get insight 
into the way referrers’ and patients’ expectations may differ. Secondly, we did not 
study the GP characteristics and the quality of the relation of the GP with the 
patient. Therefore we may have missed important other factors that may have 
affected the evaluation beyond the quality of the care of the pain centre. Thirdly, 
we need to compare responding and non-responding GPs. It cannot be excluded 
that the GPs who did not complete the questionnaire evaluated the care of the pain 
centre less positively than the responders. Finally, in our study, only patients who 
had a pain treatment within the Pain Centre were included in the study. It cannot be 
excluded that the decision of refraining from treatment may also affect referrer 
evaluation. In future studies, also patients who did not have a pain treatment as a 
consequence of the diagnosis procedure should be included.  
In conclusion, this is a first attempt to get insight into the way, referring GPs 
evaluate the care of their chronic pain patients by a multidisciplinary pain centre. 
Although there are some important limitations, the study demonstrates that it is 
important that a pain centre gains insight into the expectations of the GPs. Referral 
questions after the patient has finished the diagnosis and/or treatment procedure 
should be answered in detail. Future studies should focus on the quality of the 
communication between the GP and pain centre with respect to the concordant 
expectations of the care of a pain centre and the way, adequate information of the 
GP by a pain centre may affect referral policies. 
Chapter 8 134 
References 
1. Samwel J., Kraaimaat F., Crul B.J.P., et al: Multidisciplinary allocation of pain 
treatment: Long term outcome and correlates of cognitive-behavioral processes. J 
Musculoskel Pain. In press. 
2. Breivik H., Collett B., Ventafridda V. et al: Survey of chronic pain in Europe: 
Prevalence, impact on daily life, and treatment. European J Pain 2006;10:287-333. 
3. Elliot A.M., Smith B.H., Penny K.I. et al: The epidemiology of chronic pain in the 
community. Lancet 1999;354:1248-1252. 
4. Flor H., Fydrich T., Turk D.: Efficacy of multidisciplinary pain treatment centers: a 
meta-analytic review. Pain 1992;49:221-230. 
5. Fishbain D., Cutler R., Rosomoff H. et al: Pain facilities: a review of their effectiveness 
and referral selection criteria. Curr Rev Pain 1997;1:107-115. 
6. Tulder M. van, Ostelo R., Vlaeyen J.: Behavioral treatment of chronic low back pain: a 
systematic review within the framework of the Cochrane Back Review Group. Spine 
2001;26(3):270-281. 
7. McCracken L., Turk D.: Behavioral and cognitive-behavioral treatment for chronic 
pain.: outcome, predictors of outcome and treatment process. Spine 2002;27(22):2564-
2573. 
8. Turk D., Dworkin R., Allen R. et al: Core outcome domains for chronic pain clinical 
trials: IMMPACT recommendations. Pain 2003;106(3):337-345.   
9. Stannard C., Johnson M.: Chronic pain management, can we do better? An interview 
based survey in primary care. Curr Med Res Opin 2003;19(8):703-706. 
 
 
 
  
Chapter 9 
 
 
Psychological treatment of pain: 
Implementation in primary care. 
 
 
 
 
 
 
 
Han Samwel1, Floris W. Kraaimaat1, Jan Vercoulen1 
 
 
 
 
Departments of Medical Psychology1  
University Medical Centre St Radboud, Nijmegen, the Netherlands 
 
 
 
 
 
 
 
This chapter was published in Dutch as: 
Psychologische pijnbehandeling: implementatie in de eerstelijnszorg.  
Pijninfo 2007; 13: 43-56. 
 Abstract 
Background: In the Netherlands, psychological pain treatment is mainly provided 
by second echelon pain treatment facilities. Negative consequences of this situation 
are a long waiting period before start of psychological pain treatment and referrals 
of pain patients to pain centres only in a chronic stage of the pain who should have 
had psychological treatment in an earlier stage in order to prevent chronification of 
the pain problem. In order to solve these issues, the Pain centre of the Nijmegen 
University Medical Centre St Radboud started a project, aiming at implementing 
cognitive-behavioural treatment (CBT) in the first echelon health care by creating a 
network of first echelon psychologists, specialised in providing CBT to (chronic) 
pain patients. 
Methods: The implementation project was executed in four subsequent steps: 1) a 
symposium was organised in order to interest first echelon psychologists in 
becoming involved and providing information about a training course; 2) a training 
course was organised. In total 39 psychologists attended and completed the course; 
3) the psychologists who had completed the course joined a regional network 
“cognitive-behavioural treatment of chronic pain” with periodical intervision 
sessions, and 4) efforts were made to boost hospital and primary care referrals to 
the psychologists of the network. 
Results: In 2006 the regional network consisted of 28 skilled primary care 
psychologists. The number of referrals were 49 from the multidisciplinary pain 
centre and 53 from GPs. The average waiting list for CBT for chronic pain patients 
was 3 weeks (at the start of the project in 1997, the waiting period was 14 weeks).  
Conclusion: The implementation project was successful in creating a network of 
skilled psychologists, boosting first echelon referrals and reducing the waiting 
period before the start of treatment.  
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Introduction 
Patients suffering acute pain will initially visit their general practioner (GP) for 
alleviation of their complaints (primary intervention). Frequently, the pain has a 
manifest nociceptive origin such as tissue damage. If treatment does not ameliorate 
or eliminate the pain, the complaints become subacute and associated with 
additional adverse effects like prolonged sick leave. Psychological factors, most 
notably cognitions and behaviours, start playing an increasingly prominent role in 
the patient’s perception of the pain symptoms and their consequences. In such 
cases, patients may be referred to a primary-care psychologist to prevent the 
complaints from becoming chronic (secondary prevention1). If the pain persists for 
more than 12 weeks, the likelihood that it will abate diminishes with time and the 
risk of chronicity increases by the same token2,3. At this stage psychological factors 
that perpetuate the complaints tend to dominate, the (direct) link between the pain 
and any tissue or nerve damage has lost any tangible relevance and the interaction 
between psychological and medical factors has gained in complexity4. Here, the 
intervention of a clinical psychologist affiliated with a hospital pain clinic is 
warranted, with the treatment objective being to modify the patient’s perpetuating 
factors and to minimise the implications of any chronic complaints (tertiary 
prevention). In cases where a brief cognitive-behavioural intervention suffices, this 
may be provided by the primary-care psychologist.  
 
The pain centre of the Nijmegen University Medical Centre St Radboud operates 
from the perspective of multidisciplinary collaboration1 entailing that all 
disciplines, i.e. anaesthesiologists, physiotherapists and psychologists, are involved 
in the diagnostic process and jointly decide on the treatment goals and which 
disciplines are to deliver the care indicated. 
Psychologists affiliated with a multidisciplinary pain treatment team see numerous 
patients with chronic pain, affording them ample opportunity to gain in-depth 
knowledge of the characteristics typical of this population5. The clinical 
psychologist at the centre is annually involved in the diagnoses of at least 200 
patients. The number of patients with subacute or chronic pain that receive 
psychological treatment in a primary-care context, on the other hand, is much 
smaller. Here, psychologists see an estimated 1 to 2 patients a year, which prevents 
them from acquiring sufficient expertise. 
Psychological interventions for patients with subacute or potentially chronic pain 
should, however, preferably be delivered in a primary-care setting, as such a timely 
cognitive-behavioural treatment (CBT) of existing perpetuating factors may well 
prevent chronicity. There are additional motives for having primary-care 
professionals provide such interventions. First, the pain-centre psychologist will 
only deliver the indicated treatment and subsequently cease contact with the 
patient, whereas his primary-care colleague will keep in touch with his patient in 
view of relapse prevention as his job description includes both treatment and 
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secondary prevention. This has the advantage that patients who are finding it 
increasingly difficult to cope with their pain will be seen by their own therapist 
without delay, also because of the limited physical distance between the patient’s 
home and the consulting room. Moreover, primary-care therapists tend to have no 
or short waiting lists and aim to schedule the first visit within three workdays of 
the referral. Treatment for pain patients at risk of an imminent relapse is hence 
prompt, allowing them to quickly resume optimal pain-coping strategies. If 
treatment is unavailable or insufficiently prompt, this will heighten the risk of the 
patient relapsing and reverting to his somatic tendencies (i.e. defining the pain 
exclusively as a medical problem and seeking a medical solution). Secondly, 
communication lines between GPs and primary-care psychologists are short, 
especially if they both work at the same health centre, which enables the therapist 
to help the GP with any questions pertaining to their mutual patient. 
 
In a survey among 67 primary-care psychologists conducted within the framework 
of a further training course, 63% indicated to have difficulties in their contacts with 
(chronic) pain patients resulting from a lack of specialised knowledge and skills4. 
This shows that for these therapists in-depth insight and proficiency are crucial to 
ensure an adequate treatment of this patient group. The absence of such expertise 
may inhibit hospital psychologists, GPs and company doctors from referring pain 
patients indicated for secondary prevention, i.e. psychological treatment, to a 
primary-care psychologist, causing cumulative problems: 
- Pain teams refer few or no patients to primary-care services; 
- GPs do not refer patients to primary-care psychologists;  
- GPs refer patients to the hospital with a psychological query the primary-care 
therapist should be able to address, and 
- Primary-care psychologists are prevented from acquiring the necessary expertise 
due to the lack of referrals. 
The above illustrates that to guarantee a qualitatively sound and timely 
psychological treatment of patients with subacute pain in a primary-care context 
ample knowledge and experience as well as an adequate supply of eligible patients 
are required. Our first research question therefore was: Can we encourage a 
sufficient number of primary-care psychologists to acquire the expertise necessary 
to adequately treat patients diagnosed with subacute or chronic pain within the 
service area of the academic hospital? The second question we wished to answer 
was: Can we establish a regional referral policy for pain patients that will enable 
the primary-care psychologists to acquire the necessary expertise?  
 
In this article we give an account of our project aimed at the phased 
implementation of the cognitive-behavioural treatment of pain in a primary-care 
context. The main objectives were 1) to create a regional network of 
knowledgeable and skilled primary-care psychologists to diagnose and treat 
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patients with subacute and chronic pain and 2) to realise a sufficient volume of 
pain patients referred for treatment to the network members. 
The project comprised the following four stages: 
1. Organising a symposium to introduce primary-care psychologists to the 
cognitive-behavioural treatment of patients with pain complaints and 
cataloguing the practical problems associated with such psychological 
interventions and encouraging interested therapists to attend a training course in 
the diagnosis and treatment of patients with subacute or chronic pain symptoms.  
2. Designing a training course to help interested psychologists to acquire the 
necessary competency. 
3. Creating and supporting a regional treatment network by scheduling regular 
network meetings and promoting the network members to all GPs in the district. 
4. Boosting the number of referrals of pain patients to the network. 
Next, the various stages of the project will be described in more detail. 
 
 
The implementation roadmap 
 
Stage 1: The symposium  
With the symposium we aimed to explore how primary-care psychologists 
perceived their dealings with chronic pain patients, to interest them in becoming 
involved in the treatment of this patient group and to inform them about the 
possibility to attend a training course designed to provide them with the necessary 
knowledge and skills. We posed the following three questions: (1) Have you ever 
treated chronic pain patients?; (2) If so, which problems did you encounter with 
these patients in particular?; And (3) Would you be interested in attending an 
applied training course specifically aimed at this patient group? 
All primary-care psychologists within the service area of the Nijmegen university 
hospital received an invitation and 67 therapists responded and subsequently 
attended the conference. They indicated to have limited experience in the treatment 
of chronic pain patients and most had encountered difficulties, most notably with 
the patients’ reluctance to accept a psychological frame of reference for the 
treatment of their pain complaints. They also indicated that the patients’ somatic 
fixation and the absence of a somatic substrate tended to complicate the treatment4. 
Nearly all expressed an interest in treating patients with subacute or chronic pain as 
well as a need for additional training to raise their proficiency in this domain. 
 
Following the symposium various regional providers of ambulatory mental health 
services (GGZ Gelderland) were contacted to obtain information about and support 
for the proposed, dedicated training course. It was agreed that they would each 
appoint one of their psychologists as a liaison to assist our pain centre in the 
selection and design of the course components. Our team subsequently convened 
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several times with three of these liaisons to further delineate the needs and wishes 
of colleagues working in the field and to incorporate these in the course. The final 
course content was submitted to all local mental health centres for approval. 
 
Table 1: “The psychologist as a pain specialist” course syllabus  
Session Topic Contents 
1 Reference framework Cognitive-behavioural model of pain 
2 Diagnosis - Medical aspects of chronic benign pain 
- Diagnostics: Respondent and operant 
approaches  
3 Patient-therapist interaction  Defining patient-therapist relationship,  
resistance to treatment 
4 Treatment - Cognitive-behavioural approach 
- Respondent and operant approaches 
5 Back pain Diagnosis and treatment of lower back pain  
6 Headache Diagnosis and treatment of headache and 
neck pain  
7 Fibromyalgia 
 
Societal aspects 
Diagnosis and treatment of fibromyalgia 
and other diffuse pain syndromes  
Legislation and policies regarding health  
care  
 
 
Stage 2: The training course6 
Information about the resultant dedicated training course entitled “The 
psychologist as a pain specialist” was sent to all psychologists practising in the 
hospital’s service area. The clinical psychologist of the Nijmegen Pain Centre 
subsequently delivered the course in 1998, 1999 and 2005.  
Requisites for course subscription and attendance were a minimum of two years of 
practical experience in (mental) health-care service delivery and an adequate 
knowledge of the theoretical framework of CBT. These criteria were founded on 
evidence in the literature showing that, worldwide, CBT for chronic pain was the 
most effective of treatment approaches7,8. We, moreover, wished to attain 
homogeneity in the theoretical background of the course participants, which we 
deemed essential for all potential referring parties (predominantly GPs) as this 
would leave them in no doubt about the background, treatment principles and 
approach of the newly trained psychologists. 
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The course aimed to provide the participants with  
- Knowledge of the medical and social aspects of subacute and chronic pain, 
- The insights and skills required for a proper diagnosis and delivery of CBT for 
chronic pain patients and 
- Information regarding collaboration with other professionals involved in the 
pain treatment (GPs, medical officers, physiotherapists and medical 
consultants).  
Central to the course was the treatment protocol developed by the pain centre that 
has since been expanded and published in book form9. The course comprised seven 
three-hour sessions (see Table 1) and was attended by a total of 39 primary-care 
psychologists all working in the pain centre’s service area. 
 
Stage 3: The regional pain treatment network 
After having completed the training course, all 39 psychologists joined the regional 
network named “Cognitive-behavioural treatment of chronic pain”. By becoming a 
member, all therapists confirmed they had completed the course and pledged they 
would attend the network’s half-yearly intervision meetings (see below). Their 
names were listed in the information booklet the UMC St Radboud Pain Centre 
issues for the benefit of GPs in its service area. The network members were also 
posted on the knowledge centre’s website, which in 2006 was regularly visited by 
health professionals seeking relevant referral options.  
As stated, all network members were invited to attend the network’s biannual 
supervision/intervision meetings whose objective it was to:  
1. Update the members on the latest developments in and approaches to pain and 
pain treatments; 
2. Discuss any issues relating to hospital referrals, e.g. whether all patients the 
hospital referred for treatment actually ended up with the psychologist and 
whether the patient information the hospital provided was sufficiently detailed; 
3. Exchange therapeutic experiences; 
4. Discuss cases put forward by the members; 
5. Organise oral presentations by the members about themes pertaining to pain and 
its treatment. 
In addition, the clinical psychologist who had delivered the training courses and 
was now supervising the network meetings was always available by phone and 
email to offer advice on the diagnosis or treatment of individual patients. 
 
Stage 4: Boosting referrals  
Boosting referrals: Hospital referrals 
Once the multidisciplinary pain team had decided CBT was warranted, the 
question who should deliver the treatment became the focus of discussion. The 
decision whether a pain patient was eligible for referral to a primary-care 
psychologist was founded on the following criteria: 
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- All options for medical treatment have been exhausted or no further indications 
exist for additional medical diagnoses or interventions. 
- Implications for daily functioning (e.g. pain intensity, functional limitations, 
mood, medical consumption) are mild to severe; 
- Psychological factors negatively affecting daily functioning have been 
established; 
- Individual brief CBT is deemed opportune;  
- There are no factors, such as acute psychosocial stressors, that could interfere 
with brief CBT. 
If these criteria were fulfilled, the patient was referred to the network psychologist 
whose practice was closest to the patient’s home.  
 
Figure 1: Procedure for referrals for CBT. 
 
The procedure for hospital referrals was as follows (see Figure 1): when the 
hospital’s pain centre had decided to refer a patient to a primary-care psychologist, 
the decision was passed on to the GP in the form of a letter recommending brief 
CBT, stating the relevant details of the proposed network psychologist.  
Letter to  
GP
GP 
disagrees 
GP 
concurs 
GP makes the  
referral
Hospital Pain Centre 
recommends 
psychological treatment 
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Acting on the advice, the GP would then refer the patient to the recommended 
psychologist. If he did not concur with the recommendation, the final decision 
remained with him. If need be, the pain centre’s clinical psychologist elaborated 
the team’s recommendation but he would not oppose the course of action proposed 
by the GP, thus abiding by the GP’s coordinating role10. With this approach we 
sought to remove some of the barriers that might prevent GPs from endorsing the 
recommended treatment. 
 
Boosting referrals: Primary-care referrals 
The primary-care psychologist is trained in delivering brief, tailored interventions, 
which implies that his focus is on the amelioration or eradication of a patient’s 
psychological symptoms. The treatments he offers are hence primarily directed at 
resolving Axis-I psychopathology as described in the DSM-IV classification 
system (APA)11, which also defines pain disorder (see text box below).  
 
Text box 1: Definition of pain disorder according to the DSM-IV classification manual. 
 
The DSM-IV definition indicates that subacute or chronic pain is not to be 
(re)defined as a psychiatric disorder but should rather be treated as a disorder in its 
own right. 
Boosting the number of primary-care referrals necessitated an unequivocal referral 
procedure for both the GP and the primary-care therapist, which procedure will be 
described in more detailed next. 
Although the primary-care psychologist always voluntarily subjects himself to peer 
supervision and sometimes works in a group practice or multidisciplinary treatment 
centre, he often is the sole attending health professional, despite his association 
with the referring GP. In our treatment context it was vital that he kept in close, 
proactive contact with the GP, with the roles of the two professionals being 
organised as follows: as the pain patient’s treatment coordinator, the GP takes the 
Pain Disorder (as defined in DSM IV; APA, 1994) 
1. The primary presentation is pain in one or more anatomical sites, which 
is sufficiently severe to merit medical treatment. 
2. The pain causes significant suffering or limitations in social or 
occupational functioning or functioning in other essential domains. 
3. Psychological factors are assumed to play a key role in the onset, the 
nature and severity, and the exacerbation or perpetuation of the pain. 
4. The pain is not intentionally instigated or simulated. 
5. The pain has not been previously attributed to a mood disorder, anxiety 
disorder or psychotic disorder and does not fulfil the criteria for 
dyspareunia. 
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decisions with respect to any potential interventions, with the task of the primary-
care psychologist being limited to the delivery of the psychological intervention as 
consented by the GP. Following the GP’s referral, the psychologist makes a 
diagnosis and, if indicated, formulates a treatment plan, after which he again 
consults with the GP prior to initiating the proposed treatment, allowing the GP to 
remain actively involved in the decision-making process vis-à-vis his patient’s 
treatment. If the psychologist were to commence the treatment solely based on his 
own diagnosis without consulting the GP, the latter may feel excluded or 
disregarded, possibly creating a reluctance to refer any of his future pain patients. 
After having reached his diagnosis, it is therefore crucial for the psychologist to 
seek concurrence with the referring GP to ensure that the proposed CBT is always 
mutually agreed to and to underpin the coordinating role of the GP, thus 
strengthening the consistency of a patient’s treatment. This approach, moreover, 
ensures that in his communications with his patient the GP will adopt the 
motivations of the psychologist and thus not confuse or burden the patient with his 
lack of knowledge or irritation. In primary-care practices the collaboration among 
the affiliated physicians has not only been formalised, it is also implemented 
through frequent team meetings and mutual familiarity with the procedures applied 
by the individual members. The GP hence remains in control of his patient’s 
treatment, reducing the risk of interfering or conflicting primary and secondary 
care delivery and any resulting iatrogenic complications such as excessive and 
continued medical consumption and undertreatment of perpetuating factors.  
For GPs this referral protocol is a prerequisite allowing them to keep fulfilling their 
gatekeeper role. In all further training courses for GPs on pain treatment 
approaches it was always emphasised that coordination of a patient’s treatment(s) 
would remain with them and thus also the definitive decision about the direction 
the treatment would take. Accordingly, the protocol sets the same rules for all the 
professionals involved in a pain patient’s extramural care. Yet, many GPs are 
unfamiliar with what the primary-care psychologist can offer in the context of pain 
management, preventing many patients meriting treatment from being properly 
referred. This is why in their consultation with the GP the psychologists should 
proactively offer the following information:  
- The treatment is based on a cognitive-behavioural framework and is thus 
directed at the patient’s current cognitions and behaviours. 
- The treatment does not try to identify a psychological cause for the pain but 
targets the underlying psychological factors that intensify or perpetuate the pain. 
- The treatment is patient-specific and brief (on average 10 to 15 sessions) and 
does not entail modifying personality traits, however desirable. 
- The therapist is prepared to consult with the GP on a regular basis and will 
initiate such contacts. 
 
During the network meetings it is continuously monitored if and to what extent the 
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therapist and GP actively cooperate and how the psychologist can best inform the 
GP about treatment approaches for their pain patients. If necessary, this can be 
practised by means of role-playing. Repeatedly elucidating the referral procedure 
and the parties’ respective roles will reduce the risk of frictions and any resulting 
decline in the number of referrals. 
 
The referral network: first results  
Up until 1998 the Pain Centre’s clinical psychologist treated all pain patients 
indicated for CBT. Already after the first training course in 1999, 58 patients could 
be referred to the new network’s primary-care psychologists, reducing the time 
between referral and the first treatment session with 11 weeks (from 14 weeks in 
1997 to 3 weeks in 2005; see Table 2). Our 2006 survey among the network 
members revealed that in 2005 for the first time more patients had been referred to 
the network’s therapists by their GPs than by the pain centre (53 and 49, 
respectively). By comparison, in 1998 none of the therapists had had a single 
patient referred to them with subacute or chronic pain as the grounds for referral.  
The reduced waiting times demonstrated the success of the extramural 
collaboration as did the increment in primary-care referrals, illustrating that more 
GPs had became aware of the network psychologists. In 2006 the network 
comprised 28 active members (see Table 2); 11 had meanwhile withdrawn, among 
other reasons due to relocations outside the district or practice discontinuations. 
 
 
Table 2: Outcome of the implementation project “Psychological treatment of pain in 
primary care” 
 1996 1997 1998 1999 2005 2006 
Number  
of trained 
psychologists 
  12 13 14 
Regional  
network  
members:   28 
Number  
and origin 
of referrals  
0 0 
Pain   
centre:  22 
GPs:       0 
Pain  
centre:  58  
Pain            
centre:        49 
GPs:           53 
Time on 
waiting list 
(weeks to 
first session)  
12 14    7   3    3 3 
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Bottlenecks 
In the course of expanding the collaboration in the treatment of pain patients in the 
Netherlands, two major bottlenecks emerged. 
Firstly, not all patients that our pain team referred to a network psychologist for 
CBT adhered to the advice. A recent survey among 159 chronic pain patients from 
the Nijmegen Pain Centre (unpublished data) showed that only 13 of the 47 
patients (28%) referred for treatment to a primary-care psychologist complied with 
the recommendation, whereas 26 of the 32 patients (81%) that had been advised to 
attend a psychological group intervention delivered by the pain centre’s own 
clinical psychologist indeed did so. The patients indicated that they interpreted a 
referral for treatment outside the hospital as the end of their medical intervention 
scheme, something they did not wish to accept. The limited compliance rate could 
hence be partly attributed to the implications of the current referral process, which, 
in a relatively short space of time, forces patients to abandon their medical 
orientation and replace it by an exclusively psychological point of reference, which 
shift is likely to require more time or supplementary motivational intervention12. 
A second explanation was that not all GPs concurred with the recommendation for 
CBT. Some entertained a different view of their patients’ pain problems, and in our 
policy it is this view that is acknowledged. The rejection was in some cases also 
due to a lack of information about the treatment options the primary-care therapist 
has at his disposal. To resolve this latter problem the Pain Centre organised special 
training sessions for GPs and joint sessions for GPs and network psychologists to 
inform the local GPs more extensively about the potential of collaboration with the 
network psychologists in the context of the treatment of chronic pain. These 
sessions run parallel to the training course the new network psychologists attend. 
The medium-range objective of the courses therefore also was to overcome any 
differences in opinions the GPs and primary-care psychologists might have 
regarding psychotherapeutic treatment options. 
Secondly, in most cases the health insurers in the Netherlands do not fully 
reimburse the costs for psychological treatment in primary-care settings. Each 
insurer has its own policy as regards coverage: some provide no coverage while 
others cover ten to twenty therapy sessions or allocate a set annual amount. This 
means that for some patients the costs associated with treatments delivered by a 
primary-care therapist are prohibitive. Sometimes practical solutions can be found. 
Sessions may, for instance, be more widely spread over time, more use can be 
made of home assignments, or the therapist and client can communicate via 
telephone or the Internet. However, these methods are all likely to negatively affect 
treatment efficacy. As this problem with health insurance coverage is not limited to 
chronic pain patients but holds for all patients seeking first-line psychotherapeutic 
care, it is evident that discussion of the issue needs to take place at the national 
level.  
 
Psychological treatment of pain 147 
Discussion 
This report describes a project conducted by the Pain Centre of the Nijmegen 
University Medical Centre St Radboud to interest and train primary-care 
psychologists in the treatment of subacute or chronic pain patients with the aim to 
set up a regional treatment network and initiate an adequate supply of patients. The 
results after 8-years are positive. In 2005 the network included 28 active members 
to whom over 100 patients were referred for treatment, 53 of whom had been 
directly referred by their GPs. The project also uncovered several practical 
bottlenecks. Thus, not all patients that had been referred actually applied for 
treatment owing to a lack of internal motivation or because their GPs disagreed 
with the referral. Furthermore, the limited insurance coverage for first-line 
psychotherapeutic interventions proved to be prohibitive for some patients to seek 
treatment with a primary-care professional. 
Various steps need to be taken to remove these obstacles. The pain centre’s 
referring psychologist needs to allocate more time to convince the pain patients 
deemed eligible for first-line CBT by offering them a brief intervention to interrupt 
their somatic orientation and motivate them for a psychological approach to their 
problem. This should become an integral part of the hospital’s formal referral 
policy. In addition, the referral protocol should stipulate that in cases where the GP 
opposes the recommended referral, the clinical psychologist is duly informed of 
this decision to allow him to discuss with the GP the reasons for his opposition and 
to jointly decide on any alternative steps. Finally, the umbrella organisations 
representing the patients and health-care providers will have to discuss the issue of 
insurance coverage with representatives of the nation’s health-care insurance 
companies. 
Overall, and despite the mentioned hurdles, the delivery of psychological treatment 
for pain patients by a network of specially trained primary-care therapists 
practising in the service area of our hospital’s pain clinic was successful. This 
functional, regional network should be seen as a first step towards a national 
implementation. In view of the growing interest in the primary-care treatment of 
subacute pain and the prevention of chronicity and sick leave13 it is opportune for 
other regional service areas to set up similar networks. The medium-range 
objective is to expand the number of networks such that they can be said to form a 
national grid allowing all pain patients to receive treatment in the vicinity of their 
home by a competent psychologist who works closely together with their GP or the 
local hospital. To this end, all academic pain centres in those service areas that at 
present have no operational network will be contacted and invited to join the 
phased implementation programme presented in this article. It is not until this last 
objective is achieved that we will have succeeded in our long-term ambition to 
create a qualitatively sound nationwide care delivery system of psychological 
interventions for patients suffering from subacute or chronic pain in the 
Netherlands. 
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Summary 
In this thesis we explored psychological predictors of the course of chronic pain 
and predictors of treatment outcome in chronic pain patients referred for treatment 
to the multidisciplinary pain centre of the Radboud University Medical Centre, the 
Netherlands. We specifically focused on the cognitive-behavioural factors 
hypothesized to affect pain intensity and daily functioning within the context of the 
fear-avoidance model and helplessness models, and to identify predictors of the 
effects of medical, paramedical and cognitive-behavioural chronic pain treatment 
strategies. In addition, referrer satisfaction and implementation aspects were 
described. The first part of the thesis reported on the role of cognitive-behavioural 
factors in chronic pain patients referred to a multidisciplinary pain centre. Part 2 
discussed the predictive value of selected cognitive-behavioural factors for the 
short-term outcomes of RF-DRG (radiofrequency lesioning of the cervical spinal 
dorsal root ganglion), TENS (transcutaneous electrical nerve stimulation) and the 
short- and long-term effects of a multidisciplinary pain treatment allocation 
approach. The choice of predictors was based on the fear-avoidance and 
helplessness models and the recent literature on the role of acceptance in chronic 
pain. In Part 3, referrers’ evaluation and the implementation of the current 
knowledge of psychological factors implicated in chronic pain and the 
consequences for psychological pain treatment in primary care were described. 
 
 
Part 1: Psychological predictors of pain intensity, functional disability and 
depression in chronic pain 
In Chapter 2, the contribution of helplessness, fear of pain and passive pain-coping 
strategies of catastrophizing and avoidance behaviour was studied in 169 chronic 
pain patients. All factors proved related to the patients’ pain levels, functional 
disability and depressive symptoms although for pain level helplessness was the 
only significant predictor. Helplessness and the passive coping strategy of resting 
significantly predicted functional disability and the catastrophizing coping strategy 
significantly predicted depression. These findings show that helplessness and 
passive pain-coping patterns of catastrophizing and avoidance behaviour indeed 
play a role in the perpetuation of symptoms in chronic pain patients and that both 
aspects should be addressed in their treatment(s) if pain levels, functional disability 
and/or depressive symptoms are to be significantly reduced. Moreover, 
helplessness proved to be an important predictor beyond fear of pain, suggesting 
that, as a generalized cognition of not being capable of coping with the 
consequences of the pain problem, helplessness may seriously impede chronic pain 
patients’ functioning beyond specific pain-related fears.  
The study presented in Chapter 3 explored the predictive values of helplessness, 
fear of pain, catastrophizing and avoidance behaviour for the course of functional 
disability after three months, and also in this study helplessness contributed to the 
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prediction of change in functional disability beyond fear of pain. Of all predictors, 
avoidance behaviour most strongly predicted change in functional disability. These 
findings thus supported the relevance of helplessness as an important factor in 
chronic pain patients and hence the relevance of depressogenic cognitions in long-
term pain when pain cannot be prevented or avoided. The construct of helplessness 
implies cognitions of uncontrollability and inability to change the pain problem 
that may initiate avoidance behaviour aimed at preventing pain instead of cognitive 
and behavioural efforts directed at changing the experience of pain or attempts to 
actively cope with the consequences of the pain in daily life. In populations with 
longstanding chronic pain complaints, fear of pain may eventually generalize into a 
broader cognition of not being able to control and stop the pain experience, 
resulting in helplessness cognitions and passive coping strategies that are more 
directly linked to functional disability1. In contrast, the construct of fear of pain 
may have a focused effect in patients with musculoskeletal pain2,3 as in these 
patients physical activities and elevated pain levels may be more closely linked and 
therefore may induce a conditioning mechanism of the perception that activity will 
intensify the pain. Also, fear of pain may be more relevant in the transition from 
subacute to chronic pain as in this stage patients are more focused on trying to cope 
with their pain4. The construct of helplessness may be more closely linked with the 
experience of chronic pain sufferers that experiencing chronic pain without the 
perspective of improvement or control causes a more general physical, emotional 
and social dysfunctioning5. Instead, in chronic pain, fear of pain may be crucial for 
a limited number of pain patients that hold on to specific pain-related cognitions 
and a sense of controllability, i.e. that a decrease in pain should lead to less fear 
and an increase in activities. In many chronic pain patients, however, activities will 
induce some short-term increase in pain thereby strengthening their fear-of-pain 
cognitions but beyond these, in the long term amplifying cognitions of helplessness 
as attempts of active coping eventually fail. 
 
Part 2: Psychological predictors of the effects of chronic pain treatments  
The aim of the study presented in Chapter 4 was to investigate whether 
psychological variables (including the pain cognitions helplessness and 
catastrophizing) would be predictive of the changes in pain intensity after 
treatment with radiofrequency lesioning of the cervical spinal dorsal root ganglion 
(RF-DRG) and whether successful pain reduction would lead to a corresponding 
improvement in overall functioning. Patients suffering from chronic 
cervicobrachialgia with a mean pain duration of seven years were treated and the 
posttreatment results showed that their pretreatment levels of catastrophizing 
predicted changes in pain intensity following RF-DRG. This means that the more 
pain-related catastrophizing cognitions the patients entertained, the less their 
subjective pain levels changed after treatment. Thus, consistent with the fear-
avoidance model, our finding emphasized the importance of catastrophizing as a 
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pain cognition that negatively affects pain treatment outcomes. As far as we know, 
ours is the first study to show that catastrophizing impedes outcomes of medical 
treatments for chronic pain. Possibly, in patients who catastrophize, rumination 
negatively affects the experience of pain and thus decreases the possibilities of 
perceiving changes in pain intensity6,7. In addition, successful RF-DRG treatment, 
as reflected by a decrease in the patients’ VAS scores, was not accompanied by an 
improvement in total functioning in terms of reduced physical and psychosocial 
dysfunctioning and depression. This supports the hypothesis that chronic pain 
negatively affects the patients’ overall daily functioning and that stand-alone 
medical treatment may affect their perceived pain levels but not necessarily 
induces augmentations of other aspects of their daily functioning. Flor et al.8 
supported this assumption in their comprehensive review of the outcomes of mono- 
and multidisciplinary pain treatments by showing that multidisciplinary schemes 
were superior to monodisciplinary interventions. Theirs and our findings once 
more indicate that in chronic pain patients medical treatment alone does not 
necessarily affect other aspects of the patients’ functioning than their level of 
perceived pain. In addition, it disproves the notion that reducing their pain levels 
will subsequently automatically improve other dimensions of their daily 
functioning, a notion often used as a rationale for a monodisciplinary, medically 
oriented treatment approach. In recent years, it has repeatedly been stated that in 
their treatment programmes pain centres should focus on both pain reduction and 
improving overall functioning9,10. Based on the presented evidence, when overall 
better functioning is the goal of chronic pain treatment, a multidisciplinary 
approach might be preferred. 
In Chapter 5, predictive factors of the effects of transcutaneous electrical nerve 
stimulation (TENS) in the treatment of chronic pain were studied in a prospective, 
randomised, placebo-controlled trial comprising chronic pain patients, comparing 
high frequency TENS with sham TENS and using the patients’ satisfaction 
(willingness to continue treatment) and pain intensity as outcome measures. 
Cognitive-behavioural coping strategies were evaluated as possible predictors for 
TENS effects. In the TENS group 58% of the patients were satisfied with the 
treatment results, and for the sham-TENS group this was 42%. No significant 
differences were found for pain intensity. Avoidance behaviour (retreating when in 
pain) was the only cognitive-behavioural predictor of posttreatment patient 
satisfaction, which implies that patients that tended to retreat more in response to 
an increment in their pain were more satisfied with the results of TENS. In 
addition, more helplessness (low perceived control) appeared to predict a decrease 
in pain intensity. Accordingly, patients that use more passive coping strategies of 
avoidance behaviour and experience more feelings of helplessness seem to benefit 
more from this type of treatment. From the perspective of the fear-avoidance 
model this would also imply that TENS might stimulate passive pain-coping 
strategies that may thus prevent a patient from adopting a more active coping style. 
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If corroborated, consistent with our conclusions on mono- versus multidisciplinary 
treatment schemes described in the previous chapter, this again raises the question 
whether it should be recommended to combine TENS with a cognitive-behavioural 
treatment module aimed at helping the patients challenge their helplessness 
cognitions by replacing them by more active strategies.  
Chapter 6 dealt with the short-term effects of a multidisciplinary pain treatment 
allocation protocol for chronic pain patients and cognitive-behavioural predictors 
of treatment outcome. The study compared pain intensity, functional disability, 
depression and use of medication in an intervention group of chronic pain patients 
to the outcomes of a control group. In accordance with the fear-avoidance model 
and the helplessness model, we again took catastrophizing, fear of pain, avoidance 
behaviour and helplessness as potential predictors of outcome, but, based on recent 
publications, we also studied acceptance of pain as an additional possible predictor. 
Following treatment, all primary outcome measures had, although modest in 
proportion, significantly decreased in the intervention group: pain intensity as well 
as functional disability had significantly been reduced relative to the levels 
indicated by the controls. The moderate effects in our study are in line with other 
studies on multidisciplinary chronic pain treatments11 and may reflect a problem 
inherent to the complexity of chronic pain and the limited possibilities of outpatient 
treatment strategies. Various earlier studies had already shown that inpatient 
treatment programmes yielded better results than outpatient interventions12,13. The 
studies might suggest that the sensory, cognitive-behavioural, emotional and social 
aspects of the pain problem interact in such a complex way that outpatient 
treatments with limited contacts do not suffice Future studies might directly 
compare out- and inpatient modalities and relate the treatment effects to the 
treatment’s cost-effectiveness to gain a better insight into the different dimensions 
of treatment efficacy in chronic pain.  
With regard to the predictive role of the cognitive-behavioural factors, only higher 
pretreatment levels of acceptance proved to predict larger reductions in pain 
intensity in the treatment condition (but not in the control condition), underlining 
the significance of acceptance as a health-promoting factor in chronic pain. 
Acceptance is regarded as a health-promoting cognition14,15 as it is directed at 
living a satisfying life in spite of the perceived pain14. Cognitions of acceptance 
may reflect that a patient’s focus is more on (augmenting) adaptive coping 
patterns, which positively affects treatment outcome, supporting previous findings 
correlating acceptance with less attention to pain16 and active coping behaviour15. 
Furthermore, patients who are more accepting of their pain may cope better as they 
tend to perceive small changes in pain intensity better and are more inclined to 
interpret these changes more positively than patients with less accepting coping 
strategies. Acceptance may thus affect especially the affective and evaluative 
dimensions of pain perception17,18. The current findings extend our understanding 
of the mechanisms of improvement in multidisciplinary chronic pain treatment 
 Summary and discussion 155 
approaches as this is the first time that acceptance has been identified as a positive 
predictor of treatment outcome in this population. They also support the role of 
acceptance in chronic pain patients as contrasting a fearful and avoiding way of 
coping and acceptance may in the fear-avoidance model serve as a prerequisite for 
a more confronting coping strategy. The various results on the role of acceptance 
seem to imply that pain patients who have adopted a more accepting coping 
strategy may profit more from treatments directed at reducing pain, than patients 
who exhibit a more avoiding cognitive-behavioural pattern. The present results 
further suggest that pain treatment might benefit by including a treatment module 
specifically directed at increasing the level of acceptance. 
In the study described in Chapter 7 we looked at the long-term effects after 12 
months of a tailored multidisciplinary pain treatment allocation strategy on pain 
intensity, functional disability, depression, and medication use in patients with 
chronic pain. In addition we studied the level of short-term (3 months) changes in 
the cognitive-behavioural predictors (catastrophizing, avoidance behaviour, fear of 
pain, helplessness, and acceptance) being associated with long-term outcomes. 
Functional disability and depression had both improved significantly due to 
treatment, which is in line with the effects Flor et al.8 reported. The decrease in the 
scores of catastrophizing, fear of pain, helplessness, and avoidance behaviour after 
three months was associated with the decrease in functional disability and 
depression at twelve months. Again, although both functional disability and 
depression had improved significantly, the effects were limited. The modest short-
term reduction in subjective pain intensity had not been maintained. This is also in 
line with a recent study McCracken et al.19 conducted on the effects of an 
acceptance-based treatment. Congruent with our short-term study, the overall 
effects were also moderate, which implies that achieving a long-term reduction of 
pain and a better overall functioning in patients with longstanding pain is more 
complex and challenging to achieve as cognitive behavioural patterns may have 
become fully integrated with the patients’ everyday functioning1.  
 
Part 3: Referrer evaluation and implementation  
Chapter 8 discussed the results of a survey we held among the general practitioners 
(GPs) of chronic pain patients that were treated at the multidisciplinary pain centre. 
As it is the GPs that decide whether or not to refer their patients for treatment of 
their chronic pain complaints, it is of major importance that the pain centre keeps 
informed of how they evaluate the care and services multidisciplinary pain 
treatment facilities provide because this may affect their willingness to refer their 
patients in future. However, the pain centre had no accurate information about the 
way, GPs judged the referrals. The survey asked the GPs in a standardized self-
report measure to indicate their expectations of the referral, to judge various 
aspects of the care provided as well as give an overall impression. As to the overall 
care their patients had received, the GPs evaluated positively but they had varied 
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expectations of the referral, not only with respect to medical diagnoses and 
treatments but also in relation to paramedical or psychological treatment schemes. 
Meeting the referral expectations they had set themselves was the most important 
criteria for them. The GPs evaluated the pre-treatment information less positively, 
especially information about the waiting period and about the possibility of making 
contact with the pain specialist. Our survey emphasizes the importance of pain 
centres to communicate actively with the GPs in order to meet the specific referral 
expectations and to monitor GP retrospective referral evaluation. 
In Chapter 9, the process was described through which we implemented the 
current knowledge about the psychological factors implicated in chronic pain in a 
treatment scheme designed to be delivered in a primary care setting. After a 
symposium on the cognitive-behavioural treatment of chronic pain and after 
gathering information about treatment issues from the attending professionals, 39 
primary-care psychologists working in the pain centre’s catchment area attended a 
training course covering dedicated diagnostic techniques and a cognitive-
behavioural treatment programme for chronic pain patients. Moreover, using a 
model of collaboration, special attention was paid to the communication with 
physiotherapists and GPs concerning treatment issues. The psychologists 
subsequently joined a regional network of first-line pain psychologists and 
attended a refresher course every six months. The short-term goal of the project 
was to transfer the current knowledge of psychological pain treatment to the field 
of primary-care psychologists and to expand the existing options for health-care 
professionals in primary and secondary care to refer pain patients to specialised 
psychologists. In 2005, a survey among the then active network psychologists 
revealed that referrals from GPs had meanwhile exceeded those of the pain centre. 
Currently, the project is expanded to other locations so that in the longer term 
increasingly more specialised primary-care psychologists will be involved in the 
treatment of patients diagnosed with subacute and chronic pain. Patients with 
subacute pain may then be referred to a network psychologist as part of a standard 
multidisciplinary diagnostic procedure and will only be referred to a specialized 
multidisciplinary pain centre when the initial treatment has failed. In this way, the 
expertise of both professionals is optimally and also more cost-effectively 
exploited for the benefit of the patient. 
 
 
Extension of the fear-avoidance model 
The studies presented in this thesis all supported the relevance of the constructs of 
catastrophizing, fear of pain and avoidance behaviour within the fear-avoidance 
model. Both in our natural-course and in the effect studies cognitive-behavioural 
factors of fear-avoidance, helplessness and acceptance proved to predict patient 
outcomes. The studies in Part 1 also revealed that, when both fear-avoidance 
factors and helplessness were entered into a correlational and longitudinal 
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prediction model of chronic pain, helplessness predicted pain outcomes beyond 
fear-of-pain cognitions. This is in line with earlier studies on the role of 
helplessness in chronic pain15,20,21,22. Our current findings thus suggest that in 
chronic pain populations helplessness may be a valid factor in explaining pain 
outcomes such as pain intensity, functional disability and depression over time. It 
may further be speculated that fear of pain and helplessness have a complementary 
role in the mechanism of pain and its perception over time in different phases 
(from subacute to chronic) and populations (musculoskeletal and others). Future 
studies on the fear-avoidance model3 might focus on examining the transition from 
acute, subacute and chronic pain, study short and long term consequences of 
chronic pain and include pain populations of various pain locations.  
Figure 1: Proposed extension of Vlaeyen et al’s Fear-Avoidance Model (1995) 
 
Besides helplessness having been substantiated as an additional factor in the fear-
avoidance model, the study presented in Chapter 6 emphasized the role of 
acceptance in chronic pain. This cognitive strategy might support patients 
acknowledge that they suffer pain, which realization enables them to make an 
effort to live a satisfying life despite their complaints14,15, especially when the pain 
appears uncontrollable23. Although the exact content of the construct of acceptance 
is still under discussion24, our findings add to the already large body of recent 
research comprising correlational studies25, longitudinal studies15,19 and outcome 
studies15,26 that supported acceptance as a health-promoting factor. Together, the 
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evidence suggests that patients with longstanding pain experiences, when pain has 
become chronic, some will develop cognitions associated with catastrophizing and 
helplessness and adopt subsequent passive cognitive and behavioural coping 
patterns. However, others might develop an acceptance-based set of helpful 
cognitions that facilitate more active behavioural coping strategies, leading to a 
better overall functioning. In conclusion, based on recent and our current findings 
in chronic pain patients, the fear-avoidance model might be extended to include 
helplessness and acceptance cognitions in these patient populations (see Figure 1). 
 
 
Clinical implications 
The studies reported in this thesis unequivocally supported earlier findings that 
cognitive-behavioural factors are relevant mediators in the development and 
maintenance of chronic pain. Cognitive as well as behavioural coping strategies 
proved to have considerable impact on the patients’ perceived pain levels and 
overall functioning over time. The effect studies described in this thesis also 
indicated the relevance of these factors by showing that both cognitive and 
behavioural coping strategies are predictive of the outcome of medical, 
paramedical and multidisciplinary treatment allocation strategies. The presented 
results underscore the necessity of a multidisciplinary approach in the treatment of 
chronic pain. More specifically, cognitive-behavioural screening should be part of 
a standard diagnostic procedure to be performed in each individual chronic pain 
patient with chronic complaints that has been referred to a specialized pain centre. 
Dependent on the results, the patient should be offered a tailored, cognitive-
behavioural treatment programme, next to a possibly indicated medical or 
paramedical treatment. This implies that pain clinics should adhere to the 
biopsychosocial model of pain by operating on a multidisciplinary rather than a 
monodisciplinary basis as the monodisciplinary model is based on the assumption 
that pain reduction as a result of a medical or paramedical treatment will lead to 
improvement in daily functioning. Earlier publications as well as our study of the 
effects of RF-DRG have shown that a pain reduction resulting from successful 
stand-alone medical or paramedical interventions will not automatically induce 
improvement in the patient’s daily functioning. The studies in this thesis on pain 
treatment effectivity revealed that even with a multidisciplinary allocation protocol 
for pain treatment only moderate improvements in daily functioning were 
achieved. This implies that when treatment is aimed at both a reduction of pain and 
an augmentation of the patient’s overall daily functioning, the treatment should be 
intensive and directly target these goals by tailoring treatment to patient 
characteristics. Based on the findings presented in this thesis indicating that in 
chronic pain helplessness and acceptance play affect pain intensity and functioning 
next to fear of pain factors, pretreatment screening could be improved by involving 
a close delineation of a patient’s pain cognitive behavioural patterns (fear of pain, 
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catastrophizing, avoidance behaviour, helplessness and acceptance).  
With regard to pain treatment strategies, our studies indicate that chronic pain 
treatment may benefit from including treatment modules based on altering 
cognitive behavioural factors (fear of pain, catastrophizing, avoidance behaviour, 
helplessness and acceptance. In cases where helplessness cognitions prevail, 
treatment could benefit from adding a cognitive training module aimed at inducing 
cognitions of internal control and more positive expectational schemes27 in 
accordance with the principles of Beck’s cognitive therapy28. If, on the other hand, 
cognitions related to the fear of pain concept are prominent, the programme should 
include exposure in vivo29. A cognitive module might replace negative cognitions 
that exacerbate the pain problem by a more accepting attitude that acknowledges 
rather than fights the enduring complaints, to enhance the patient’s ability to ignore 
the pain and redirect his focus to other stimuli than the pain sensation30,31. 
McCracken et al.32 defined pain perception as the practice of broad, present-
focused, and behavioural neutral awareness. In the case of avoidance behaviour, an 
operant treatment module should be offered that helps the patient adopt active and 
confronting pain-coping behaviours33,34. Finally, patients scoring low on 
acceptance should receive an acceptance-based intervention to stop them fighting 
the pain and helps them to fit their pain sensations into their daily lives, enhancing 
their overall functioning19. 
  
The modest effects of the multidisciplinary pain treatments obtained in the studies 
in the second part of this thesis point to a specific problem pain centres in the 
Netherlands are faced with. Along the lines of the biopsychosocial model of pain 
and the widely accepted definition of pain of the IASP (the International 
Association for the Study of Pain), chronic pain should be regarded as a total of 
pain suffering. This implies that treating chronic pain means diminishing the pain 
itself as well as the associated symptoms and consequences of the pain (functional 
disability and depressive mood). Pain treatment should therefore also always be 
aimed at improving functioning in daily life. This implies that, when a reduction of 
pain is not attainable, improving overall functioning is still a legitimate goal. In 
sum, within the context of our findings, pain centres should not solely focus on 
conquering pain or alleviating its intensity by means of (para-) medically oriented 
interventions but should put the emphasis on cognitive-behavioural coping 
strategies. However, this does not coincide with the expectations of the patients 
that are referred to specialized pain facilities. McCracken et al.35 showed that 
patient satisfaction is associated with the perceived reduction in pain intensity.  
As was shown in Chapter 8, the reasons and expectations of the GPs that referred 
their pain patients to the Pain Centre included a broad spectrum of reasons, 
including desire to call a halt to their patients’ endless, futile search for pain relief 
and subsequent medical consumption. This again raises the question about the 
function of pain centres within the spectrum of pain treatment facilities that treat 
Chapter 10 160 
any pain complaint from acute pain to chronic, medically unsolvable pain. At 
present they define themselves as facilities that aim at relieving pain and at 
addressing the associated symptoms of pain suffering as well as at ending the 
vicious cycle of seeking medical pain relief36. For a sound and transparent chronic 
pain care, treatment goals of pain centres have to be clearly defined to offer both 
the referrers and patients a clear insight into the possible treatment options.  
 
 
Conclusions and recommendations 
In line with the summary and discussion, the main conclusions of this thesis for the 
care of patients with chronic pain referred to a Multidisciplinary Pain Centre can 
be formulated as follows: 
- Cognitive-behavioural factors affect pain outcomes of pain intensity, functional 
disability and depression.  
- Cognitive-behavioural factors affect the effects of monodisciplinary (medical 
and paramedical) and multidisciplinary chronic pain treatment strategies. 
- Helplessness and acceptance have a role in predicting pain outcomes and 
predicting treatment effects in addition to the fear-avoidance factors of 
catastrophizing, fear of pain and avoidance behaviour. 
- Referrers’ evaluation predominantly depends on expectations for referral being 
met/fulfilled.  
 
In line with the conclusions of the thesis, the following recommendations can be 
formulated: 
- For patients with chronic pain referred to a Multidisciplinary Pain Centre, the 
fear-avoidance model might be extended by including helplessness and 
acceptance cognitions.  
- Pre-treatment screening of chronic pain patients referred to a Multidisciplinary 
Pain Centre should include cognitive-behaviour factors of fear-of-pain, 
catastrophizing, avoidance behaviour, helplessness and acceptance.  
- Chronic pain treatment for patients referred to a Multidisciplinary Pain Centre 
may benefit by including helplessness and acceptance oriented treatment 
modules. 
- A multidisciplinary chronic pain treatment facility has to provide a transparant 
and pro-active communication with the referrers in order to meet the referral 
expectations. 
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Inleiding 
In dit proefschrift hebben we psychologische voorspellers van het beloop van 
chronische pijn en van de behandeleffecten onderzocht bij patiënten die voor 
pijnbehandeling werden verwezen naar het Multidisciplinaire Pijncentrum van het 
UMC St Radboud in Nijmegen. We hebben ons daarbij vooral gericht op 
cognitieve en gedragsfactoren waarvan werd verondersteld dat zij invloed hebben 
op zowel het pijnniveau als op het dagelijkse functioneren. Daarnaast werd 
onderzoek gedaan naar mogelijke voorspellers van de effecten van medische, 
paramedische en cognitief-gedragsmatige vormen van chronische pijnbehandeling. 
Deze factoren werden onderzocht binnen de context van het Fear-avoidance model 
en het Learned Helplessness model. Aansluitend werden de evaluaties van ver-
wijzers over de zorg voor hun patiënten door het pijncentrum en het project van 
implementatie van psychologische pijnbehandeling binnen de eerstelijnszorg 
beschreven.  
In het eerste deel van het proefschrift werd de rol van cognitieve en gedrags-
factoren beschreven bij patiënten die gemiddeld meer dan zes jaar last hadden van 
pijnklachten.  
In het tweede deel werd de voorspellende waarde beschreven van enkele 
cognitieve en gedragsfactoren voor de korte termijn effecten van RF-DRG (radio 
frequente laesie van de cervicale spinale dorsale ganglion), van TENS (transcutane 
electrische zenuw stimulatie) en de korte en lange termijn effecten van een multi-
disciplinaire pijnbehandeling strategie waarbij patiënten op grond van het 
diagnostisch onderzoek werden toegewezen aan één of meerdere behandelmodules. 
De keuze van de verschillende voorspellers was gebaseerd op het Fear-avoidance 
model, het Learned Helplessness model en de meest recente literatuur over de rol 
van acceptatie bij chronische pijn.  
In deel 3 werd de wijze waarop huisartsen in hun rol als verwijzer van chronische 
pijnpatiënten dachten over de zorg voor hun patiënten onderzocht. Tot slot werd 
het proces van implementatie binnen de eerstelijnszorg beschreven van de huidige 
kennis over psychologische aspecten bij chronische pijn en de consequenties daar-
van voor de psychologische pijnbehandeling. 
 
Deel 1: psychologische voorspellers van pijnintensiteit, functionele 
beperkingen en depressie bij chronische pijn 
In hoofdstuk 2 werd de bijdrage bestudeerd van hulpeloosheid, angst voor pijn en 
passieve pijncoping strategieën aan het niveau van pijnintensiteit en functioneren 
bij 169 chronische pijnpatiënten. Alle genoemde factoren bleken gerelateerd te zijn 
aan het pijnniveau, de functionele beperkingen en depressieve symptomen. 
Hulpeloosheid bleek echter de enige significante voorspeller. Hulpeloosheid en de 
passieve copingstrategie rusten voorspelden functionele beperkingen en 
catastroferen voorspelde depressie. Deze bevindingen tonen aan dat hulpeloosheid 
en passieve copingstrategieën een rol spelen bij het voortduren van symptomen bij 
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chronische pijnpatiënten en dat zowel hulpeloosheid als passieve copingstrategieën 
deel zouden moeten uitmaken van behandelingen die ten doel hebben om pijn, 
functionele beperkingen en depressie te verminderen. Daarnaast bleek hulpeloos-
heid een belangrijker voorspeller te zijn dan angst voor pijn, wat een aanwijzing 
kan zijn dat een gegeneraliseerde cognitie van hulpeloosheid, nl. het idee dat men 
niet in staat is om adequaat om kunnen gaan met de consequenties van de 
pijnklacht, een grotere invloed heeft op het functioneren van een chronisch 
pijnpatiënt dan een meer specifieke angst voor pijn. 
In het onderzoek, dat in hoofdstuk 3 werd gepresenteerd, werd de voorspellende 
waarde onderzocht van hulpeloosheid, angst voor pijn, catastroferen en ver-
mijdingsgedrag (rusten en terugtrekken) voor het beloop van de functionele 
beperkingen na drie maanden. Ook in deze studie bleek hulpeloosheid een 
belangrijkere voorspeller te zijn dan angst voor pijn. Van alle predictoren bleek 
vermijdingsgedrag de verandering van de functionele beperkingen het beste te 
voorspellen. Deze eerste bevindingen ondersteunen de relevantie van hulpeloos-
heid als een belangrijke factor bij chronische pijnpatiënten en als een depressogene 
cognitie bij langdurige pijn die niet voorkomen of vermeden kan worden. Het 
construct van hulpeloosheid behelst cognities van oncontroleerbaarheid en 
onvermogen om het pijnprobleem te veranderen. Deze cognitie werkt daarmee 
vermijdingsgedrag in de hand welke gericht is op het voorkomen van pijntoename 
in plaats van cognitieve of gedragsmatige pogingen om de ervaring van de pijn zelf 
te veranderen of pogingen om actief met de consequenties van de pijn in het 
dagelijkse leven om te gaan. 
Het is mogelijk dat bij patiënten met langdurige pijn de specifieke angst voor de 
pijn kan generaliseren naar een bredere cognitie waarbij men denkt, niet in staat te 
zijn om de pijnervaring te controleren of te stoppen. Dit kan uitmonden in cognities 
van hulpeloosheid en een meer passieve, vermijdende wijze van omgaan met de 
pijn en kan daardoor leiden tot meer functionele beperkingen. Het construct van de 
angst voor de pijn kan een meer specifiek effect hebben voor patiënten met pijn 
aan het bewegingsapparaat. Dit heeft wellicht ermee te maken dat bij deze 
patiënten fysieke activiteiten en een verhoogd pijnniveau sterker met elkaar 
verbonden zijn en een mechanisme van operante conditionering induceert van de 
waarneming dat activiteiten leiden tot meer pijn en daarom vermeden dienen te 
worden. Daarnaast kan angst voor pijn relevanter zijn voor de overgang van 
subacute naar chronische pijn daar in dit stadium patiënten meer gericht zijn op het 
zoeken naar manieren om om te kunnen gaan met de pijn. Een recente review van 
de literatuur kon deze hypothese echter niet bevestigen. Mogelijk is het construct 
van hulpeloosheid directer verbonden met de ervaring van patiënten met 
chronische pijn dat het ervaren van pijn zonder een perspectief van herstel of een 
vorm van controle over de pijn kan leiden tot een algemener fysiek, emotioneel en 
sociaal lijden. Angst voor pijn daarentegen zou van meer belang kunnen zijn voor 
een beperkt aantal pijnpatiënten dat blijft vasthouden aan specifieke 
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pijngerelateerde cognities en een mate van controleerbaarheid van de pijn, 
bijvoorbeeld dat een pijnvermindering zou leiden tot minder angst en daardoor tot 
meer activiteiten. Echter, bij veel chronische pijnpatiënten zal een toename van 
activiteiten op korte termijn leiden tot meer pijn. De hogere pijnintensiteit 
induceert angstcognities die in de loop van de pijnepisode kunnen leiden tot meer 
cognities van hulpeloosheid wanneer pogingen om tot meer activiteiten te komen 
uiteindelijk blijken te falen. 
 
Deel 2: Psychologische voorspellers van de effecten van chronische pijn-
behandelingen 
Het doel van de studie, gepresenteerd in hoofdstuk 4, was het onderzoeken van de 
vraag of psychologische variabelen (pijncognities: hulpeloosheid en catastroferen, 
fysiek en psychosociaal dysfunctioneren) voorspellend zijn voor veranderingen in 
pijnintensiteit na behandeling met radiofrequente laesie van cervicale spinale 
dorsale root ganglion (RF-DRG) en de vraag in hoeverre een gerealiseerde pijn-
reductie leidt tot een overeenkomstige verbetering in het dagelijkse functioneren. 
Vierenvijftig patiënten met chronische cervicobrachialgie en een gemiddelde 
pijnduur van zeven jaar werden behandeld en de resultaten na behandeling lieten 
zien dat het niveau van catastroferen vóór behandeling voorspellend was voor 
veranderingen van de pijnintensiteit na RF-DRG. Dat betekent dat hoe meer 
catastroferende cognities patiënten onderhielden, hoe minder de pijn als gevolg van 
de behandeling veranderde. Dit resultaat bevestigt, in overeenstemming met het 
fear-avoidance model, dat pijngerelateerd catastroferen een belangrijke cognitie is 
die de effecten van pijbehandeling negatief beïnvloedt. Voor zover wij kunnen 
nagaan, is dit de eerste studie die aantoont dat catastroferen de uitkomsten van een 
medische pijnbehandeling bij chronische pijnpatiënten negatief beïnvloedt. 
Mogelijk betekent dit dat bij patiënten die catastroferen, overdreven negatieve 
aandacht voor de pijn de pijnervaring versterkt en het daarmee moeilijker maakt 
om (positieve) veranderingen in het pijnniveau na behandeling te kunnen 
waarnemen. Daarnaast ging een succesvolle RF-DRG behandeling, zoals weer-
spiegeld in een lagere VAS-score na behandeling, niet samen met een verbetering 
van het dagelijkse functioneren (het samengaan van fysiek en psychosociaal 
functioneren en depressie). Deze bevinding bevestigt de hypothese dat chronische 
pijn het dagelijkse functioneren negatief beïnvloedt en dat een uitsluitend medische 
behandeling mogelijk het ervaren pijnniveau vermindert maar dat dit niet 
noodzakelijkerwijs betekent dat ook het dagelijkse functioneren mee verandert. 
Flor et al bevestigden deze hypothese in hun uitgebreide review over de uitkomsten 
van monodisciplinaire en multidisciplinaire pijnbehandelingen door aan te tonen 
dat multidisciplinaire behandelingen effectiever waren dan mono-disciplinaire 
behandelingen. Deze en andere bevindingen vormen een aanwijzing dat bij 
chronische pijnpatiënten a) uitsluitend een medische behandeling niet per definitie 
ook invloed heeft op andere aspecten van het dagelijkse functioneren dan het 
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ervaren pijnniveau en b) de hypothese dat het verlagen van het pijnniveau 
automatisch leidt tot verbetering van andere aspecten van het dagelijkse 
functioneren niet ondersteund wordt. Deze hypothese wordt vaak gebruikt als 
rationale voor een monodisciplinaire, medisch gerichte behandelstrategie. Het 
onderstreept nog eens de vraag wat de primaire doelstellingen van chronische 
pijnbehandelingen dienen te zijn. De laatste jaren is herhaaldelijk aangegeven dat 
pijncentra zich met hun behandelstrategieën dienen te richten op zowel pijnreductie 
alsook op het verbeteren van het dagelijkse functioneren. Op grond van de 
gepresenteerde bevindingen ondersteunen we het uitgangspunt dat, wanneer ook 
het verbeteren van het dagelijkse functioneren een centrale doelstelling van 
behandeling is, een multidisciplinaire benadering gewenst is. 
 
In hoofdstuk 5 werden de voorspellende factoren bestudeerd van de effecten van 
transcutane elektrische zenuwstimulatie (TENS) in een prospectieve 
gerandomiseerde placebo gecontroleerde studie. In deze studie werden 163 
chronische pijnpatiënten onderzocht waarbij hoge frequentie TENS vergeleken 
werd met sham TENS en de tevredenheid van patiënten (de bereidheid om de 
behandeling voort te zetten) en pijnreductie werden beschouwd als primaire 
uitkomstmaten. De pijnintensiteit vóór de behandeling en cognitief-gedragsmatige 
coping factoren werden onderzocht als mogelijke voorspellers voor de effecten van 
TENS. In de TENS groep waren 58 procent van de patiënten tevreden met de 
behandelresultaten en voor de sham TENS was dit 42 procent. Er werden geen 
significante verschillen gevonden met betrekking tot pijnreductie. De behandel-
modaliteit (TENS of sham TENS) of interacties met de behandelmodaliteit bleken 
geen voorspellers te zijn voor de pijnintensiteit na behandeling. Terugtrekken bleek 
de enige cognitief-gedragsmatige voorspeller van de tevredenheid van patiënten na 
de behandeling wat inhoudt dat patiënten die geneigd zijn om zich terug te trekken 
in reactie op een verhoging van de pijnintensiteit, meer tevreden waren met de 
resultaten van TENS behandeling. Tot onze verrassing, en in tegenstelling tot de 
bevindingen met betrekking tot patiëntentevredenheid, bleek hulpeloosheid (lage 
ervaren controle) pijnreductie te voorspellen. Dit betekent dat patiënten die ge-
neigd zijn om passief om te gaan met de pijn en meer hulpeloosheid cognities 
hanteren meer lijken te profiteren van deze behandeling. Vanuit het perspectief van 
het fear-avoidance model zou dit ook inhouden dat het toepassen van TENS 
behandeling het toepassen van passieve copingstrategieën stimuleert en daarmee 
voorkomt dat de patiënt op langere termijn een meer actieve copingstijl ontwikkelt. 
Dit roept de vraag op of, in overeenstemming met onze conclusies over mono- 
versus multidisciplinaire behandelingstrategieën welke in het vorige hoofdstuk 
beschreven werden, het combineren van TENS met een cognitief-gedragsmatige 
behandelingsmodule een zinvolle optie is waarbij patiënten met cognities van 
hulpeloosheid of die geneigd zijn om zich terug te trekken bij pijnvermeerdering 
uitgedaagd worden om meer actieve copingstrategieën te ontwikkelen.  
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Hoofdstuk 6 handelde over de korte termijn effecten van een multidisciplinair 
toewijzingsprotocol ten behoeve van verschillende pijnbehandelingsmodules en 
werden de voorspellers van de behandeluitkomsten gepresenteerd. In deze studie 
werden pijnintensiteit, functionele beperkingen, depressie en het gebruik van pijn-
medicatie in een interventiegroep van 110 chronisch pijnpatiënten vergeleken met 
de uitkomsten van een wachtlijst controlegroep van ook 110 patiënten. In over-
eenstemming met het fear-avoidance model en het helplessness model werden 
catastroferen, angst voor pijn, vermijdingsgedrag en hulpeloosheid onderzocht als 
mogelijke voorspellers van de behandeluitkomsten en, gebaseerd op de meest 
recente onderzoeksliteratuur, werd acceptatie van pijn toegevoegd als een 
mogelijke voorspeller. Hoewel beperkt bleken alle uitkomstmaten na behandeling 
significant verminderd te zijn in de interventiegroep. Zowel pijnintensiteit als 
functionele beperkingen waren bovendien significant verminderd in vergelijking 
met de controlegroep. De relatief beperkte resultaten in onze studie zijn in 
overeenstemming met andere studies over multidisciplinaire chronische pijn-
behandelingen hetgeen een illustratie is van een probleem dat inherent is aan de 
complexiteit van chronische pijn en de beperkte mogelijkheden van poliklinische 
pijnbehandelstrategieën. Een aantal eerdere studies hadden al aangetoond dat 
klinische behandelprogramma’s betere behandelresultaten lieten zien dan poli-
klinische behandelingsvormen. Deze studies lijken aan te geven dat de sensorische, 
cognitief-gedragsmatige, emotionele en sociale aspecten van pijn op een dermate 
complexe wijze interacteren dat poliklinische behandelvormen met beperkte 
contactmomenten met behandelaars niet voldoende zijn en op deze wijze niet meer 
dan beperkte behandelresultaten zullen bereiken. Daarmee rijst de vraag op naar de 
kosteneffectiviteit. Poliklinische pijnbehandelvormen met een beperkt aantal 
contactmomenten zijn natuurlijk veel goedkoper dan klinische behandelvormen. 
Maar, wanneer betere behandelresultaten worden verlangd, zouden meer financiële 
bronnen dienen te worden aangewend om deze behandelingen mogelijk te maken. 
Omdat dit echter een meer politiek dan gezondheidszorgtechnisch onderwerp is, 
dient deze discussie op een ander niveau gevoerd te worden hetgeen buiten het 
domein van dit proefschrift valt. Het zou desalniettemin raadzaam kunnen zijn om 
studies naar behandeleffecten in de toekomst te relateren aan kosteneffectiviteit 
daar een dergelijke benadering ertoe kan bijdragen dat er een nauwkeuriger inzicht 
komt in de werkelijke behandel-effectiviteit van chronische pijn. 
Met betrekking tot de voorspellende waarde van de cognitief-gedragsmatige 
factoren bleek dat slechts acceptatie van pijn een grotere pijnreductie voorspelde in 
de interventiegroep (maar niet in de controlegroep). Deze bevinding onderstreept 
daarmee het belang van acceptatie als een krachtige, adaptieve coping strategie bij 
chronische pijn. Er werden geen voorspellers gevonden voor een reductie van de 
functionele beperkingen. Acceptatie wordt beschouwd als een gezondheid-
bevorderende cognitie welke zich richt op het ontwikkelen van een bevredigend 
leven ondanks de ervaren pijn. Acceptatie cognities lijken te wijzen op een 
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gerichtheid van patiënten op het ontwikkelen van adaptieve coping-strategieën, 
welke een positief effect hebben op behandeluitkomsten en daarmee eerdere 
studies bevestigen die verbanden traceerden tussen acceptatie en minder aandacht 
voor de pijn en een actief coping gedrag. Daarnaast zouden patiënten die meer 
accepterende cognities hanteren, meer in staat zijn om kleine ver-anderingen in het 
pijnniveau te traceren en zijn zij meer geneigd om deze veranderingen positiever te 
evalueren dan patiënten met minder accepterende cognities. Op deze wijze kan 
acceptatie vooral invloed hebben op de affectieve en evaluatieve dimensie van de 
pijnwaarneming. De bevindingen zoals hiervoor beschreven kunnen daarmee het 
begrip vergroten van de verklarende mechanismen van pijnvermindering als 
gevolg van multidisciplinaire chronische pijnbe-handelingen daar het de eerste 
keer is dat acceptatie beschreven werd als een positieve voorspeller van de 
behandeluitkomsten van chronische pijn. De studies bevestigen acceptatie ook als 
contrasterend een met angstige en vermijdende wijze van coping. Daarmee zou 
acceptatie binnen het fear-avoidance model gedefinieerd kunnen worden als een 
voorwaarde voor een meer confronterende wijze van pijncoping. De verschillende 
bevindingen over de rol van acceptatie lijken erop te duiden dat pijnpatiënten die 
een meer accepterende wijze van pijncoping hebben ontwikkeld meer baat kunnen 
hebben bij behandelingen waarbij het persoonlijke contact beperkt is, zoals het 
geval is bij poliklinische behandelvormen, dan patiënten die een meer vermijdende 
copingstijl hebben ontwikkeld of een meer depressieve grondstemming hebben. 
Deze laatste groep zou meer kunnen profiteren van een meer intensieve 
behandeling welke klinisch gegeven wordt. 
In de studie, beschreven in hoofdstuk 7, keken we naar de lange termijn effecten 
van een multidisciplinair toewijzingsprotocol van verschillende pijnbehandelings-
modules. Ook in deze studie werden pijnintensiteit, functionele beperkingen, 
depressie en het gebruik van pijnmedicatie onderzocht als primaire uitkomstmaten. 
Daarnaast werd gekeken in hoeverre de korte termijn (3 maanden) veranderingen 
in de cognitief-gedragsmatige voorspellers (catastroferen, vermijdingsgedrag, angst 
voor pijn, hulpeloosheid en acceptatie) geassocieerd waren met de lange termijn 
effecten. Functionele beperkingen en depressie verbeterden beide significant als 
gevolg van de behandeling, hetgeen overeenkomt met de effecten die door Flor 
et.al8 werden gepresenteerd. De vermindering van het niveau van catastroferen, 
angst voor pijn, hulpeloosheid en vermijdingsgedrag na 3 maanden waren 
geassocieerd met de vermindering van functionele beperkingen en depressie na 12 
maanden.  
Hoewel functionele beperkingen en depressie significant verbeterden waren de 
resultaten ook in deze studie beperkt. De korte termijn reductie van de 
pijnintensiteit bleek op lange termijn niet stabiel. Deze bevinding kan erop duiden 
dat een hoger niveau van accepteren vóór behandeling niet voldoende is om korte 
termijn effecten vast te houden. Zoals in de vorige studie werd gevonden is 
acceptatie een belangrijke positieve copingfactor. Het toevoegen van een 
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behandelmodule, gericht op het verhogen van het niveau van acceptatie zou 
wellicht de lange termijn effectiviteit kunnen vergroten. Dit is ook in 
overeenstemming met een recente studie van McCracken et al over de resultaten 
van een behandeling, gericht op het vergroten van niveau van acceptatie. Ook in 
deze studie waren de resultaten echter niet meer dan gemiddeld, wat ook weer lijkt 
te wijzen op de grote complexiteit van chronische pijn waarbij het copinggedrag 
steeds meer geïntegreerd is in het dagelijkse functioneren en het daarom ook veel 
moeilijker is om dit gedrag te veranderen1. 
 
Deel 3: Evaluatie van verwijzers en implementatie 
In hoofdstuk 8 werden de resultaten beschreven van een onderzoek dat gehouden 
werd onder huisartsen van 83 chronisch pijnpatiënten die werden behandeld in het 
multidisciplinaire pijncentrum UMC St Radboud Nijmegen. Daar het vooral de 
huisartsen zijn die beslissen over het al of niet verwijzen van hun patiënten ten 
behoeve van behandeling van hun pijnklachten, is het uiteraard belangrijk dat het 
pijncentrum op de hoogte is en blijft van de wijze waarop de huisartsen de zorg 
van een multidisciplinair pijncentrum evalueren. Deze evaluatie kan invloed 
hebben op mogelijke toekomstige verwijzingen. Het pijncentrum UMC St 
Radboud had echter geen actuele informatie over de wijze waarop de huisartsen de 
zorg voor hun patiënten waardeerden. In het onderzoek werd de huisartsen 
gevraagd naar hun verwachting over de zorg voor hun patiënt, naar verschillende 
aspecten van de gegeven zorg en een algemene conclusie. 
De huisartsen bleken de zorg voor hun patiënten positief te waarderen. Zij hadden 
echter zeer uiteenlopende verwachtingen over de verwijzing. Deze hadden niet 
alleen met betrekking het stellen van een medische diagnose of behandeling, maar 
ook op paramedische en psychologische zorg. Het voldoen aan die verwachting 
bleek in het onderzoek het belangrijkste criterium voor hun uiteindelijke evaluatie 
van de zorg. De huisartsen waardeerden de informatie voorafgaand aan de 
behandeling het meest negatief, vooral als het ging om informatie over de 
wachttijden en de mogelijkheid om contact te maken met de pijnspecialist. De 
resultaten van het onderzoek benadrukken het belang voor pijncentra om pro-actief 
te communiceren met de huisartsen om op deze wijze tegemoet te kunnen komen 
aan hun verwachtingen en om achteraf de evaluaties van de huisartsen te 
registreren.  
In hoofdstuk 9 werd het proces beschreven van de implementatie van de kennis 
over de psychologische factoren bij chronische pijn en een daaruit voortvloeiende 
kortdurende psychologische behandeling, toegespitst op uitvoering binnen de 
eerstelijnszorg. Allereerst werd een symposium georganiseerd over cognitief-
gedragsmatige behandeling van chronische pijn en werd informatie ingewonnen bij 
eerstelijnspsychologen over hun kennis en behoeften aan bijscholing. Daarna 
kregen 39 eerstelijnspsychologen binnen het verzorgingsgebied van het UMC St 
Radboud een training over het uitvoeren van diagnostische technieken en het geven 
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van een kortdurende cognitief-gedragsmatige behandeling aan chronische 
pijnpatiënten. Ook werd, vanuit een samenwerkingsmodel beschreven in het boek 
“De psycholoog als pijnbehandelaar” (2002), veel aandacht besteed aan de com-
municatie met fysiotherapeuten en huisartsen over behandelingsaspecten. De 
psychologen die de training hadden afgerond, werden opgenomen in een regionaal 
netwerk van eerstelijnspsychologen en woonden elk half jaar een inter- en 
supervisiebijeenkomst bij. Het korte termijn doel van het project was het 
overbrengen van de actuele wetenschappelijke en klinische kennis over de 
mogelijkheden van een psychologische behandeling naar het werkveld van 
eerstelijnspsychologen en het vergroten van de bestaande mogelijkheden voor 
tweede- en eerstelijns professionals (medisch specialisten, huisartsen en 
fysiotherapeuten) om chronische pijnpatiënten te verwijzen naar gespecialiseerde 
psychologen. Onze lange termijn doelstelling echter was ook om vooral huisartsen 
te stimuleren om pijnpatiënten eerder, in het subacute stadium van het 
pijnprobleem, te verwijzen naar een eerstelijnspsycholoog daar juist in deze 
periode het omgaan met de pijn minder geïntegreerd is binnen het dagelijkse 
functioneren en daardoor meer veranderbaar lijkt. Een onderzoek uit 2005 liet zien 
dat bij de eerstelijnspsychologen die op dat moment actief waren binnen het 
netwerk, het aantal verwijzingen door huisartsen hoger was dan het aantal 
verwijzingen vanuit het pijncentrum. In 2007 bestond het netwerk uit 29 
eerstelijnspsychologen. Deze resultaten zijn veelbelovend en het is de bedoeling 
dat het project wordt uitgebreid naar andere regio’s van Nederland zodat in de 
naaste toekomst steeds meer gespecialiseerde eerstelijnspsychologen betrokken 
zullen zijn bij de diagnostiek en behandeling van subacute en chronische 
pijnpatiënten. Patiënten met subacute pijn zullen dan verwezen kunnen worden als 
deel van een multidisciplinaire diagnostische procedure en zullen alleen dan 
verwezen worden naar een gespecialiseerd multidisciplinair pijncentrum wanneer 
de behandeling binnen de eerstelijnszorg niet effectief bleek. Op deze wijze wordt 
de expertise van zowel de eerstelijns- als tweedelijns professionals optimaal en 
kosteneffectief benut ten behoeve van de zorg voor pijnpatiënten 
 
 
Uitbreiding van het Fear-avoidance model 
De studies die in dit proefschrift werden beschreven ondersteunden het belang van 
de constructen catastroferen, angst voor pijn en vermijdingsgedrag binnen het fear-
avoidance model. Zowel binnen de beloopstudies als de effectstudies bleken fear-
avoidance cognities en gedrag een voorspellende waarde te hebben voor de 
uitkomsten. De studies in het eerste deel van dit proefschrift lieten echter ook zien 
dat, wanneer naast fear-avoidance factoren ook hulpeloosheid werd geïntroduceerd 
binnen een correlationeel en longitudinaal predictiemodel, hulpeloosheid een 
grotere voorspellende waarde had voor de uitkomsten dan fear-avoidance 
cognities. Deze bevindingen zijn in overeenstemming met eerdere studies over de 
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rol van hulpeloosheid bij chronische pijn. Onze resultaten suggereren dat bij 
patiënten met chronische pijn, hulpeloosheid een belangrijke factor kan zijn bij het 
verklaren van negatieve aspecten van het functioneren zoals pijnintensiteit, 
functionele beperkingen en depressie in de tijd. Ook zijn er aanwijzingen dat angst 
voor pijn en hulpeloosheid een complementaire rol kunnen hebben bij de 
mechanismen van pijn en functioneren in de tijd. Binnen het fear-avoidance model 
zou angst voor pijn de meest belangrijke cognitie kunnen zijn voor een beperkt 
aantal patiënten met pijn in het bewegingsapparaat terwijl hulpeloosheid een veel 
nadrukkelijker rol kan hebben bij vergeefse pogingen van patiënten om de pijn te 
beïnvloeden bij patiënten met andere pijnlocaties dan die van het 
bewegingsapparaat. Deze hypothese houdt in, dat toekomstige studies rond het 
eerste fear-avoidance model3 zich dienen te richten op de korte en lange termijn 
consequenties van chronische pijn en patiënten dienen te includeren met 
verschillende pijnlocaties.  
Naast hulpeloosheid als een belangrijke bijkomende factor binnen het fear-
avoidance model, werd in hoofdstuk 6 de rol van acceptatie van chronische pijn 
beschreven. Deze positieve copingstrategie helpt patiënten te erkennen dat zij 
chronisch pijn hebben, en door zich dit te realiseren kunnen zij zich richten op 
pogingen om ondanks de pijn een voor hen waardevol leven te leiden, vooral 
wanneer de pijn oncontroleerbaar blijkt. Hoewel de exacte betekenis van het 
construct van acceptatie nog onderwerp is van discussie, ondersteunen onze 
resultaten de bevindingen van een uitdijend aantal correlationele studies, 
longitudinale studies en effectstudies die acceptatie als een veelbelovende 
positieve, gezondheidbevorderende copingfactor definiëren. Deze studies 
suggereren dat patiënten met langdurige pijn, wanneer de pijn chronisch is 
geworden en niet gecontroleerd kan worden door eerder toegepaste 
copingstrategieën, zich op een kruispunt bevinden van potentiële cognitieve 
copingstrategieën. Aan de ene kant kunnen patiënten negatieve cognities 
ontwikkelen zoals catastroferen en hulpeloosheid met daaraan gekoppelde passieve 
gedragsmatige coping patronen. Aan de andere kant echter kunnen patiënten een 
meer acceptatie georiënteerde manier van omgaan met de pijn ontwikkelen wat een 
meer actief copinggedrag faciliteert hetgeen op langere termijn kan leiden tot een 
beter dagelijks functioneren. Samenvattend, gebaseerd op de recente literatuur en 
onze onderzoeksbevindingen, kunnen we concluderen dat het fear-avoidance 
model uitgebreid kan worden door hulpeloosheid en acceptatie toe te voegen (zie 
figuur 1). 
  
 
 
Chapter 11 174 
Figuur 1: Voorstel voor uitbreiding van het Fear-Avoidance Model (Vlaeyen et al, 1995) 
 
 
Klinische implicaties 
De studies die in dit proefschrift werden beschreven, bevestigden alle de eerdere 
bevindingen nl. dat cognitief-gedragsmatige factoren belangrijke mediatoren zijn 
in het ontwikkelen en onderhouden van chronische pijn. Zowel cognitieve als 
gedragsmatige copingstrategieën bleken een aanzienlijke invloed te hebben op de 
door de patiënten ervaren pijn en dagelijkse functioneren in de tijd. De 
effectstudies in dit proefschrift wezen ook op het belang van deze psychologische 
factoren door aan te tonen dat zowel cognitieve als gedragsmatige coping-
strategieën voorspellers waren van de uitkomsten van een toewijzingsprotocol van 
medische, paramedische, psychologische en multidisciplinaire behandeling. De 
beschreven effecten onderstrepen daarmee de noodzaak van een multidisciplinaire 
benadering bij de behandeling van chronische pijn. Daarbij zou een psychologisch 
screeningsonderzoek deel moeten uitmaken van een gestandaardiseerde 
diagnostische procedure bij elke patiënt met chronische pijn die verwezen wordt 
naar een gespecialiseerd pijncentrum. Afhankelijk van de resultaten van dit 
onderzoek, zou de patiënt een toegespitste cognitief-gedragsmatige behandeling 
aangeboden dienen te krijgen naast of voorafgaan aan een mogelijk geïndiceerde 
medische of paramedische behandeling. Dit houdt in dat pijncentra zich dienen te 
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conformeren aan een biopsychosociaal model van pijn en een multidisciplinair 
diagnose en behandelingsbeleid te formuleren. Monodisciplinariteit is in strijd met 
het biopsychosociaal model van pijn daar het uitgaat van de veronderstelling dat 
pijnreductie als gevolg van een medische of paramedische behandeling per 
definitie zou leiden tot een verbetering van het dagelijkse functioneren. Onze 
studie over de effecten van RF-DRG (beschreven in hoofdstuk 4) en eerdere 
publicaties hebben laten zien dat een pijnreductie als gevolg van een effectieve 
monodisciplinaire, medische of paramedische interventie, niet automatisch leidt tot 
een verbetering van het functioneren van een patiënt. De effectstudies in dit 
proefschrift lieten zien dat zelfs met een multidisciplinair toewijzingsprotocol voor 
pijnbehandeling slechts beperkte resultaten werden bereikt. Dit betekent dat, 
wanneer behandeling gericht is op zowel pijnreductie als het verbeteren van het 
dagelijkse functioneren, deze behandeling intensief dient te zijn en meer gericht 
dient te zijn op deze doelstellingen door deze te koppelen aan specifieke 
patiëntkenmerken.  
De studies welke in dit proefschrift werden gepresenteerd laten zien dat bij 
chronische pijn hulpeloosheid en acceptatie invloed hebben op de pijnintensiteit en 
het dagelijkse functioneren naast angst voor pijn. Op basis hiervan zou het 
diagnostisch onderzoek vóór behandeling kwalitatief verbeterd kunnen worden 
door de cognities van de patiënt (angst voor pijn, catastroferen, hulpeloosheid en 
acceptatie) en het pijngedrag (pijnvermijding of accepterend gedragspatroon) 
nauwkeurig in kaart te brengen. Wanneer deze factoren zijn onderzocht, kan de 
pijnbehandeling zelf verbeterd worden door die copingmechanismen te veranderen 
die voor de individuele patiënt belangrijk blijken te zijn. 
Met betrekking tot de pijnbehandelstrategieën laten onze studies zien dat 
chronische pijnbehandeling aan kwaliteit zou kunnen winnen door modules te 
integreren die gebaseerd zijn op het veranderen van pijncognities (angst voor pijn, 
catastroferen, hulpeloosheid en acceptatie) en/of het veranderen van specifiek 
pijngedrag (vermijdende of accepterende gedragspatronen). 
Voor patiënten die hulpeloosheid cognities hanteren zou de behandeling een 
trainingsmodule moeten includeren, gericht op het induceren van cognities van 
interne controle en meer positieve verwachtingen in overeenstemming met de 
principes van de cognitieve therapie van Beck en een gedragsmodule, gebaseerd op 
de principes van graded activity. Wanneer angst voor pijn cognities meer op de 
voorgrond staan, zou de behandeling een module dienen te bevatten met exposure 
in vivo. In het geval van de aanwezigheid van catastroferende cognities zou een 
cognitieve module kunnen worden geïncludeerd, gericht op het vervangen van 
negatieve cognities die het pijnprobleem versterken door accepterende cognities 
die meer uitgaan van het erkennen van het pijnprobleem in plaats van het blijven 
vechten tegen de voortdurende pijnklachten. Daarnaast zou een gedragsmodule 
zinvol kunnen zijn die het vermogen van de patiënt versterkt om de pijn te negeren 
en de aandachtsfocus te verleggen naar concurrerende stimuli in plaats van de 
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pijnstimulus. In aansluiting daarop zou de acceptance and commitment therapy 
(ACT) toegepast kunnen worden. Deze therapievorm stimuleert de patiënt om met 
de aandacht bij de pijnsensatie te blijven, echter zonder de gebruikelijke daaraan 
gekoppelde negatieve gedachten. McCracken et al definieerde de pijnwaarneming 
in dit verband als een neutraal, actief bewustzijn van de pijnsensatie zonder een 
vorm van cognitieve of gedragsmatige vermijding. Wanneer er sprake is van 
vermijdingsgedrag, zou een operante behandelings-module aangeboden kunnen 
worden dat de patiënt helpt om een meer actief en pijngericht gedragspatroon te 
ontwikkelen. Tot slot zou aan patiënten die zeer laag scoren op het hanteren van 
accepterende cognities een acceptatie gerichte interventie aangeboden kunnen 
worden die tot doel heeft om te stoppen met het bevechten of ontkennen van de 
pijn en consequenties en ertoe kan bijdragen dat de pijn wordt geïntegreerd in het 
dagelijkse leven, waardoor op de langere termijn het dagelijkse functioneren 
kwalitatief kan verbeteren. 
 
De beperkte effecten van de multidisciplinaire behandeling welke naar voren 
kwamen in de studies in het tweede deel van dit proefschrift wijzen op een 
specifiek probleem waarmee pijncentra in Nederland mee te maken hebben. In 
overeenstemming met het biopsychosociaal pijnmodel en de wijd geaccepteerde 
definitie van pijn volgens de IASP (International Association for the Study of Pain) 
dient pijn beschouwd te worden als een totaal van pijnlijden. Dit houdt in dat de 
behandeling van chronische pijn zowel het verminderen van de pijnintensiteit 
inhoudt als de daarmee gepaard gaande symptomen en gevolgen van de pijn (zoals 
functionele beperkingen en depressie). Pijnbehandeling dient daarom altijd te 
streven naar functioneel herstel en het verbeteren van de grondstemming. Dit houdt 
dus ook in dat, wanneer pijnreductie niet haalbaar blijkt, het verbeteren van het 
dagelijkse functioneren een legitieme doelstelling blijft. Samenvattend betekent dit 
dat pijncentra, in overeenstemming met onze bevindingen, zich niet uitsluitend 
dienen te richten op het verminderen van de pijnintensiteit door het uitvoeren van 
(para-) medische behandelingen maar zich meer dienen te richten op het 
ontwikkelen van cognitieve gedragsmatige interventies. Dit komt echter niet 
overeen met de verwachtingen van patiënten die verwezen worden naar 
gespecialiseerde pijncentra. McCracken et al toonden aan dat de patiënten-
tevredenheid vooral samenhangt met de mate van ervaren pijnreductie.  
Zoals in hoofdstuk 8 werd aangetoond, waren de grond en de verwachtingen van 
huisartsen die patiënten naar het pijncentrum verwezen meer geassocieerd met het 
verlangen om de eindeloze en vaak vergeefse zoektocht van hun patiënt naar 
pijnreductie en de daarmee gepaard gaande medische consumptie te stoppen. Dit 
roept des te meer de vraag op naar de status van de pijncentra en de manier waarop 
zij zichzelf definiëren in het spectrum van instellingen die pijn behandelen vanaf 
acute pijn tot chronische, medisch onbehandelbare pijn. Tot op heden definiëren zij 
zichzelf als instellingen die ernaar streven om pijn te verzachten en om daaraan 
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gekoppelde symptomen van pijnlijden alsook het beëindigen van de vicieuze cirkel 
van het eindeloos zoeken naar het beëindigen van het pijnprobleem. Tot dusverre 
zijn in Nederland de definities van behandeldoelstellingen, de inhoud van 
behandelmodules en de profielen van de pijncentra niet consistent, wat veel ruis 
veroorzaakt in de perceptie van zowel de verwijzende huisartsen als de betrokken 
patiënten. Er is behoefte aan een systeem van duidelijke en transparante chronische 
pijnbehandeling en het is daarom belangrijk dat de pijncentra zowel aan de 
verwijzende huisartsen als aan de patiënten een eenduidig inzicht geven in hun 
doelstellingen, die kunnen variëren van pijnvermindering tot het aanleren van 
betere pijncoping strategieën. Deze houding van openheid en transparantie zal 
onrealistische verwachtingen bij alle betrokken partijen kunnen voorkomen. 
 
 
Conclusies en aanbevelingen 
In overeenstemming met de samenvatting en discussie, kunnen de belangrijkste 
conclusies als volgt worden geformuleerd: 
 
- Cognitief-gedragsmatige factoren hebben invloed op pijnintensiteit, functionele 
beperkingen en depressie. 
- Cognitief-gedragsmatige factoren hebben invloed op de effecten van medische, 
paramedische en multidisciplinaire chronische pijnbehandelingsstrategieën. 
- Hulpeloosheid en acceptatie spelen een rol in het voorspellen van 
pijnuitkomsten en in het voorspellen van behandeleffecten naast de fear-
avoidance factoren (catastroferen, angst voor pijn en vermijdingsgedrag). 
- De waardering van verwijzers is vooral gebaseerd op de mate waarin tegemoet 
wordt gekomen aan de eigen verwachtingen van de verwijzing.  
 
In overeenstemming met de hierboven geformuleerde conclusies, kunnen de 
volgende aanbevelingen worden geformuleerd: 
 
- Bij chronische pijn kan het concept van het fear-avoidance model worden 
uitgebreid door de cognities hulpeloosheid en acceptatie in het model te 
integreren. 
- Bij het diagnostisch onderzoek, voorafgaand aan de pijnbehandeling, is het 
zinvol om pijncognities (angst voor pijn, catastroferen, hulpeloosheid en 
acceptatie) en vermijdingsgedrag te onderzoeken. 
- Behandeling van chronische pijn kan kwalitatief verbeteren door het integreren 
van behandelmodules, gericht op het veranderen van hulpeloosheid en 
acceptatie. 
- Een instelling voor het behandelen van chronische pijn dient transparant en pro-
actief te communiceren om meer tegemoet te kunnen komen aan de 
verwachtingen van de verwijzers. 
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Het lijkt zo logisch, dat er één het hele proefschrift vertegenwoordigt. Maar achter 
deze ene schuilen zovele die de stenen hebben verzameld waarmee het huis is 
gebouwd. Ik bedank dan ook nadrukkelijk de mensen, die ik hierna met name in de 
schijnwerpers van mijn grote waardering wil plaatsen. 
 
Als eerste wil ik noemen Andrea Evers. Jij hebt door je onaantastbare eerlijkheid 
en kritische zin mij door vele donk’re dalen laten dwalen maar telkens gaf je tijdig 
weer de richting aan. Zo heb je me heel veel geleerd over de essentie van 
onderzoek doen (“je schrijft teveel als clinicus”). Jij hebt me voor zover mogelijk 
de draai leren maken van het klinisch kijken naar de empirie tot het zuiverder 
kijken naar wat ik over de werkelijkheid wel en vooral ook niet zeggen kon. Ik 
moest van zeer ruimhartig formuleren naar zeer nauwgezet en dat viel van de 
weeromstuit niet mee. Ik heb lange tijd gedacht dat je het op wou geven (dan 
hoefde ik het in elk geval niet te doen) maar tot mijn verbazing hield jij het 
vertrouwen. Jij ontwaarde blijkbaar iets dat ik lange tijd niet bevroedde. 
 
Ik wil natuurlijk mijn promotoren noemen: Floor Kraaimaat, die mij in het nalezen 
van de laatste concepten, terwijl ik elke keer weer dacht dat het goed zou zijn, nog 
zovele thema’s noemde die een artikel zouden aanscherpen in zijn kenmerkende 
formuleringen (“er moet nog héél wat gebeuren” en “ je schrijft teveel als 
clinicus”) en elke keer weer was ik verwonderd, zowel over zijn scherpe wijze van 
theoretisch denken als over mijn klaarblijkelijk gebrek eraan. Floor, jij hebt mij 
heel veel geleerd over het kritisch kijken naar wat beweerd wordt en wat 
volharding in de meest brede zin inhoudt.  
En Ben Crul die aan de wieg heeft gestaan van mijn leerweg in de pijn. Die mij 
zoveel jaren met zijn visionaire bespiegelingen stimuleerde om verbanden te 
ontwaren buiten het direct waarneembare, om verder te kijken in de jaren en om 
stelling te durven nemen op de brug tussen de verschillende disciplines die zich 
buigen over de pijn. Ben, ik heb heel veel aan je te danken, heel veel geleerd, zeker 
ook van de wijze waarop je bezield bleef in het zoeken naar wegen om pijn en het 
lijden op de maatschappelijke kaart te zetten en vooral ook te houden. 
 
Er zijn veel mensen die mij in de praktische uitwerking van mijn studies hebben 
bijgestaan. Ik wil er een aantal noemen, vergeef mij als ik een enkele verzuim te 
noemen, het is slechts te wijten aan mijn allengs haperend geheugen. 
De secretaresses die mij hielpen bij het verzamelen van alle data: Annemarie, 
Anne, Anita, Anneke, Lonneke, de secretaresses die mij vooral mentaal gesteund 
hebben met een opbeurend woord, veelal in welkome ironie gegoten: Dedi, Helma, 
Inger, Jacintha, Jeske, Nancy, Willy. Hanneke, die zorgde voor het zeer accuraat en 
meepeinzend vertalen van mijn engels naar Engels. Marianne, die tijdens de vele 
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pauzewandelingen meer commentaar gaf op de talloze concepten dan in mijn 
donkerste fantasie mogelijk zou zijn. Een speciaal woord voor Ria te Winkel, jij 
verbaasde me elke keer weer over de tijd die je nam om mijn vragen te 
beantwoorden, om mee te denken. Ook bij jou vreesde ik het moment dat je zou 
zeggen: ”en nu is het genoeg, er moet nog veel teveel gebeuren”, maar het bleef tot 
mijn stille opluchting almaar uit. En dan je zoon Koen, die als een digitale cowboy 
onverschrokken en met onthutsende volharding de overvloedige data feilloos de 
computer indreef. 
 
De mensen van het pijnteam, met name de knoesten van het eerste uur: Robert van 
Dongen, Dik Snijdelaar, Monique Steegers, Jan Oosterhof, Quirine Anderegg, Piet 
de Ruyter, Monique Hendrikx, Paul Vogelaar, aan hen heb ik heel veel te danken, 
het vertrouwen, de vriendschap, het zeer, zéér kritische commentaar op mijn 
allereerste onderzoeksvoorstel. Dit voorstel, vol naïef vertrouwen door mij 
gepresenteerd, werd tot de grond toe afgebrand waardoor ik al vroeg mij kon 
wennen aan de gedachte dat er “er nog héél veel moet gebeuren”. Daar heb ik later 
in menig opzicht veel profijt van gehad want uit dié as verrees mijn koppigheid. 
Met name ook mijn directe collega Elke Pothof, die door haar nauwgezet werken 
mijn mentale chaos telkenmale tijdig temperde. 
 
Het Pijnkenniscentrum heeft het mij mogelijk gemaakt, om via het geven van 
scholingen in contact te komen met andere disciplines die zich bezighouden met 
pijn: anesthesiologen, huis-,  bedrijfs- en verzekeringsartsen, fysiotherapeuten, 
verpleegkundigen. Dit heeft mij veel inzicht gegeven in het verschillend 
perspectief van deze disciplines ten opzichte van pijn- en pijnbehandeling en de 
wijze waarop het werk van de psycholoog daarin waargenomen werd. Dit heeft 
mijn liefde voor juist het onderzoek naar multidisciplinaire aspecten van pijn en 
pijnbehandeling flink aangewakkerd. In die zin is het voltooien van het proefschrift 
voor mij ook een kroon op het werk bij, en zeker ook van, het helaas mogelijk 
binnenkort voorbije Pijnkenniscentrum. 
 
De Heeren van de Grut, Jeroen, Peter en Pieter, het culinair genootschap van 
opleidingsveteranen dat mij periodiek onbevangen en uitermate kritisch bevroeg 
over de wetenschappelijke vorderingen in het dreigende besef dat een finaal 
stagneren van het project zou leiden tot een collectieve narcistische krenking en 
een verzuurd maal. 
 
Echter, los van allen, niets kan in de schaduw staan van mijn prachtige gezin dat de 
omhulling vormt van mijn schuchtere pogingen om te ontdekken wat “waardevrije 
wetenschap” te betekenen zou hebben. 
Elisa, jij hebt me in deze periode kritisch gevolgd, achtervolgd en vervolgd, vroeg 
me vele malen waarom ik wilde promoveren en waarom ik het in vredesnaam, in 
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het licht van de vele strubbelingen en vertwijfelingen, nog steeds wilde; jij dwong 
mij zo om mijzelf te blijven afvragen wat ik eigenlijk wilde laten zien of wilde 
zeggen, en die verdieping heeft me meer gebracht dan ik zeggen kan.  
Maar, bovenal, je bleef van mij houden, ondanks de frequente momenten dat ik 
met mijn gedachten aan het schrijven was in plaats van aan het afwassen. Liefde in 
het alledaagse is omvattender dan ik schrijven kan. 
En toch, in de grond is er maar één aan wie ik, vanzelfsprekend, mijn proefschrift 
opdraag omdat hij woont in alle stille plekjes van mijn ziel, en die voor mij zoveel 
belangrijker is dan het werk dat ik doe,  
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lagere school deed hij een uitermate vergeefse poging op de HBS en verhuisde na 
een angstig jaar opgelucht naar de MULO die hij vervolgens in 3 jaar afrondde. In 
de twee jaar die daarop volgden, voltooide hij de HAVO. Als zoon van een kleine 
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en ging als leerling Z-verpleegkundige werken in het Westerhonk, een instelling 
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Na een jaar ging hij als leerling B-verpleegkundige werken bij de stichting 
Bloemendaal, een instelling voor psychiatrische patiënten waar hij in 1983 zijn 
diploma behaalde. Direct daarna startte hij zijn studie Psychologie, tot 1986 in 
Leiden, omdat hij “dieper met mensen wilde werken”. Na de verpletterende 
ontmoeting met Elisa, zijn latere vrouw, op een zwalkend schip in zwaar tij 
verbrandde hij terstond alle (andere) schepen achter zich en volgde haar met 
verlicht gemoed naar Nijmegen waar hij manmoedig de plots opdoemende 
Bourgondische verleidingen weerstond en in voortvarend tempo in 1989 zijn 
diploma Psychologie, klinische richting behaalde. Hij ging met zijn diploma, de 
eerste jaren nog onder vergeefs protest onbezoldigd, werken bij het pijncentrum 
van het UMC St Radboud dat in die periode langzaam gestalte kreeg. Hij heeft 
mede de psychologische diagnostiek en behandeling vormgegeven en zich ingezet 
voor een actieve samenwerking tussen de verschillende disciplines. Dit heeft in 
2002 geleid tot de publicatie van het boek:”De psycholoog als pijnbehandelaar”. 
Van 1993 tot 1998 volgde hij de specialisatie tot klinisch psycholoog- 
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psychotherapeut. Daarna, op zoek naar alweer een uitdaging, nam hij het initiatief 
tot een onderzoek naar de effecten van de behandeling door het pijncentrum, iets 
wat tot dan nog niet uitgevoerd was. Dit onderzoek leidde, gedrenkt in het zweet 
van de zoektocht naar de onderzoeker in de clinicus, tot dit proefschrift.  
Naast zijn werk in het UMC St Radboud is hij vanaf 1990 tot heden ook werkzaam 
in het Canisius Wilhelmina Ziekenhuis bij de afdeling Klinische Psychologie waar 
hij vooral actief is op de afdelingen Longziekten en cardiologie. 
Han Samwel is sinds 1990 gehuwd met Elisa Bol en zij hebben een zoon, Singha, 
die in 1994 werd geboren. 
 
 
 
 
 
